US20080199894A1 - Device and method for automatic data acquisition and/or detection - Google Patents

Device and method for automatic data acquisition and/or detection Download PDF

Info

Publication number
US20080199894A1
US20080199894A1 US12/031,660 US3166008A US2008199894A1 US 20080199894 A1 US20080199894 A1 US 20080199894A1 US 3166008 A US3166008 A US 3166008A US 2008199894 A1 US2008199894 A1 US 2008199894A1
Authority
US
United States
Prior art keywords
test strip
resistance value
fluid delivery
information
delivery device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/031,660
Inventor
John R. Galasso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Priority to US12/031,660 priority Critical patent/US20080199894A1/en
Priority to EP08730051A priority patent/EP2124720A4/en
Priority to PCT/US2008/054171 priority patent/WO2008101217A2/en
Priority to CA002677739A priority patent/CA2677739A1/en
Priority to BRPI0807500-0A2A priority patent/BRPI0807500A2/en
Priority to RU2009134335/14A priority patent/RU2009134335A/en
Assigned to ABBOTT DIABETES CARE, INC. reassignment ABBOTT DIABETES CARE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GALASSO, JOHN R.
Publication of US20080199894A1 publication Critical patent/US20080199894A1/en
Priority to US14/829,611 priority patent/US10022499B2/en
Priority to US16/020,966 priority patent/US10617823B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/4875Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
    • G01N33/48771Coding of information, e.g. calibration data, lot number
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0295Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/08Sensors provided with means for identification, e.g. barcodes or memory chips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/7405Details of notification to user or communication with user or patient ; user input means using sound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/7455Details of notification to user or communication with user or patient ; user input means characterised by tactile indication, e.g. vibration or electrical stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/7475User input or interface means, e.g. keyboard, pointing device, joystick
    • A61B5/749Voice-controlled interfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3576Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/005Parameter used as control input for the apparatus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/20Blood composition characteristics
    • A61M2230/201Glucose concentration
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis

Definitions

  • a hand-held electronic meter such as blood glucose meters such as Freestyle® blood glucose monitoring system available from Abbott Diabetes Care, Inc., of Alameda, Calif. which receives blood samples via enzyme-based test strips.
  • blood glucose meters such as Freestyle® blood glucose monitoring system available from Abbott Diabetes Care, Inc., of Alameda, Calif. which receives blood samples via enzyme-based test strips.
  • the patient lances a finger or alternate body site to obtain a blood sample, applies the drawn blood sample to the test strip, and the strip is inserted into a test strip opening or port in the meter housing.
  • the blood glucose meter converts a current generated by the enzymatic reaction in the test strip to a corresponding blood glucose value which is displayed or otherwise provided to the patient to show the level of glucose at the time of testing.
  • Such periodic discrete glucose testing helps diabetic patients to take any necessary corrective actions to better manage diabetic conditions.
  • Presently available glucose meters have limited functionalities (for example, providing the glucose value measured using the test strip and storing the data for subsequent recall or display) and do not provide any additional information or capability to assist patients in managing diabetes.
  • Type-1 diabetic patients who require periodic infusion or injection of insulin typically use glucose meters in addition to, for example, wearing an external infusion device, or a pen type injection device.
  • external infusion devices because of the strip port on the meter receives the test strip (which is generally not a water tight seal), it is not desirable to incorporate the discrete glucose meter functionalities to the housing of the external infusion devices.
  • presently available external infusion devices typically include an input mechanism such as buttons through which the patient may program and control the infusion device.
  • Such infusion devices also typically include a user interface such as a display which is configured to display information relevant to the patient's infusion progress, status of the various components of the infusion device, as well as other programmable information such as patient specific basal profiles.
  • the external infusion devices are typically connected to an infusion set which includes a cannula that is placed transcutaneously through the skin of the patient to infuse a select dosage of insulin based on the infusion device's programmed basal rates or any other infusion rates as prescribed by the patient's doctor.
  • the patient is able to control the pump to administer additional doses of insulin during the course of wearing and operating the infusion device such as for, administering a carbohydrate bolus prior to a meal.
  • Certain infusion devices include food database that has associated therewith, an amount of carbohydrate, so that the patient may better estimate the level of insulin dosage needed for, for example, calculating a bolus amount.
  • Programming and controlling the pump functions are typically performed by the patient using the pump user interface which includes input buttons and a display.
  • the amount of information which is provided to the user generally focuses on infusion management such as programming temporary basals, bolus calculation, and the like, in addition to the device operational functions such as alerts for occlusion detection.
  • infusion management such as programming temporary basals, bolus calculation, and the like
  • alerts for occlusion detection the device operational functions
  • a therapy management systems including infusion devices and analyte monitoring systems including continuous glucose monitoring systems and discrete blood glucose meters with improved capabilities.
  • FIG. 1 is a block diagram illustrating a therapy management system for practicing one embodiment of the present disclosure
  • FIG. 2 is a block diagram of an fluid delivery device of FIG. 1 in one embodiment of the present disclosure
  • FIG. 3 is a flowchart illustrating the time zone detection procedure in the therapy management system in one embodiment of the present disclosure
  • FIG. 4 is a flowchart illustrating the time zone detection procedure in the therapy management system in another embodiment of the present disclosure
  • FIG. 5 is a flowchart illustrating the device synchronization procedure in the therapy management system in one embodiment of the present disclosure
  • FIG. 6 is a flowchart illustrating device condition notification function in the therapy management system in one embodiment of the present disclosure
  • FIG. 7 is a flowchart illustrating automatic time information detection function incorporated in a medical device such as a blood glucose meter in one embodiment of the present disclosure
  • FIG. 8 is a flowchart illustrating automatic time information detection function incorporated in a medical device such as a blood glucose meter in another embodiment of the present disclosure.
  • FIGS. 9A-9C illustrate embodiments of automatic expiration detection function on blood glucose meter test strips in accordance with one embodiment of the present disclosure.
  • user interface features associated with the operation of the various components or devices in a therapy management system such as automatic time change based functions, automatic expiration date detection on test strips, for example, synchronization of the components in the therapy management system, user interface changes based on the user configuration, notification functions for programmable events associated with the therapy management, and voice enabled communication between devices in the therapy management system.
  • FIG. 1 is a block diagram illustrating a therapy management system for practicing one embodiment of the present disclosure.
  • the therapy management system 100 includes an analyte monitoring system 110 operatively coupled to a fluid delivery device 120 , which may be in turn, operatively coupled to a remote terminal 140 .
  • the analyte monitoring system 110 is, in one embodiment, coupled to the patient 130 so as to monitor or measure the analyte levels of the patient.
  • the fluid delivery device 120 is coupled to the patient using, for example, an infusion set and tubing connected to a cannula (not shown) that is placed transcutaneously through the skin of the patient so as to infuse medication such as, for example, insulin, to the patient.
  • the analyte monitoring system 110 in one embodiment may include one or more analyte sensors subcutaneously positioned such that at least a portion of the analyte sensors are maintained in fluid contact with the patient's analytes.
  • the analyte sensors may include, but are not limited to short term subcutaneous analyte sensors or transdermal analyte sensors, for example, which are configured to detect analyte levels of a patient over a predetermined time period, and after which, a replacement of the sensors is necessary.
  • the one or more analyte sensors of the analyte monitoring system 110 is coupled to a respective one or more of a data transmitter unit which is configured to receive one or more signals from the respective analyte sensors corresponding to the detected analyte levels of the patient, and to transmit the information corresponding to the detected analyte levels to a receiver device, and/or fluid delivery device 120 . That is, over a communication link, the transmitter units may be configured to transmit data associated with the detected analyte levels periodically, and/or intermittently and repeatedly to one or more other devices such as the fluid delivery device and/or the remote terminal 140 for further data processing and analysis.
  • each of the one or more receiver devices of the analyte monitoring system 110 and the fluid delivery device includes a user interface unit which may include a display unit, an audio output unit such as, for example, a speaker, or any other suitable user interface mechanism for displaying or informing the user of such devices.
  • a user interface unit which may include a display unit, an audio output unit such as, for example, a speaker, or any other suitable user interface mechanism for displaying or informing the user of such devices.
  • the transmitter units of the analyte monitoring system 110 may in one embodiment be configured to transmit the analyte related data substantially in real time to the fluid delivery device 120 and/or the remote terminal 140 after receiving it from the corresponding analyte sensors such that the analyte level such as glucose level of the patient 130 may be monitored in real time.
  • the analyte levels of the patient may be obtained using one or more of a discrete blood glucose testing devices such as blood glucose meters that employ glucose test strips, or continuous analyte monitoring systems such as continuous glucose monitoring systems.
  • the analyte monitoring system 110 may include a blood glucose meter such as FreeStyle and Precision meters available from Abbott Diabetes Care, Inc., of Alameda Calif.
  • the blood glucose meter may be used to calibrate the sensors in the analyte monitoring system 110 .
  • Exemplary analyte systems that may be employed are described in, for example, U.S. Pat. Nos. 6,134,461, 6,175,752, 6,121,611, 6,560,471, 6,746,582, and elsewhere, the disclosures of which are herein incorporated by reference.
  • Analytes that may be monitored, determined or detected in the analyte monitoring system 110 include, for example, acetyl choline, amylase, amyln, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, measures for oxidative stress (such as 8-iso PGF2gamma), peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin.
  • oxidative stress such as 8-iso PGF2gamma
  • the concentration of drugs may also be determined.
  • antibiotics e.g., gentamicin, vancomycin, and the like
  • biguanides digitoxin, digoxin, drugs of abuse, GLP-1, insulin, PPAR agonists, sulfonylureas, theophylline, thiazolidinediones, and warfarin.
  • the transmitter units of the analyte monitoring system 110 may be configured to directly communicate with one or more of the remote terminal 140 or the fluid delivery device 120 .
  • additional devices may be provided for communication in the analyte monitoring system 100 including additional receiver/data processing unit, remote terminals (such as a physician's terminal and/or a bedside terminal in a hospital environment, for example).
  • one or more of the analyte monitoring system 110 , the fluid delivery device 120 and the remote terminal 140 may be configured to communicate over a wireless data communication link such as, but not limited to RF communication link, Bluetooth communication link, infrared communication link, or any other type of suitable wireless communication connection between two or more electronic devices, which may further be uni-directional or bi-directional communication between the two or more devices.
  • the data communication link may include wired cable connection such as, for example, but not limited to RS232 connection, USB connection, or serial cable connection.
  • the fluid delivery device 120 may include in one embodiment, but not limited to, an external infusion device such as an external insulin infusion pump, an implantable pump, a pen-type insulin injector device, a patch pump, an inhalable infusion device for nasal insulin delivery, or any other type of suitable delivery system.
  • the remote terminal 140 in one embodiment may include for example, a desktop computer terminal, a data communication enabled kiosk, a laptop computer, a handheld computing device such as a personal digital assistant (PDAs), or a data communication enabled mobile telephone.
  • PDAs personal digital assistant
  • the analyte monitoring system 110 includes a strip port configured to receive a test strip for capillary blood glucose testing.
  • the glucose level measured using the test strip may in addition, be configured to provide periodic calibration of the analyte sensors of the analyte monitoring system 110 to assure and improve the accuracy of the analyte levels detected by the analyte sensors.
  • the fluid delivery device 120 may be configured to include a voice signal activation/generation unit for voice communication with the remote terminal 140 configured as a voice device such as a mobile telephone, a voice enabled personal digital assistant, a Blackberry device, or the like.
  • the communication between the fluid delivery device 120 and the remote terminal 140 may be voice based such that the information or data output to the user from the fluid delivery device 120 is configured to be transmitted to the user's telephone.
  • the fluid delivery device 120 may additionally be configured to receive voice commands from the remote terminal 140 configured as a telephone or any other voice signal communication device (such as personal computers or PDAs with voice signal capabilities).
  • the user interface of the fluid delivery device 120 may be configured with the voice signal activation/generation unit such that, output information for the user is converted into a voice signal and transmitted to the voice signal enabled remote terminal 140 .
  • the fluid delivery device 120 detects an alarm condition, the fluid delivery device 120 is configured to initiate a telephone call to the user's telephone (remote terminal 140 ), and when the user picks up the telephone line, the user is provided with a voice signal representing the alarm condition.
  • the fluid delivery device 120 may be configured to initial a telephone call directly to a preprogrammed telephone number of a health care physician, a local hospital, or emergency medical care facilities, in addition to or instead of initiating a telephone call to the user of the fluid delivery device 120 .
  • interaction and programming of the fluid delivery device 120 may be exclusively or partially exclusively performed over the user's telephone in voice communication with the fluid delivery device 120 . That is, when the user wishes to calculate a carbohydrate bolus in the fluid delivery device 120 , the user may dial a predetermined number using the user's telephone (remote terminal 140 ) to connect with the fluid delivery device 120 , and the user may provide voice commands to the fluid delivery device 120 via the telephone connection between the user's telephone (remote terminal 140 ) and the fluid delivery device 120 .
  • FIG. 2 is a block diagram of an fluid delivery device of FIG. 1 in one embodiment of the present disclosure.
  • the fluid delivery device 120 in one embodiment includes a processor 210 operatively coupled to a memory unit 240 , an input unit 220 , a display unit 230 , an output unit 260 , and a fluid delivery unit 250 .
  • the processor 210 includes a microprocessor that is configured to and capable of controlling the functions of the fluid delivery device 120 by controlling and/or accessing each of the various components of the fluid delivery device 120 .
  • multiple processors may be provided as safety measure and to provide redundancy in case of a single processor failure.
  • processing capabilities may be shared between multiple processor units within the fluid delivery device 120 such that pump functions and/or control may be performed faster and more accurately.
  • the input unit 220 operatively coupled to the processor 210 may include a jog dial key pad buttons, a touch pad screen, or any other suitable input mechanism for providing input commands to the fluid delivery device 120 . More specifically, in case of a jog dial input device, or a touch pad screen, for example, the patient or user of the fluid delivery device 120 will manipulate the respective jog dial or touch pad in conjunction with the display unit 230 which performs as both a data input and output unit.
  • the display unit 230 may include a touch sensitive screen, an LCD screen, or any other types of suitable display unit for the fluid delivery device 120 that is configured to display alphanumeric data as well as pictorial information such as icons associated with one or more predefined states of the fluid delivery device 120 , or graphical representation of data such as trend charts and graphs associated with the insulin infusion rates, trend data of monitored glucose levels over a period of time, or textual notification to the patients.
  • the alphanumeric representation displayed on the display unit 230 may be configured to be modified by the user of the fluid delivery device such that the size of the displayed number or character may be adjusted to suit the user's visual needs.
  • the user may apply font size adjustment request via the input unit 220 to instruct the processor 210 to modify the size of the displayed number or character on the display unit 230 .
  • the font size may be increased or decreased for each character, value or word displayed on the display unit 230 .
  • the font size adjustment may be applied globally to all output settings, for example, under the control of the processor 210 such that the user setting of the size adjustment may be configured to apply to substantially all displayed values or characters on the display unit 230 of the fluid delivery device 120 ( FIG. 1 ).
  • the relative size adjustment of the displayed character or value may be determined by the processor 210 so that the relative size adjustment may be implemented to the output display on the display unit 230 .
  • the display size adjustment may be implemented within the predetermined size restrictions for the respective value or character. For example, a 10% relative increase in the font size for display area designated for insulin dosage level may correspond to a 5% relative increase in the size of the display area designated for the insulin delivery time display.
  • the processor 210 may be configured to determine the relative size modification for each area of the display unit 230 based on the user inputted size adjustment values to appropriately apply the relative size differential adjustment.
  • the processor 210 may be configured to temporarily increase the font size displayed on the display unit 230 based on the user input commands such that the user requested size modification on the display unit 230 may be implemented only for the displayed screen at the time the user input commands for size adjustment is received by the processor 210 . In this manner, the processor may be configured to revert to the previously programmed display size settings for the display unit 230 when the user is no longer viewing the particular displayed screen from which the user has requested font size adjustment.
  • the user interface of the receiver unit of the analyte monitoring system 110 may be configured with similar size adjustment capabilities so as to allow the user to instruct the controller or processor of the analyte monitoring system 110 to appropriately adjust the size of the displayed character or value on the display unit of the analyte monitoring system 110 .
  • the display unit 230 may be configured to display an indication or marker for the type of insulin or other medication being used by the fluid delivery device 120 such as, for example, Symlin and Byetta. Such a marker may, in one embodiment, be associated with a predefined icon or character for display on the display unit 230 .
  • the information associated with the displayed marker or indication may be stored in the memory unit 240 so that the user may retrieve this information as desired.
  • an indication or a marker for shift work may be programmed in the fluid delivery device 120 ( FIG. 1 ) such that shift workers using the fluid delivery device 120 may align days and nights upon command based on the markers.
  • this daily work pattern information may be stored, identified or marked in the fluid delivery device 120 to provide additional data management functionalities and a more robust therapy analysis. For example, meal times such as breakfasts, for example, at 8 pm on Monday and 9 pm on Tuesday (during the nightshifts) may be aligned with the breakfasts at 7 am on Thursday and 8 am on Friday. In this manner, the user may conveniently access meal (e.g., breakfast) related data and associated therapy information in conjunction with the operation of the fluid delivery device 120 . This may assist the user in improving upon the user's diet such as the daily food intake.
  • meal times e.g., breakfast
  • meal e.g., breakfast
  • This may assist the user in improving upon the user's diet such as the daily food intake.
  • the output unit 260 operatively coupled to the processor 210 may include an audible alarm or alarms including one or more tones and/or preprogrammed or programmable tunes or audio clips, or vibratory alert features having one or more pre-programmed or programmable vibratory alert levels.
  • each alert event or alarm event may be programmed with combined notification features such that, depending upon the level of importance associated with each alert or alarm, a combination of vibratory, audible, or displayed indications may be provided to the user using the display unit 230 in combination with the output unit 260 .
  • the processor 210 may be configured to provide combined vibratory and increasingly audible alerts on the output unit 260 in addition to intermittently flashing background light on the display unit 230 for one or more predetermined alarms that require immediate user attention.
  • An example may include unexpected pressure increase in the infusion tubing which may indicate an occlusion or other undesirable condition that the user should be immediately notified.
  • the processor 210 may be configured such that the alarm or alert may be automatically reasserted within a predetermined time period in the event the associated alarm or alert condition has not been cleared by the user.
  • each alert/alarm feature may be individually programmed to include a wide selection of tones, audible levels, vibratory strength, and intensity of visual display.
  • the fluid delivery device 120 may be configured to provide an alarm or alert indication associated with a change in temperature. That is, when the fluid delivery device 120 which contains the insulin (for example, in a reservoir) experiences a rise or drop in temperature, such change in the temperature may have adverse effect on the insulin contained within the device 120 .
  • a temperature sensor may be coupled to the processor 210 of the fluid delivery device 120 to detect the operating condition of the fluid delivery device 120 and to notify the user of changes in the temperature, when, for example, the temperature change reaches a predetermined threshold level that may potentially have adverse impact upon the efficacy of the insulin being delivered.
  • the fluid delivery unit 250 which is operatively coupled to the processor 210 and configured to deliver the insulin doses or amounts to the patient from the insulin reservoir or any other types of suitable containment for insulin to be delivered (not shown) in the fluid delivery device 120 via an infusion set coupled to a subcutaneously positioned cannula under the skin of the patient.
  • the memory unit 240 may include one or more of a random access memory (RAM), read only memory (ROM), or any other type of data storage unit that is configured to store data as well as program instructions for access by the processor 210 and execution to control the fluid delivery device 120 and/or to perform data processing based on data received from the analyte monitoring system 110 , the remote terminal 140 , the patient 130 or any other data input source.
  • RAM random access memory
  • ROM read only memory
  • the memory unit 240 may include one or more of a random access memory (RAM), read only memory (ROM), or any other type of data storage unit that is configured to store data as well as program instructions for access by the processor 210 and execution to control the fluid delivery device 120 and/or to perform data processing based on data received from the analyte monitoring system 110 , the remote terminal 140 , the patient 130 or any other data input source.
  • FIG. 3 is a flowchart illustrating the time zone detection procedure in the therapy management system in one embodiment of the present disclosure.
  • the fluid delivery device 120 may be configured to transmit a location position request to for example, a global positioning system (GPS). Thereafter, the location information is received by the processor 210 of the fluid delivery device 120 .
  • the processor 210 is further configured to determine whether the location information has changed. That is, the processor 210 in one embodiment is configured to compare the receive location information which may include a current time zone information associated with the location of the fluid delivery device 120 , with the previously stored and operating time zone information in the fluid delivery device 120 in operation.
  • the routine terminates.
  • the location change information is output to the user on the display unit 230 , for example.
  • the processor 210 may be configured to generate a user prompt or notification to modify the time zone information of the fluid delivery device 120 such that it is updated to the new location where the fluid delivery device 120 is operating.
  • the fluid delivery device 120 when the fluid delivery device 120 is programmed with predetermined basal profiles and/or bolus functions that are time based and associated with an internal clock of the fluid delivery device 120 , it may be desired to modify some or all of the time based insulin delivery profiles programmed in the fluid delivery device 120 so as to correspond to the location of the fluid delivery device 120 . More specifically, if a user is traveling from a first location to a second location, in which one or more time zones are traversed, e.g., by way of example from San Francisco to Paris, given the time difference, the meal times, and sleep times, for example, will change. In this case, it may be desirable to modify the preprogrammed time based insulin delivery profiles so that they are synchronized with the user events such as meals and sleep times.
  • the processor 210 may be configured in one embodiment, to propagate the time change associated with the preprogrammed insulin delivery profile and notify the user to confirm the changes, prior to implementing the modification to the delivery profiles and any associated alerts or notifications. For example, in the case where the user has programmed to be alerted at a particular time of day, e.g., noon each day, for a bolus determination prior to lunch, the processor 210 in one embodiment is configured to either modify the internal clock of the fluid delivery device 120 or alternatively, modify the programmed alert for bolus determination so as to correspond to the new location of the user and the fluid delivery device 120 .
  • the fluid delivery device 120 may be configured to include a time zone detection unit, such as for example, the processor 210 may be configured to communicate with a geographical location change detection mechanism (e.g., an atomic clock) operatively coupled to the processor 210 for performing the time zone detection procedure as described above in conjunction with FIG. 3 .
  • the analyte monitoring system 110 may be configured to include a time zone detection unit as described above to automatically or based on a preprogrammed procedure, detect any location change associated with the analyte monitoring system 110 . In this manner, the analyte monitoring system 110 may be configured to automatically or based on a preprogrammed procedure, implement modifications to functions associated with the operation of the analyte monitoring system 110 that are temporally associated with the time of day information.
  • FIG. 4 is a flowchart illustrating the time zone detection procedure in the therapy management system in another embodiment of the present disclosure.
  • the fluid delivery device 120 may be configured to transmit a location position request to for example, a global positioning system (GPS). Thereafter, the location information is received by the processor 210 of the fluid delivery device 120 .
  • the processor 210 is further configured to determine whether the location information has changed. That is, the processor 210 in one embodiment is configured to compare the receive location information which may include a current time zone information associated with the location of the fluid delivery device 120 , with the previously stored and operating time zone information in the fluid delivery device 120 in operation.
  • the routine terminates.
  • the processor 210 in one embodiment is configured to retrieve one or more time based programmed functions from the memory unit 240 of the fluid delivery device 120 , for example.
  • the processor 210 may be further configured to modify the retrieved time based preprogrammed functions in accordance with the location change information received. Then, the modified retrieved functions are provided to the user on the display unit 230 , for example, to request confirmation of the time based adjustments, prior to the processor 210 executing the modified retrieved functions.
  • the fluid delivery device 120 may be configured to detect for daylight savings time and the processor 210 may be configured to either automatically execute the time change in the internal clock of the fluid delivery device, and/or provide a user notification to accept such time based change so that the operation of the fluid delivery device 120 performing time based programs are updated with any time based change in the insulin delivery system 120 operating environment.
  • the fluid delivery device 120 may be configured to receive location information from any positioning system which provides updated time information based on location.
  • the fluid delivery device 120 may be configured with a positioning transceiver that is configured to transmit location information request to a satellite network, for example, and to receive the location information therefrom.
  • the fluid delivery device 120 may be configured to update its location information locally upon synchronization with another device operating in the local (or at the new location).
  • This may include a host computer terminal connectable to the fluid delivery device 120 such as, for example, the remote terminal 140 ( FIG. 1 ), the analyte monitoring system 110 , or any other electronic device operating in the new location with communication capabilities with the fluid delivery device 120 such as a cellular telephone, a personal digital assistant, and the like.
  • the procedure and processes described in conjunction with FIGS. 3-4 associated with location change information and corresponding modification to the time based preprogrammed functions in the fluid delivery device 120 may be provided to the analyte monitoring system 110 such that the analyte monitoring system 110 is also configured to receive new location information and correspondingly perform modifications to any time based preprogrammed functions.
  • FIG. 5 is a flowchart illustrating the device synchronization procedure in the therapy management system in one embodiment of the present disclosure.
  • the fluid delivery device 120 may be configured to detect a synchronization request from another device such as the remote terminal 140 or the analyte monitoring system 110 ( FIG. 1 ). Thereafter, data communication connection is established between the fluid delivery device 120 and the synchronization requesting device.
  • the fluid delivery device 120 is configured to verify the authenticity or identity of the device requesting synchronization, and upon synchronization approval, the fluid delivery device 120 is configured to establish communication with the synchronization requesting device.
  • the fluid delivery device 120 may be configured to periodically or at a predetermined time interval, establish communication connection with another device for synchronization.
  • the fluid delivery device may be configured to attempt communication connection when another device for synchronization is detected within a predefined distance from the location of the fluid delivery device 120 .
  • the fluid delivery device 120 is configured in one embodiment to transmit its programmed and operating settings to the connected device, and the connected device is configured to update and store the data received from the fluid delivery device 120 based on predetermined conditions.
  • the predetermined conditions may include a predefined set of rules associated with the type of data from the fluid delivery device 120 to be updated such as historical infusion related information, programmed functions in the fluid delivery device 120 such as bolus calculations, temporarily basal profiles, programmed basal profiles, insulin usage level, and any other information that is associated with the user.
  • periodic synchronization of the fluid delivery device 120 settings and functions may be synchronized to another device so that when the user replaces the fluid delivery device 120 , the new or upgrade fluid delivery device may be easily and readily programmed to the user's specification.
  • the synchronization described above may be configured to be performed periodically at a regular interval such as, once a week, once per day, when certain predefined criteria are met such as when the devices are within a predetermined distance from each other, and/or upon user command.
  • the fluid delivery device 120 may be configured with any communication protocol which would allow data transfer between the fluid delivery device 120 and the synchronizing device. This may include, wired or wireless communication including for example, Bluetooth protocol, 801.1x protocol, USB cable connection and the like.
  • FIG. 6 is a flowchart illustrating device condition notification function in the therapy management system in one embodiment of the present disclosure.
  • the fluid delivery device 120 may be configured to detect a notification condition.
  • the processor 210 may be configured to detect such notification conditions at a preprogrammed time interval (such as about every 24 hours, for example). Thereafter, the programmed profile associated with the condition is retrieved.
  • An example of the programmed profile associated with the condition includes a reminder to start an overnight fast for the user.
  • the processor 210 in one embodiment is further configured to generate a message associated with the notification condition and/or the retrieved programmed profile, and, the generated message is provided to the user on one or more of the display unit 230 or the output unit 260 .
  • the fluid delivery device 120 may be programmed with automatic reminders for conditions to assist the user to improve insulin therapy management.
  • the notification condition detection may be skipped and the processor 210 may be configured to retrieve the appropriate programmed profile associated with notification conditions based on the user programming of the fluid delivery device 120 .
  • any other therapy related reminders or device operating condition reminders may be programmed for execution by the processor 210 to remind the user. Examples of such reminders include, but are not limited to, infusion set replacement reminder, battery replacement reminder, data synchronization reminder, insulin replenishment reminder, glucose testing reminder, and the like.
  • the procedure described in conjunction with FIG. 6 may be incorporated in the analyte monitoring system 110 for programming suitable automatic reminders such as, for example, sensor replacement reminder, sensor calibration reminder, and the like.
  • FIG. 7 is a flowchart illustrating automatic time information detection function incorporated in a medical device such as a blood glucose meter of the analyte monitoring system 110 in one embodiment of the present disclosure.
  • a routine is called by the processor of the medical device to automatically initiate time acquisition protocol. That is, upon power on of the medical device, the device is automatically configured to perform time acquisition protocol to, among others, transmit request for time and/or date information to available communication channels, and upon receiving the information, to store, update and/or otherwise set and/or display the received or acquired time/date information in the medical device ( 720 - 740 ).
  • the time information is received at step 730 , and thereafter, the received time information is stored and/or displayed on a display unit of the medical device.
  • the medical device is configured to update all previously stored time associated data (for example, blood glucose readings taken at certain times of the day (or week, month, or any other time period)).
  • the processor or controller of the glucose meter when the medical device such as the blood glucose meter is activated by the user, the processor or controller of the glucose meter is configured to enable or activate time/date receiver (for example, a communication component such as a radio frequency transceiver coupled to the processor of the glucose meter).
  • time/date receiver in one embodiment is configured to seek or acquire automatically, upon activation, time and date information from one or more available communication networks within range.
  • the time/date receiver may be configured to detect the time/date information from one or more radio frequencies on public, government, or private airwaves using AM band short frequency or FM band long wave frequency.
  • current local time/date information may be received from global positioning satellites, as well as cellular telephone networks such as GSM, CDMA, AMPS, and the like within range of the time/date receiver in the medical device.
  • WiFi network may be used to receive the time/data information, if available and within range.
  • the medical device such as a blood glucose meter
  • the medical device may be configured to automatically acquire time information that is continuously broadcast on frequency which antenna and the receiver of the blood glucose meter is configured to operate.
  • the internal clock function or component is updated or adjusted with the acquired time/date information and displayed to the user, for example.
  • the medical device such as a blood glucose meter may be configured to use GMT time as the reference time for all log entry (for example, for each blood glucose test performed) timestamps associated with each data stored in the medical device. Thereafter, the medical device may be configured to convert the stored GMT based time information for each log entry stored in the medical device to the local time based on the location of the medical device.
  • FIG. 8 is a flowchart illustrating automatic time information detection function incorporated in a medical device such as a blood glucose meter in another embodiment of the present disclosure.
  • the automatic time acquisition protocol is initiated based on a detection of one or more changed or preconfigured parameters associated with the medical device and/or the user of the medical device.
  • the device parameter may include a preconfigured time for periodically checking for time and date information (such as every 24 hours, 48 hours, or based on a programmed calendar such as to compensate for daylight savings time change).
  • the device parameter may include an environmental condition change associated with the medical device or the user, such as a detection of the medical device location such as during travel by air or a vehicle.
  • the medical device may be configured to include an altimeter which is coupled to the processor of the medical device to detect a change in altitude of the medical device location for example, when the user of the medical device is traveling by air.
  • the medical device may be configured to initiate the time acquisition protocol to confirm or verify the time and date information of the medical device.
  • the medical device may include an accelerometer which may be configured to initiate the automatic time acquisition protocol on the medical device when a predetermined threshold level of acceleration force is reached.
  • an accelerometer which may be configured to initiate the automatic time acquisition protocol on the medical device when a predetermined threshold level of acceleration force is reached.
  • other parameters may be used in conjunction with the medical device to trigger the automatic time acquisition protocol on the medical device such that, without user intervention, prompting, or initiating, the medical device is configured to automatically initiate time and date information acquisition routine.
  • the functionality of the automatic time and date information acquisition may be incorporated in other medical devices such as infusion pumps, continuous glucose monitoring devices, heart rate monitors, and the like that are configured to maintain a time associated log of physiological data (such as glucose levels, insulin infusion rates, cardiac signal levels and so on) of a patient or a user.
  • FIGS. 9A-9C illustrate embodiments of automatic expiration detection function on blood glucose meter test strips in accordance with one embodiment of the present disclosure.
  • test strips for use with blood glucose meters are sold or made available in containers that include the expiration date information of the test strips contained therein.
  • test strips may be configured with predefined parameters to allow automatic expiration date detection of the test strip.
  • resistance values are provided on the test strips such that when the test strip is inserted into the strip port of the blood glucose meter, the meter is configured to compare the detected resistance value to a stored value of resistance, and determine whether the inserted test strip has expired or not. More specifically, in one embodiment, using the resistance value on the test strip, the expiration date information may be coded, and the meter may be configured to detect the resistance value of the test strip and determine whether the test strip has expired.
  • the resistance value on the test strip may be controlled with the ink formulation on the wake up bar and/or patterns provided thereon. Silver, gold, carbon or any other suitable conductive material may be used to increase the resistance as may be desired.
  • the blood glucose meter may be configured such that the strip port includes a current connector and predetermined control lines that may be configured to measure the resistance values coded on the test strips. More specifically, in one embodiment, the expiration dates may be coded using the resistance value on the wake-up bar in a logical sequence such as follows:
  • FIGS. 9A-9C it can be seen that the wavy lines may increase in thickness or length to change the resistance on the test strip. Furthermore, the pads on the test strip are shown to make contact with the wake-up bar on the strip port.
  • FIG. 9A illustrates 300 KOhm trace width
  • FIG. 9B illustrates 315 KOhm trace width
  • FIG. 9C illustrates 350 KOhm trace width, each associated with a predefined expiration date as described above.
  • expiration date of test strips may be automatically detected so that the user is notified of expired date of a given test strip before it used to test for blood glucose levels.
  • automatic expiration detection is described in conjunction with test strip and blood glucose meters, within the scope of the present disclosure, other medical device or comsumable items with expiration dates may benefit from the technique described herein.
  • the expiration time information may be provided on the test strip using techniques other than, for example, resistance values provided on the wake up bar. That is, the coded or stored expiration time information may be provided on the test strip or other medical components such as analyte sensors, catheters, medication cartridges, for example, using capacitance, or thermal coating. Accordingly, the expiration of the test strip or consumable medical components may be readily and easily ascertained.
  • a method in one aspect of the present disclosure includes detecting a presence of a medical component, determining a resistance value associated with the medical component, retrieving a stored resistance value associated with a predetermined time information, comparing the determined resistance value to the stored resistance value, and generating an output signal based on the comparison.
  • the predetermined time information may include expiration information associated with the medical component.
  • the medical component may include one or more of an analyte sensor, a blood glucose test strip, a medication cartridge, an infusion device infusion set, or a catheter.
  • the medical component may include a glucose test strip for determining a glucose level using a predetermined volume of blood sample, where the predetermined volume may include 1.0 microliter or less of blood sample, 0.5 microliter or less of blood sample, 0.25 microliter or less of blood sample, or 0.1 microliter or less of blood sample. Additional description related to using a small volume of sample to determine analyte levels using in vitro analyte sensor is provided in U.S. Pat. Nos. 6,143,164 and 6,592,745, the disclosure of which is incorporated herein by reference for all purposes.
  • the resistance value may be provided on the medical component, using for example, silver, gold, carbon, one or more combinations thereof, or ink formulation based thereon.
  • the medical component may include a glucose test strip having a wake up bar, and further, where the resistance value is provided using ink formulation on the wake up bar.
  • the method may include outputting the generated output signal, where the generated output signal may include one or more of an audible signal such as an audible alarm, a visual signal such as, for example, graphical or text display of the information, or a vibratory signal.
  • an audible signal such as an audible alarm
  • a visual signal such as, for example, graphical or text display of the information
  • a vibratory signal such as, for example, graphical or text display of the information.
  • the generated output signal may include a notification of the medical component expiration.
  • An apparatus in a further aspect of the present disclosure includes a housing, a test strip port coupled to the housing for receiving a test strip, a memory unit coupled to the housing, and a processing unit operatively coupled to the memory unit, the test strip port and the housing, the processing unit configured to detect a resistance value associated with the test strip, to retrieve a predetermined time information associated with the detected resistance value, and to generate an output signal based on the retrieved predetermined time information.
  • the test strip may include a glucose test strip.
  • the memory unit may be configured to store a plurality of predetermined resistance values, each associated with a respective predetermined time information.
  • the predetermined time information may be associated with expiration information for the test strip.
  • the predetermined time information may include time and date information.
  • the apparatus may include an output unit coupled to the housing, the display unit configured to display the generated output signal, where the output unit may include one or more of an audible output unit, a textual output unit, a vibratory output unit, or a graphical output unit.
  • the generated output signal may include a notification of the test strip expiration information.
  • a method in a further embodiment may include detecting insertion of a glucose test strip, determining a resistance value associated with the test strip, retrieving an expiration information associated with the determined resistance value, and generating an expiration notification based on the expiration information.
  • the resistance value may be provided on the test strip, for example, using ink formulation.
  • a therapy management system in one embodiment of the present disclosure includes an infusion device including a processing unit configured to perform data processing, and a user interface unit operatively coupled to a processing unit, where the processing unit is configured to detect a location information associated with the infusion device for output to the user interface unit.
  • the location information in one embodiment is time based.
  • the location information is associated with a local time information based on the location of the infusion device, where the location information may be received from a global positioning system (GPS) or from another device, such as a mobile telephone, a GPS enabled personal digital assistant, which has received that information from a global positioning system.
  • GPS global positioning system
  • a clock unit may be operatively coupled to the processing unit, where the clock unit is configured to dynamically adjust the location information based on the location of the infusion device.
  • the clock unit may include an atomic clock.
  • the processor unit may be configured to generate a notification associated with the detected location information for output to the user interface unit, where the notification may be output to the user interface unit as one or more of a date information and time information associated with the location of the infusion device.
  • the processing unit may be configured to retrieve one or more programmed procedures associated with time, where the one or more programmed procedures may include one or more basal profiles, a programmed bolus determination schedule, a time based condition alert.
  • the time based condition alert may include one or more of a time based reminder associated with the operation of the infusion device. Further, the time based condition alert may include one or more of a time based reminder associated with the condition of the infusion device user.
  • the processor unit may be configured to automatically adjust one or more time based functions associated with the operation of the infusion device based on the detected location information.
  • a method in accordance with another embodiment includes detecting a change in the location information of a therapy management device, comparing the detected change with a stored location information, and executing one or more processes associated with the operation of the therapy management device based on the detected change.
  • the detected change in the location information may include one of a time zone change, a time standard change, a date change, or combinations thereof.
  • the one or more processes may include generating a notification associated with the detected change in the location information.
  • the one or more processes may include modifying one or more programmed time based functions of the therapy management device and which may include one or more of a programmed time based alert, a programmed time based fluid delivery determination; a programmed time based fluid delivery profile, or a programmed time based operational condition of the therapy management device.
  • the therapy management device may include one or more of an infusion device or an analyte monitoring unit.
  • a therapy management system in accordance with still another embodiment of the present disclosure includes an infusion device, and a communication unit operatively coupled to the infusion device over a wireless data network, the communication device configured to transmit a request for synchronization to the infusion device, where the infusion device may be configured to transmit one or more data to the communication unit in response to the received synchronization request.
  • the wireless data network may be based on one or more of a Bluetooth communication protocol, an RF communication protocol, an infrared communication protocol, a Zigbee communication protocol, an 802.1x communication protocol, or a wireless personal area network such as ANT protocol.
  • the wireless data network may include one or more of a wireless local area network, or a WiFi network.
  • the communication unit may be configured to periodically transmit the synchronization request at a predetermined time interval.
  • the infusion device may be configured to verify the received synchronization request before transmitting the one or more data to the communication unit.
  • the transmitted one or more data to the communication unit may be encrypted, and also, the communication unit may be configured to decrypt the received one or more encrypted data.
  • the transmitted one or more data may include one or more information associated with the stored user profile of the infusion device, an operating parameter of the infusion device, or infusion delivery information.
  • the communication unit may include one or more of an analyte monitoring unit, a personal digital assistant, a mobile telephone, a computer terminal, a server terminal or an additional infusion device.
  • a system for communicating with an infusion device in still another embodiment of the present disclosure includes a voice enabled device and an infusion device configured to communicate with the voice enabled device using one or more voice signals.
  • the voice enabled device may include one or more of a telephone set, a mobile telephone, a voice of IP (Internet Protocol) telephone, a voice enabled computing device, or a voice enabled computer terminal.
  • IP Internet Protocol
  • the infusion device may be configured to initiate a voice enabled communication to the voice enabled device.
  • the infusion device may be integrated with mobile telephone components.
  • the voice enabled communication may include a telephone call.
  • the infusion device may be configured to receive one or more voice commands from the voice enabled device, where the infusion device may be configured to process the one or more voice commands to execute one or more associated functions of the infusion device operation.
  • the one or more associated functions include a bolus dosage determination, a programmable notification, or a temporarily basal dosage determination.
  • a method in accordance with yet still another embodiment of the present disclosure includes initiating a voice signal based communication from an infusion device, and transmitting a voice signal associated with the operation of the infusion device.
  • the method may also include receiving a voice signal based request over a communication network, and executing one or more functions associated with the operation of the infusion device based on the received voice signal based request.
  • the voice signal based communication may include a telephone call.
  • a therapy management kit in accordance with still yet another embodiment includes an infusion device including a processing unit configured to perform data processing, and a user interface unit operatively coupled to a processing unit, where the processing unit is configured to detect a location information associated with the infusion device for output to the user interface unit.
  • the kit may further include a clock unit operatively coupled to the processing unit, where the clock unit is configured to dynamically adjust the location information based on the location of the infusion device.
  • the clock unit may include an atomic clock.
  • the kit may also include a voice enabled device, where the infusion device may be further configured to communicate with the voice enabled device using one or more voice signals.
  • the voice enabled device may include one or more of a telephone set, a mobile telephone, a voice of IP (Internet Protocol) telephone, a voice enabled computing device, or a voice enabled computer terminal.
  • IP Internet Protocol
  • the various processes described above including the processes performed by the processor 210 in the software application execution environment in the fluid delivery device 120 as well as any other suitable or similar processing units embodied in the analyte monitoring system 120 and the remote terminal 140 , including the processes and routines described in conjunction with FIGS. 3-8 , may be embodied as computer programs developed using an object oriented language that allows the modeling of complex systems with modular objects to create abstractions that are representative of real world, physical objects and their interrelationships.
  • the software required to carry out the inventive process which may be stored in the memory unit 240 (or similar storage devices in the analyte monitoring system 110 or the remote terminal 140 ) of the processor 210 , may be developed by a person of ordinary skill in the art and may include one or more computer program products.

Abstract

Methods and system for providing diabetes management including automatic time acquisition protocol and expiration date detection are provided.

Description

    RELATED APPLICATION
  • The present application claims priority under §35 U.S.C. 119(e) to U.S. provisional patent application No. 60/890,161 filed Feb. 15, 2007, entitled “Device And Method For Automatic Data Acquisition And/Or Detection”, and assigned to the Assignee of the present application, Abbott Diabetes Care, Inc. of Alameda, Calif., the disclosure of which is incorporated herein by reference for all purposes.
  • BACKGROUND
  • In diabetes management, there exist devices which allow diabetic patients to measure the blood glucose levels. One such device is a hand-held electronic meter such as blood glucose meters such as Freestyle® blood glucose monitoring system available from Abbott Diabetes Care, Inc., of Alameda, Calif. which receives blood samples via enzyme-based test strips. Typically, the patient lances a finger or alternate body site to obtain a blood sample, applies the drawn blood sample to the test strip, and the strip is inserted into a test strip opening or port in the meter housing. The blood glucose meter converts a current generated by the enzymatic reaction in the test strip to a corresponding blood glucose value which is displayed or otherwise provided to the patient to show the level of glucose at the time of testing.
  • Such periodic discrete glucose testing helps diabetic patients to take any necessary corrective actions to better manage diabetic conditions. Presently available glucose meters have limited functionalities (for example, providing the glucose value measured using the test strip and storing the data for subsequent recall or display) and do not provide any additional information or capability to assist patients in managing diabetes. For example, Type-1 diabetic patients who require periodic infusion or injection of insulin, typically use glucose meters in addition to, for example, wearing an external infusion device, or a pen type injection device. Also, in the case of external infusion devices, because of the strip port on the meter receives the test strip (which is generally not a water tight seal), it is not desirable to incorporate the discrete glucose meter functionalities to the housing of the external infusion devices.
  • Presently available external infusion devices typically include an input mechanism such as buttons through which the patient may program and control the infusion device. Such infusion devices also typically include a user interface such as a display which is configured to display information relevant to the patient's infusion progress, status of the various components of the infusion device, as well as other programmable information such as patient specific basal profiles.
  • The external infusion devices are typically connected to an infusion set which includes a cannula that is placed transcutaneously through the skin of the patient to infuse a select dosage of insulin based on the infusion device's programmed basal rates or any other infusion rates as prescribed by the patient's doctor. Generally, the patient is able to control the pump to administer additional doses of insulin during the course of wearing and operating the infusion device such as for, administering a carbohydrate bolus prior to a meal. Certain infusion devices include food database that has associated therewith, an amount of carbohydrate, so that the patient may better estimate the level of insulin dosage needed for, for example, calculating a bolus amount.
  • Programming and controlling the pump functions are typically performed by the patient using the pump user interface which includes input buttons and a display. Typically, depending on the type of the infusion device, the amount of information which is provided to the user generally focuses on infusion management such as programming temporary basals, bolus calculation, and the like, in addition to the device operational functions such as alerts for occlusion detection. Given the decreasing cost of microprocessor, communication and other electronic components, and increasing sophistication of patients and users of medical devices such as blood glucose meters, infusion devices, and continuous glucose monitoring systems, it would be desirable to provide additional features and functionalities to improve health related management by the user using these medical devices.
  • SUMMARY
  • In accordance with the various embodiments of the present disclosure, there are provided methods and system for providing robust functionalities for a therapy management systems including infusion devices and analyte monitoring systems including continuous glucose monitoring systems and discrete blood glucose meters with improved capabilities.
  • These and other objects, features and advantages of the present disclosure will become more fully apparent from the following detailed description of the embodiments, the appended claims and the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a block diagram illustrating a therapy management system for practicing one embodiment of the present disclosure;
  • FIG. 2 is a block diagram of an fluid delivery device of FIG. 1 in one embodiment of the present disclosure;
  • FIG. 3 is a flowchart illustrating the time zone detection procedure in the therapy management system in one embodiment of the present disclosure;
  • FIG. 4 is a flowchart illustrating the time zone detection procedure in the therapy management system in another embodiment of the present disclosure;
  • FIG. 5 is a flowchart illustrating the device synchronization procedure in the therapy management system in one embodiment of the present disclosure;
  • FIG. 6 is a flowchart illustrating device condition notification function in the therapy management system in one embodiment of the present disclosure;
  • FIG. 7 is a flowchart illustrating automatic time information detection function incorporated in a medical device such as a blood glucose meter in one embodiment of the present disclosure;
  • FIG. 8 is a flowchart illustrating automatic time information detection function incorporated in a medical device such as a blood glucose meter in another embodiment of the present disclosure; and
  • FIGS. 9A-9C illustrate embodiments of automatic expiration detection function on blood glucose meter test strips in accordance with one embodiment of the present disclosure.
  • DETAILED DESCRIPTION
  • As described below, within the scope of the present disclosure, there are provided user interface features associated with the operation of the various components or devices in a therapy management system such as automatic time change based functions, automatic expiration date detection on test strips, for example, synchronization of the components in the therapy management system, user interface changes based on the user configuration, notification functions for programmable events associated with the therapy management, and voice enabled communication between devices in the therapy management system.
  • FIG. 1 is a block diagram illustrating a therapy management system for practicing one embodiment of the present disclosure. Referring to FIG. 1, the therapy management system 100 includes an analyte monitoring system 110 operatively coupled to a fluid delivery device 120, which may be in turn, operatively coupled to a remote terminal 140. As shown in the Figure, the analyte monitoring system 110 is, in one embodiment, coupled to the patient 130 so as to monitor or measure the analyte levels of the patient. Moreover, the fluid delivery device 120 is coupled to the patient using, for example, an infusion set and tubing connected to a cannula (not shown) that is placed transcutaneously through the skin of the patient so as to infuse medication such as, for example, insulin, to the patient.
  • Referring to FIG. 1, the analyte monitoring system 110 in one embodiment may include one or more analyte sensors subcutaneously positioned such that at least a portion of the analyte sensors are maintained in fluid contact with the patient's analytes. The analyte sensors may include, but are not limited to short term subcutaneous analyte sensors or transdermal analyte sensors, for example, which are configured to detect analyte levels of a patient over a predetermined time period, and after which, a replacement of the sensors is necessary.
  • The one or more analyte sensors of the analyte monitoring system 110 is coupled to a respective one or more of a data transmitter unit which is configured to receive one or more signals from the respective analyte sensors corresponding to the detected analyte levels of the patient, and to transmit the information corresponding to the detected analyte levels to a receiver device, and/or fluid delivery device 120. That is, over a communication link, the transmitter units may be configured to transmit data associated with the detected analyte levels periodically, and/or intermittently and repeatedly to one or more other devices such as the fluid delivery device and/or the remote terminal 140 for further data processing and analysis.
  • In one aspect, each of the one or more receiver devices of the analyte monitoring system 110 and the fluid delivery device includes a user interface unit which may include a display unit, an audio output unit such as, for example, a speaker, or any other suitable user interface mechanism for displaying or informing the user of such devices.
  • The transmitter units of the analyte monitoring system 110 may in one embodiment be configured to transmit the analyte related data substantially in real time to the fluid delivery device 120 and/or the remote terminal 140 after receiving it from the corresponding analyte sensors such that the analyte level such as glucose level of the patient 130 may be monitored in real time. In one aspect, the analyte levels of the patient may be obtained using one or more of a discrete blood glucose testing devices such as blood glucose meters that employ glucose test strips, or continuous analyte monitoring systems such as continuous glucose monitoring systems. In a further embodiment, the analyte monitoring system 110 may include a blood glucose meter such as FreeStyle and Precision meters available from Abbott Diabetes Care, Inc., of Alameda Calif. The blood glucose meter may be used to calibrate the sensors in the analyte monitoring system 110. Exemplary analyte systems that may be employed are described in, for example, U.S. Pat. Nos. 6,134,461, 6,175,752, 6,121,611, 6,560,471, 6,746,582, and elsewhere, the disclosures of which are herein incorporated by reference.
  • Analytes that may be monitored, determined or detected in the analyte monitoring system 110 include, for example, acetyl choline, amylase, amyln, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, measures for oxidative stress (such as 8-iso PGF2gamma), peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), biguanides, digitoxin, digoxin, drugs of abuse, GLP-1, insulin, PPAR agonists, sulfonylureas, theophylline, thiazolidinediones, and warfarin, may also be determined.
  • Moreover, within the scope of the present disclosure, the transmitter units of the analyte monitoring system 110 may be configured to directly communicate with one or more of the remote terminal 140 or the fluid delivery device 120. Furthermore, within the scope of the present disclosure, additional devices may be provided for communication in the analyte monitoring system 100 including additional receiver/data processing unit, remote terminals (such as a physician's terminal and/or a bedside terminal in a hospital environment, for example).
  • In addition, within the scope of the present disclosure, one or more of the analyte monitoring system 110, the fluid delivery device 120 and the remote terminal 140 may be configured to communicate over a wireless data communication link such as, but not limited to RF communication link, Bluetooth communication link, infrared communication link, or any other type of suitable wireless communication connection between two or more electronic devices, which may further be uni-directional or bi-directional communication between the two or more devices. Alternatively, the data communication link may include wired cable connection such as, for example, but not limited to RS232 connection, USB connection, or serial cable connection.
  • The fluid delivery device 120 may include in one embodiment, but not limited to, an external infusion device such as an external insulin infusion pump, an implantable pump, a pen-type insulin injector device, a patch pump, an inhalable infusion device for nasal insulin delivery, or any other type of suitable delivery system. In addition, the remote terminal 140 in one embodiment may include for example, a desktop computer terminal, a data communication enabled kiosk, a laptop computer, a handheld computing device such as a personal digital assistant (PDAs), or a data communication enabled mobile telephone.
  • Referring back to FIG. 1, in one embodiment, the analyte monitoring system 110 includes a strip port configured to receive a test strip for capillary blood glucose testing. In one aspect, the glucose level measured using the test strip may in addition, be configured to provide periodic calibration of the analyte sensors of the analyte monitoring system 110 to assure and improve the accuracy of the analyte levels detected by the analyte sensors.
  • Referring yet again to FIG. 1, in one embodiment of the present disclosure, the fluid delivery device 120 may be configured to include a voice signal activation/generation unit for voice communication with the remote terminal 140 configured as a voice device such as a mobile telephone, a voice enabled personal digital assistant, a Blackberry device, or the like. For example, in one embodiment, the communication between the fluid delivery device 120 and the remote terminal 140 may be voice based such that the information or data output to the user from the fluid delivery device 120 is configured to be transmitted to the user's telephone. In turn, the fluid delivery device 120 may additionally be configured to receive voice commands from the remote terminal 140 configured as a telephone or any other voice signal communication device (such as personal computers or PDAs with voice signal capabilities).
  • In this manner, in one embodiment, the user interface of the fluid delivery device 120 may be configured with the voice signal activation/generation unit such that, output information for the user is converted into a voice signal and transmitted to the voice signal enabled remote terminal 140. For example, when the fluid delivery device 120 detects an alarm condition, the fluid delivery device 120 is configured to initiate a telephone call to the user's telephone (remote terminal 140), and when the user picks up the telephone line, the user is provided with a voice signal representing the alarm condition.
  • In a further embodiment, for certain predetermined patient conditions, the fluid delivery device 120 may be configured to initial a telephone call directly to a preprogrammed telephone number of a health care physician, a local hospital, or emergency medical care facilities, in addition to or instead of initiating a telephone call to the user of the fluid delivery device 120.
  • In addition, within the scope of the present disclosure, interaction and programming of the fluid delivery device 120 may be exclusively or partially exclusively performed over the user's telephone in voice communication with the fluid delivery device 120. That is, when the user wishes to calculate a carbohydrate bolus in the fluid delivery device 120, the user may dial a predetermined number using the user's telephone (remote terminal 140) to connect with the fluid delivery device 120, and the user may provide voice commands to the fluid delivery device 120 via the telephone connection between the user's telephone (remote terminal 140) and the fluid delivery device 120.
  • FIG. 2 is a block diagram of an fluid delivery device of FIG. 1 in one embodiment of the present disclosure. Referring to FIG. 2, the fluid delivery device 120 in one embodiment includes a processor 210 operatively coupled to a memory unit 240, an input unit 220, a display unit 230, an output unit 260, and a fluid delivery unit 250. In one embodiment, the processor 210 includes a microprocessor that is configured to and capable of controlling the functions of the fluid delivery device 120 by controlling and/or accessing each of the various components of the fluid delivery device 120. In one embodiment, multiple processors may be provided as safety measure and to provide redundancy in case of a single processor failure. Moreover, processing capabilities may be shared between multiple processor units within the fluid delivery device 120 such that pump functions and/or control may be performed faster and more accurately.
  • Referring back to FIG. 2, the input unit 220 operatively coupled to the processor 210 may include a jog dial key pad buttons, a touch pad screen, or any other suitable input mechanism for providing input commands to the fluid delivery device 120. More specifically, in case of a jog dial input device, or a touch pad screen, for example, the patient or user of the fluid delivery device 120 will manipulate the respective jog dial or touch pad in conjunction with the display unit 230 which performs as both a data input and output unit. The display unit 230 may include a touch sensitive screen, an LCD screen, or any other types of suitable display unit for the fluid delivery device 120 that is configured to display alphanumeric data as well as pictorial information such as icons associated with one or more predefined states of the fluid delivery device 120, or graphical representation of data such as trend charts and graphs associated with the insulin infusion rates, trend data of monitored glucose levels over a period of time, or textual notification to the patients.
  • In one embodiment, the alphanumeric representation displayed on the display unit 230 may be configured to be modified by the user of the fluid delivery device such that the size of the displayed number or character may be adjusted to suit the user's visual needs. For example, in one embodiment, the user may apply font size adjustment request via the input unit 220 to instruct the processor 210 to modify the size of the displayed number or character on the display unit 230. In one aspect, the font size may be increased or decreased for each character, value or word displayed on the display unit 230. Alternatively, the font size adjustment may be applied globally to all output settings, for example, under the control of the processor 210 such that the user setting of the size adjustment may be configured to apply to substantially all displayed values or characters on the display unit 230 of the fluid delivery device 120 (FIG. 1).
  • Moreover, referring back to FIG. 2, in a further aspect of the present disclosure, the relative size adjustment of the displayed character or value may be determined by the processor 210 so that the relative size adjustment may be implemented to the output display on the display unit 230. In this manner, depending upon the type or configuration of the display unit 230 (whether bit map or icon type display), in one embodiment, the display size adjustment may be implemented within the predetermined size restrictions for the respective value or character. For example, a 10% relative increase in the font size for display area designated for insulin dosage level may correspond to a 5% relative increase in the size of the display area designated for the insulin delivery time display. In one embodiment, the processor 210 may be configured to determine the relative size modification for each area of the display unit 230 based on the user inputted size adjustment values to appropriately apply the relative size differential adjustment.
  • In a further aspect, the processor 210 may be configured to temporarily increase the font size displayed on the display unit 230 based on the user input commands such that the user requested size modification on the display unit 230 may be implemented only for the displayed screen at the time the user input commands for size adjustment is received by the processor 210. In this manner, the processor may be configured to revert to the previously programmed display size settings for the display unit 230 when the user is no longer viewing the particular displayed screen from which the user has requested font size adjustment.
  • In addition, the user interface of the receiver unit of the analyte monitoring system 110 (FIG. 1) may be configured with similar size adjustment capabilities so as to allow the user to instruct the controller or processor of the analyte monitoring system 110 to appropriately adjust the size of the displayed character or value on the display unit of the analyte monitoring system 110.
  • In a further embodiment, the display unit 230 may be configured to display an indication or marker for the type of insulin or other medication being used by the fluid delivery device 120 such as, for example, Symlin and Byetta. Such a marker may, in one embodiment, be associated with a predefined icon or character for display on the display unit 230. In addition, within the scope of the present disclosure, the information associated with the displayed marker or indication may be stored in the memory unit 240 so that the user may retrieve this information as desired. In addition, an indication or a marker for shift work may be programmed in the fluid delivery device 120 (FIG. 1) such that shift workers using the fluid delivery device 120 may align days and nights upon command based on the markers.
  • For example, if a user worked nightshifts on Mondays and Tuesdays and dayshifts on Thursdays and Fridays, this daily work pattern information may be stored, identified or marked in the fluid delivery device 120 to provide additional data management functionalities and a more robust therapy analysis. For example, meal times such as breakfasts, for example, at 8 pm on Monday and 9 pm on Tuesday (during the nightshifts) may be aligned with the breakfasts at 7 am on Thursday and 8 am on Friday. In this manner, the user may conveniently access meal (e.g., breakfast) related data and associated therapy information in conjunction with the operation of the fluid delivery device 120. This may assist the user in improving upon the user's diet such as the daily food intake.
  • Referring to FIG. 2, the output unit 260 operatively coupled to the processor 210 may include an audible alarm or alarms including one or more tones and/or preprogrammed or programmable tunes or audio clips, or vibratory alert features having one or more pre-programmed or programmable vibratory alert levels.
  • In addition, in one embodiment of the present disclosure, each alert event or alarm event may be programmed with combined notification features such that, depending upon the level of importance associated with each alert or alarm, a combination of vibratory, audible, or displayed indications may be provided to the user using the display unit 230 in combination with the output unit 260.
  • For example, the processor 210 may be configured to provide combined vibratory and increasingly audible alerts on the output unit 260 in addition to intermittently flashing background light on the display unit 230 for one or more predetermined alarms that require immediate user attention. An example may include unexpected pressure increase in the infusion tubing which may indicate an occlusion or other undesirable condition that the user should be immediately notified. The processor 210 may be configured such that the alarm or alert may be automatically reasserted within a predetermined time period in the event the associated alarm or alert condition has not been cleared by the user. In addition, each alert/alarm feature may be individually programmed to include a wide selection of tones, audible levels, vibratory strength, and intensity of visual display.
  • In a further aspect, the fluid delivery device 120 may be configured to provide an alarm or alert indication associated with a change in temperature. That is, when the fluid delivery device 120 which contains the insulin (for example, in a reservoir) experiences a rise or drop in temperature, such change in the temperature may have adverse effect on the insulin contained within the device 120. Accordingly, a temperature sensor may be coupled to the processor 210 of the fluid delivery device 120 to detect the operating condition of the fluid delivery device 120 and to notify the user of changes in the temperature, when, for example, the temperature change reaches a predetermined threshold level that may potentially have adverse impact upon the efficacy of the insulin being delivered.
  • Also shown in FIG. 2 is the fluid delivery unit 250 which is operatively coupled to the processor 210 and configured to deliver the insulin doses or amounts to the patient from the insulin reservoir or any other types of suitable containment for insulin to be delivered (not shown) in the fluid delivery device 120 via an infusion set coupled to a subcutaneously positioned cannula under the skin of the patient.
  • Referring yet again to FIG. 2, the memory unit 240 may include one or more of a random access memory (RAM), read only memory (ROM), or any other type of data storage unit that is configured to store data as well as program instructions for access by the processor 210 and execution to control the fluid delivery device 120 and/or to perform data processing based on data received from the analyte monitoring system 110, the remote terminal 140, the patient 130 or any other data input source.
  • FIG. 3 is a flowchart illustrating the time zone detection procedure in the therapy management system in one embodiment of the present disclosure. Referring to FIG. 3, the fluid delivery device 120 (FIG. 1) may be configured to transmit a location position request to for example, a global positioning system (GPS). Thereafter, the location information is received by the processor 210 of the fluid delivery device 120. The processor 210 is further configured to determine whether the location information has changed. That is, the processor 210 in one embodiment is configured to compare the receive location information which may include a current time zone information associated with the location of the fluid delivery device 120, with the previously stored and operating time zone information in the fluid delivery device 120 in operation.
  • Referring back, if it is determined that the location information has not changed, then the routine terminates. On the other hand, if it is determined that the fluid delivery device location information has changed, then, the location change information is output to the user on the display unit 230, for example. Thereafter, the processor 210 may be configured to generate a user prompt or notification to modify the time zone information of the fluid delivery device 120 such that it is updated to the new location where the fluid delivery device 120 is operating.
  • For example, when the fluid delivery device 120 is programmed with predetermined basal profiles and/or bolus functions that are time based and associated with an internal clock of the fluid delivery device 120, it may be desired to modify some or all of the time based insulin delivery profiles programmed in the fluid delivery device 120 so as to correspond to the location of the fluid delivery device 120. More specifically, if a user is traveling from a first location to a second location, in which one or more time zones are traversed, e.g., by way of example from San Francisco to Paris, given the time difference, the meal times, and sleep times, for example, will change. In this case, it may be desirable to modify the preprogrammed time based insulin delivery profiles so that they are synchronized with the user events such as meals and sleep times.
  • Referring back to FIG. 3, in one embodiment, the user responds to the time based programming change prompt provided by the processor 210, then the processor 210 may be configured in one embodiment, to propagate the time change associated with the preprogrammed insulin delivery profile and notify the user to confirm the changes, prior to implementing the modification to the delivery profiles and any associated alerts or notifications. For example, in the case where the user has programmed to be alerted at a particular time of day, e.g., noon each day, for a bolus determination prior to lunch, the processor 210 in one embodiment is configured to either modify the internal clock of the fluid delivery device 120 or alternatively, modify the programmed alert for bolus determination so as to correspond to the new location of the user and the fluid delivery device 120.
  • In another embodiment, the fluid delivery device 120 may be configured to include a time zone detection unit, such as for example, the processor 210 may be configured to communicate with a geographical location change detection mechanism (e.g., an atomic clock) operatively coupled to the processor 210 for performing the time zone detection procedure as described above in conjunction with FIG. 3. In addition, the analyte monitoring system 110 may be configured to include a time zone detection unit as described above to automatically or based on a preprogrammed procedure, detect any location change associated with the analyte monitoring system 110. In this manner, the analyte monitoring system 110 may be configured to automatically or based on a preprogrammed procedure, implement modifications to functions associated with the operation of the analyte monitoring system 110 that are temporally associated with the time of day information.
  • FIG. 4 is a flowchart illustrating the time zone detection procedure in the therapy management system in another embodiment of the present disclosure. Referring to FIG. 4, the fluid delivery device 120 (FIG. 1) may be configured to transmit a location position request to for example, a global positioning system (GPS). Thereafter, the location information is received by the processor 210 of the fluid delivery device 120. The processor 210 is further configured to determine whether the location information has changed. That is, the processor 210 in one embodiment is configured to compare the receive location information which may include a current time zone information associated with the location of the fluid delivery device 120, with the previously stored and operating time zone information in the fluid delivery device 120 in operation.
  • Referring back, if it is determined that the location information has not changed, then the routine terminates. On the other hand, if it is determined that the fluid delivery device 330 location information has changed, then, the processor 210 in one embodiment is configured to retrieve one or more time based programmed functions from the memory unit 240 of the fluid delivery device 120, for example.
  • Thereafter, the processor 210 may be further configured to modify the retrieved time based preprogrammed functions in accordance with the location change information received. Then, the modified retrieved functions are provided to the user on the display unit 230, for example, to request confirmation of the time based adjustments, prior to the processor 210 executing the modified retrieved functions.
  • In addition, in one embodiment of the present disclosure, the fluid delivery device 120 may be configured to detect for daylight savings time and the processor 210 may be configured to either automatically execute the time change in the internal clock of the fluid delivery device, and/or provide a user notification to accept such time based change so that the operation of the fluid delivery device 120 performing time based programs are updated with any time based change in the insulin delivery system 120 operating environment.
  • Within the scope of the present disclosure, the fluid delivery device 120 may be configured to receive location information from any positioning system which provides updated time information based on location. The fluid delivery device 120 may be configured with a positioning transceiver that is configured to transmit location information request to a satellite network, for example, and to receive the location information therefrom.
  • Alternatively, the fluid delivery device 120 may be configured to update its location information locally upon synchronization with another device operating in the local (or at the new location). This may include a host computer terminal connectable to the fluid delivery device 120 such as, for example, the remote terminal 140 (FIG. 1), the analyte monitoring system 110, or any other electronic device operating in the new location with communication capabilities with the fluid delivery device 120 such as a cellular telephone, a personal digital assistant, and the like.
  • In addition, within the scope of the present disclosure, the procedure and processes described in conjunction with FIGS. 3-4 associated with location change information and corresponding modification to the time based preprogrammed functions in the fluid delivery device 120 may be provided to the analyte monitoring system 110 such that the analyte monitoring system 110 is also configured to receive new location information and correspondingly perform modifications to any time based preprogrammed functions.
  • FIG. 5 is a flowchart illustrating the device synchronization procedure in the therapy management system in one embodiment of the present disclosure. Referring to FIG. 5, in one embodiment the fluid delivery device 120 (FIG. 1) may be configured to detect a synchronization request from another device such as the remote terminal 140 or the analyte monitoring system 110 (FIG. 1). Thereafter, data communication connection is established between the fluid delivery device 120 and the synchronization requesting device. In one embodiment, the fluid delivery device 120 is configured to verify the authenticity or identity of the device requesting synchronization, and upon synchronization approval, the fluid delivery device 120 is configured to establish communication with the synchronization requesting device.
  • In addition, within the scope of the present disclosure, the fluid delivery device 120 may be configured to periodically or at a predetermined time interval, establish communication connection with another device for synchronization. Alternatively, the fluid delivery device may be configured to attempt communication connection when another device for synchronization is detected within a predefined distance from the location of the fluid delivery device 120.
  • Referring back to FIG. 5, the fluid delivery device 120 is configured in one embodiment to transmit its programmed and operating settings to the connected device, and the connected device is configured to update and store the data received from the fluid delivery device 120 based on predetermined conditions. For example, the predetermined conditions may include a predefined set of rules associated with the type of data from the fluid delivery device 120 to be updated such as historical infusion related information, programmed functions in the fluid delivery device 120 such as bolus calculations, temporarily basal profiles, programmed basal profiles, insulin usage level, and any other information that is associated with the user.
  • In this manner, in one embodiment of the present disclosure, periodic synchronization of the fluid delivery device 120 settings and functions may be synchronized to another device so that when the user replaces the fluid delivery device 120, the new or upgrade fluid delivery device may be easily and readily programmed to the user's specification. The synchronization described above may be configured to be performed periodically at a regular interval such as, once a week, once per day, when certain predefined criteria are met such as when the devices are within a predetermined distance from each other, and/or upon user command.
  • In addition, within the scope of the present disclosure, the fluid delivery device 120 may be configured with any communication protocol which would allow data transfer between the fluid delivery device 120 and the synchronizing device. This may include, wired or wireless communication including for example, Bluetooth protocol, 801.1x protocol, USB cable connection and the like.
  • FIG. 6 is a flowchart illustrating device condition notification function in the therapy management system in one embodiment of the present disclosure. Referring to FIG. 6 the fluid delivery device 120 may be configured to detect a notification condition. For example, the processor 210 may be configured to detect such notification conditions at a preprogrammed time interval (such as about every 24 hours, for example). Thereafter, the programmed profile associated with the condition is retrieved. An example of the programmed profile associated with the condition includes a reminder to start an overnight fast for the user.
  • Referring back to FIG. 6, the processor 210 in one embodiment is further configured to generate a message associated with the notification condition and/or the retrieved programmed profile, and, the generated message is provided to the user on one or more of the display unit 230 or the output unit 260. In this manner, in one embodiment of the present disclosure, the fluid delivery device 120 may be programmed with automatic reminders for conditions to assist the user to improve insulin therapy management.
  • In one embodiment, the notification condition detection may be skipped and the processor 210 may be configured to retrieve the appropriate programmed profile associated with notification conditions based on the user programming of the fluid delivery device 120. Additionally, while a reminder for overnight fast is described as an example, any other therapy related reminders or device operating condition reminders may be programmed for execution by the processor 210 to remind the user. Examples of such reminders include, but are not limited to, infusion set replacement reminder, battery replacement reminder, data synchronization reminder, insulin replenishment reminder, glucose testing reminder, and the like. In addition, within the scope of the present disclosure, the procedure described in conjunction with FIG. 6 may be incorporated in the analyte monitoring system 110 for programming suitable automatic reminders such as, for example, sensor replacement reminder, sensor calibration reminder, and the like.
  • FIG. 7 is a flowchart illustrating automatic time information detection function incorporated in a medical device such as a blood glucose meter of the analyte monitoring system 110 in one embodiment of the present disclosure. Referring to FIG. 7, when the medical device active state is detected (710) for example, by the user initiated power on procedure of the medical device such as a blood glucose meter, a routine is called by the processor of the medical device to automatically initiate time acquisition protocol. That is, upon power on of the medical device, the device is automatically configured to perform time acquisition protocol to, among others, transmit request for time and/or date information to available communication channels, and upon receiving the information, to store, update and/or otherwise set and/or display the received or acquired time/date information in the medical device (720-740).
  • Referring back to FIG. 7, in one embodiment, the time information is received at step 730, and thereafter, the received time information is stored and/or displayed on a display unit of the medical device. In one aspect, the medical device is configured to update all previously stored time associated data (for example, blood glucose readings taken at certain times of the day (or week, month, or any other time period)).
  • More specifically, in one embodiment, when the medical device such as the blood glucose meter is activated by the user, the processor or controller of the glucose meter is configured to enable or activate time/date receiver (for example, a communication component such as a radio frequency transceiver coupled to the processor of the glucose meter). The time/date receiver in one embodiment is configured to seek or acquire automatically, upon activation, time and date information from one or more available communication networks within range. For example, the time/date receiver may be configured to detect the time/date information from one or more radio frequencies on public, government, or private airwaves using AM band short frequency or FM band long wave frequency. Alternatively, as discussed above, current local time/date information may be received from global positioning satellites, as well as cellular telephone networks such as GSM, CDMA, AMPS, and the like within range of the time/date receiver in the medical device. Additionally, WiFi network may be used to receive the time/data information, if available and within range.
  • In this manner, in one embodiment, the medical device such as a blood glucose meter, may be configured to automatically acquire time information that is continuously broadcast on frequency which antenna and the receiver of the blood glucose meter is configured to operate. Upon obtaining and verifying the time and date information, the internal clock function or component is updated or adjusted with the acquired time/date information and displayed to the user, for example.
  • In a further embodiment, the medical device such as a blood glucose meter may be configured to use GMT time as the reference time for all log entry (for example, for each blood glucose test performed) timestamps associated with each data stored in the medical device. Thereafter, the medical device may be configured to convert the stored GMT based time information for each log entry stored in the medical device to the local time based on the location of the medical device.
  • FIG. 8 is a flowchart illustrating automatic time information detection function incorporated in a medical device such as a blood glucose meter in another embodiment of the present disclosure. Referring to FIG. 8, in one embodiment, the automatic time acquisition protocol is initiated based on a detection of one or more changed or preconfigured parameters associated with the medical device and/or the user of the medical device. For example, the device parameter may include a preconfigured time for periodically checking for time and date information (such as every 24 hours, 48 hours, or based on a programmed calendar such as to compensate for daylight savings time change).
  • Alternatively, the device parameter may include an environmental condition change associated with the medical device or the user, such as a detection of the medical device location such as during travel by air or a vehicle. That is, in one embodiment, the medical device may be configured to include an altimeter which is coupled to the processor of the medical device to detect a change in altitude of the medical device location for example, when the user of the medical device is traveling by air. In such a case, the medical device may be configured to initiate the time acquisition protocol to confirm or verify the time and date information of the medical device.
  • Further, the medical device may include an accelerometer which may be configured to initiate the automatic time acquisition protocol on the medical device when a predetermined threshold level of acceleration force is reached. Within the scope of the present disclosure, other parameters may be used in conjunction with the medical device to trigger the automatic time acquisition protocol on the medical device such that, without user intervention, prompting, or initiating, the medical device is configured to automatically initiate time and date information acquisition routine. In addition, the functionality of the automatic time and date information acquisition may be incorporated in other medical devices such as infusion pumps, continuous glucose monitoring devices, heart rate monitors, and the like that are configured to maintain a time associated log of physiological data (such as glucose levels, insulin infusion rates, cardiac signal levels and so on) of a patient or a user.
  • FIGS. 9A-9C illustrate embodiments of automatic expiration detection function on blood glucose meter test strips in accordance with one embodiment of the present disclosure. Presently, test strips for use with blood glucose meters are sold or made available in containers that include the expiration date information of the test strips contained therein. For diabetic patients or healthcare providers using glucose meters, it is important to check the expiration information of the test strip before testing for glucose levels so that the obtained results are accurate.
  • Referring to FIGS. 9A-9C, in one embodiment, test strips may be configured with predefined parameters to allow automatic expiration date detection of the test strip. In one aspect, resistance values are provided on the test strips such that when the test strip is inserted into the strip port of the blood glucose meter, the meter is configured to compare the detected resistance value to a stored value of resistance, and determine whether the inserted test strip has expired or not. More specifically, in one embodiment, using the resistance value on the test strip, the expiration date information may be coded, and the meter may be configured to detect the resistance value of the test strip and determine whether the test strip has expired.
  • In one aspect, the resistance value on the test strip may be controlled with the ink formulation on the wake up bar and/or patterns provided thereon. Silver, gold, carbon or any other suitable conductive material may be used to increase the resistance as may be desired. The blood glucose meter may be configured such that the strip port includes a current connector and predetermined control lines that may be configured to measure the resistance values coded on the test strips. More specifically, in one embodiment, the expiration dates may be coded using the resistance value on the wake-up bar in a logical sequence such as follows:
  • Resistance Value Expiration Date
    300-310 kOhm Q1 of odd year
    315-320 kOhm Q2 of odd year
    . . .
    350-360 kOhm Q1 of even year
  • Referring to FIGS. 9A-9C, it can be seen that the wavy lines may increase in thickness or length to change the resistance on the test strip. Furthermore, the pads on the test strip are shown to make contact with the wake-up bar on the strip port. By way of an example, FIG. 9A illustrates 300 KOhm trace width, FIG. 9B illustrates 315 KOhm trace width, and FIG. 9C illustrates 350 KOhm trace width, each associated with a predefined expiration date as described above.
  • In this manner, in one embodiment of the present disclosure, expiration date of test strips may be automatically detected so that the user is notified of expired date of a given test strip before it used to test for blood glucose levels. Moreover, while the automatic expiration detection is described in conjunction with test strip and blood glucose meters, within the scope of the present disclosure, other medical device or comsumable items with expiration dates may benefit from the technique described herein.
  • Furthermore, within the scope of the present disclosure, the expiration time information may be provided on the test strip using techniques other than, for example, resistance values provided on the wake up bar. That is, the coded or stored expiration time information may be provided on the test strip or other medical components such as analyte sensors, catheters, medication cartridges, for example, using capacitance, or thermal coating. Accordingly, the expiration of the test strip or consumable medical components may be readily and easily ascertained.
  • A method in one aspect of the present disclosure includes detecting a presence of a medical component, determining a resistance value associated with the medical component, retrieving a stored resistance value associated with a predetermined time information, comparing the determined resistance value to the stored resistance value, and generating an output signal based on the comparison.
  • The predetermined time information may include expiration information associated with the medical component.
  • The medical component may include one or more of an analyte sensor, a blood glucose test strip, a medication cartridge, an infusion device infusion set, or a catheter.
  • The medical component may include a glucose test strip for determining a glucose level using a predetermined volume of blood sample, where the predetermined volume may include 1.0 microliter or less of blood sample, 0.5 microliter or less of blood sample, 0.25 microliter or less of blood sample, or 0.1 microliter or less of blood sample. Additional description related to using a small volume of sample to determine analyte levels using in vitro analyte sensor is provided in U.S. Pat. Nos. 6,143,164 and 6,592,745, the disclosure of which is incorporated herein by reference for all purposes.
  • The resistance value may be provided on the medical component, using for example, silver, gold, carbon, one or more combinations thereof, or ink formulation based thereon.
  • The medical component may include a glucose test strip having a wake up bar, and further, where the resistance value is provided using ink formulation on the wake up bar.
  • The method may include outputting the generated output signal, where the generated output signal may include one or more of an audible signal such as an audible alarm, a visual signal such as, for example, graphical or text display of the information, or a vibratory signal.
  • The generated output signal may include a notification of the medical component expiration.
  • An apparatus in a further aspect of the present disclosure includes a housing, a test strip port coupled to the housing for receiving a test strip, a memory unit coupled to the housing, and a processing unit operatively coupled to the memory unit, the test strip port and the housing, the processing unit configured to detect a resistance value associated with the test strip, to retrieve a predetermined time information associated with the detected resistance value, and to generate an output signal based on the retrieved predetermined time information.
  • The test strip may include a glucose test strip.
  • The memory unit may be configured to store a plurality of predetermined resistance values, each associated with a respective predetermined time information.
  • The predetermined time information may be associated with expiration information for the test strip.
  • The predetermined time information may include time and date information.
  • The apparatus may include an output unit coupled to the housing, the display unit configured to display the generated output signal, where the output unit may include one or more of an audible output unit, a textual output unit, a vibratory output unit, or a graphical output unit.
  • The generated output signal may include a notification of the test strip expiration information.
  • A method in a further embodiment may include detecting insertion of a glucose test strip, determining a resistance value associated with the test strip, retrieving an expiration information associated with the determined resistance value, and generating an expiration notification based on the expiration information.
  • The resistance value may be provided on the test strip, for example, using ink formulation.
  • A therapy management system in one embodiment of the present disclosure includes an infusion device including a processing unit configured to perform data processing, and a user interface unit operatively coupled to a processing unit, where the processing unit is configured to detect a location information associated with the infusion device for output to the user interface unit.
  • The location information in one embodiment is time based.
  • In one aspect, the location information is associated with a local time information based on the location of the infusion device, where the location information may be received from a global positioning system (GPS) or from another device, such as a mobile telephone, a GPS enabled personal digital assistant, which has received that information from a global positioning system.
  • In one aspect, a clock unit may be operatively coupled to the processing unit, where the clock unit is configured to dynamically adjust the location information based on the location of the infusion device.
  • In a further embodiment, the clock unit may include an atomic clock.
  • The processor unit may be configured to generate a notification associated with the detected location information for output to the user interface unit, where the notification may be output to the user interface unit as one or more of a date information and time information associated with the location of the infusion device.
  • The processing unit may be configured to retrieve one or more programmed procedures associated with time, where the one or more programmed procedures may include one or more basal profiles, a programmed bolus determination schedule, a time based condition alert.
  • The time based condition alert may include one or more of a time based reminder associated with the operation of the infusion device. Further, the time based condition alert may include one or more of a time based reminder associated with the condition of the infusion device user.
  • In a further aspect, the processor unit may be configured to automatically adjust one or more time based functions associated with the operation of the infusion device based on the detected location information.
  • A method in accordance with another embodiment includes detecting a change in the location information of a therapy management device, comparing the detected change with a stored location information, and executing one or more processes associated with the operation of the therapy management device based on the detected change.
  • The detected change in the location information may include one of a time zone change, a time standard change, a date change, or combinations thereof.
  • The one or more processes may include generating a notification associated with the detected change in the location information.
  • Further, the one or more processes may include modifying one or more programmed time based functions of the therapy management device and which may include one or more of a programmed time based alert, a programmed time based fluid delivery determination; a programmed time based fluid delivery profile, or a programmed time based operational condition of the therapy management device.
  • In still another aspect, the therapy management device may include one or more of an infusion device or an analyte monitoring unit.
  • A therapy management system in accordance with still another embodiment of the present disclosure includes an infusion device, and a communication unit operatively coupled to the infusion device over a wireless data network, the communication device configured to transmit a request for synchronization to the infusion device, where the infusion device may be configured to transmit one or more data to the communication unit in response to the received synchronization request.
  • The wireless data network may be based on one or more of a Bluetooth communication protocol, an RF communication protocol, an infrared communication protocol, a Zigbee communication protocol, an 802.1x communication protocol, or a wireless personal area network such as ANT protocol.
  • In a further aspect, the wireless data network may include one or more of a wireless local area network, or a WiFi network.
  • The communication unit may be configured to periodically transmit the synchronization request at a predetermined time interval.
  • Further, the infusion device may be configured to verify the received synchronization request before transmitting the one or more data to the communication unit.
  • The transmitted one or more data to the communication unit may be encrypted, and also, the communication unit may be configured to decrypt the received one or more encrypted data.
  • The transmitted one or more data may include one or more information associated with the stored user profile of the infusion device, an operating parameter of the infusion device, or infusion delivery information.
  • The communication unit may include one or more of an analyte monitoring unit, a personal digital assistant, a mobile telephone, a computer terminal, a server terminal or an additional infusion device.
  • A system for communicating with an infusion device in still another embodiment of the present disclosure includes a voice enabled device and an infusion device configured to communicate with the voice enabled device using one or more voice signals.
  • In one aspect, the voice enabled device may include one or more of a telephone set, a mobile telephone, a voice of IP (Internet Protocol) telephone, a voice enabled computing device, or a voice enabled computer terminal.
  • The infusion device may be configured to initiate a voice enabled communication to the voice enabled device. For example, the infusion device may be integrated with mobile telephone components.
  • In one aspect, the voice enabled communication may include a telephone call.
  • The infusion device may be configured to receive one or more voice commands from the voice enabled device, where the infusion device may be configured to process the one or more voice commands to execute one or more associated functions of the infusion device operation.
  • The one or more associated functions include a bolus dosage determination, a programmable notification, or a temporarily basal dosage determination.
  • A method in accordance with yet still another embodiment of the present disclosure includes initiating a voice signal based communication from an infusion device, and transmitting a voice signal associated with the operation of the infusion device.
  • The method may also include receiving a voice signal based request over a communication network, and executing one or more functions associated with the operation of the infusion device based on the received voice signal based request.
  • The voice signal based communication may include a telephone call.
  • A therapy management kit in accordance with still yet another embodiment includes an infusion device including a processing unit configured to perform data processing, and a user interface unit operatively coupled to a processing unit, where the processing unit is configured to detect a location information associated with the infusion device for output to the user interface unit.
  • The kit may further include a clock unit operatively coupled to the processing unit, where the clock unit is configured to dynamically adjust the location information based on the location of the infusion device.
  • The clock unit may include an atomic clock.
  • In a further aspect, the kit may also include a voice enabled device, where the infusion device may be further configured to communicate with the voice enabled device using one or more voice signals.
  • In one aspect, the voice enabled device may include one or more of a telephone set, a mobile telephone, a voice of IP (Internet Protocol) telephone, a voice enabled computing device, or a voice enabled computer terminal.
  • The various processes described above including the processes performed by the processor 210 in the software application execution environment in the fluid delivery device 120 as well as any other suitable or similar processing units embodied in the analyte monitoring system 120 and the remote terminal 140, including the processes and routines described in conjunction with FIGS. 3-8, may be embodied as computer programs developed using an object oriented language that allows the modeling of complex systems with modular objects to create abstractions that are representative of real world, physical objects and their interrelationships. The software required to carry out the inventive process, which may be stored in the memory unit 240 (or similar storage devices in the analyte monitoring system 110 or the remote terminal 140) of the processor 210, may be developed by a person of ordinary skill in the art and may include one or more computer program products.
  • In addition, all references cited above herein, in addition to the background and summary of the invention sections, are hereby incorporated by reference into the detailed description of the preferred embodiments as disclosing alternative embodiments and components.
  • Various other modifications and alterations in the structure and method of operation of this invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. It is intended that the following claims define the scope of the present disclosure and that structures and methods within the scope of these claims and their equivalents be covered thereby.

Claims (31)

1. A method, comprising:
detecting a presence of a medical component;
determining a resistance value associated with the medical component;
retrieving a stored resistance value associated with a predetermined time information;
comparing the determined resistance value to the stored resistance value; and
generating an output signal based on the comparison.
2. The method of claim 1 wherein the predetermined time information includes expiration information associated with the medical component.
3. The method of claim 1 wherein the medical component includes one or more of an analyte sensor, a blood glucose test strip, a medication cartridge, an infusion device infusion set, or a catheter.
4. The method of claim 1 wherein the medical component includes a glucose test strip for determining a glucose level using a predetermined volume of blood sample.
5. The method of claim 4 wherein the predetermined volume includes 1.0 microliter or less of blood sample.
6. The method of claim 4 wherein the predetermined volume includes 0.5 microliter or less of blood sample.
7. The method of claim 4 wherein the predetermined volume includes 0.25 microliter or less of blood sample.
8. The method of claim 4 wherein the predetermined volume includes 0.1 microliter or less of blood sample.
9. The method of claim 1 wherein the resistance value is provided on the medical component.
10. The method of claim 4 wherein the resistance value is provided on the medical component using ink formulation.
11. The method of claim 1 wherein the medical component includes a glucose test strip having a wake up bar, and further, wherein the resistance value is provided using ink formulation on the wake up bar.
12. The method of claim 1 including outputting the generated output signal.
13. The method of claim 12 wherein the generated output signal includes one or more of an audible signal, a visual signal, or a vibratory signal.
14. The method of claim 12 wherein the generated output signal includes a notification of the medical component expiration.
15. An apparatus, comprising:
a housing;
a test strip port coupled to the housing for receiving a test strip;
a memory unit coupled to the housing; and
a processing unit operatively coupled to the memory unit, the test strip port and the housing, the processing unit configured to detect a resistance value associated with the test strip, to retrieve a predetermined time information associated with the detected resistance value, and to generate an output signal based on the retrieved predetermined time information.
16. The apparatus of claim 15 wherein the test strip includes an analyte test strip.
17. The apparatus of claim 16 wherein the analyte test strip includes a sample chamber for receiving a predetermined volume of blood sample to determine a glucose level.
18. The apparatus of claim 17 wherein the predetermined volume includes 1.0 microliter or less of blood sample.
19. The apparatus of claim 17 wherein the predetermined volume includes 0.5 microliter or less of blood sample.
20. The apparatus of claim 17 wherein the predetermined volume includes 0.25 microliter or less of blood sample.
21. The apparatus of claim 17 wherein the predetermined volume includes 0.1 microliter or less of blood sample.
22. The apparatus of claim 15 wherein the memory unit is configured to store a plurality of predetermined resistance values, each associated with a respective predetermined time information.
23. The apparatus of claim 15 wherein the predetermined time information is associated with expiration information for the test strip.
24. The apparatus of claim 15 wherein the predetermined time information includes time and date information.
25. The apparatus of claim 15 including an output unit coupled to the housing, the display unit configured to display the generated output signal.
26. The apparatus of claim 25 wherein the output unit includes one or more of an audible output unit, a textual output unit, a vibratory output unit, or a graphical output unit.
27. The apparatus of claim 15 wherein the generated output signal includes a notification of the test strip expiration information.
28. A method, comprising:
detecting insertion of a glucose test strip;
determining a resistance value associated with the test strip;
retrieving an expiration information associated with the determined resistance value; and
generating an expiration notification based on the expiration information.
29. The method of claim 18 wherein the resistance value is provided on the test strip.
30. The method of claim 29 wherein the resistance value is provided on the test strip using ink formulation.
31. The method of claim 30 wherein the ink formulation includes one or more of carbon, silver, gold, or one or more combinations thereof.
US12/031,660 2007-02-15 2008-02-14 Device and method for automatic data acquisition and/or detection Abandoned US20080199894A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US12/031,660 US20080199894A1 (en) 2007-02-15 2008-02-14 Device and method for automatic data acquisition and/or detection
EP08730051A EP2124720A4 (en) 2007-02-15 2008-02-15 Device and method for automatic data acquisition and/or detection
PCT/US2008/054171 WO2008101217A2 (en) 2007-02-15 2008-02-15 Device and method for automatic data acquisition and/or detection
CA002677739A CA2677739A1 (en) 2007-02-15 2008-02-15 Device and method for automatic data acquisition and/or detection
BRPI0807500-0A2A BRPI0807500A2 (en) 2007-02-15 2008-02-15 APPARATUS AND METHOD FOR AUTOMATIC DATA ACQUISITION AND / OR DETECTION
RU2009134335/14A RU2009134335A (en) 2007-02-15 2008-02-15 DEVICE AND METHOD FOR AUTOMATIC DATA COLLECTION AND / OR DETECTION
US14/829,611 US10022499B2 (en) 2007-02-15 2015-08-18 Device and method for automatic data acquisition and/or detection
US16/020,966 US10617823B2 (en) 2007-02-15 2018-06-27 Device and method for automatic data acquisition and/or detection

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89016107P 2007-02-15 2007-02-15
US12/031,660 US20080199894A1 (en) 2007-02-15 2008-02-14 Device and method for automatic data acquisition and/or detection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/829,611 Continuation US10022499B2 (en) 2007-02-15 2015-08-18 Device and method for automatic data acquisition and/or detection

Publications (1)

Publication Number Publication Date
US20080199894A1 true US20080199894A1 (en) 2008-08-21

Family

ID=39690834

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/031,660 Abandoned US20080199894A1 (en) 2007-02-15 2008-02-14 Device and method for automatic data acquisition and/or detection
US14/829,611 Active 2029-03-13 US10022499B2 (en) 2007-02-15 2015-08-18 Device and method for automatic data acquisition and/or detection
US16/020,966 Active US10617823B2 (en) 2007-02-15 2018-06-27 Device and method for automatic data acquisition and/or detection

Family Applications After (2)

Application Number Title Priority Date Filing Date
US14/829,611 Active 2029-03-13 US10022499B2 (en) 2007-02-15 2015-08-18 Device and method for automatic data acquisition and/or detection
US16/020,966 Active US10617823B2 (en) 2007-02-15 2018-06-27 Device and method for automatic data acquisition and/or detection

Country Status (6)

Country Link
US (3) US20080199894A1 (en)
EP (1) EP2124720A4 (en)
BR (1) BRPI0807500A2 (en)
CA (1) CA2677739A1 (en)
RU (1) RU2009134335A (en)
WO (1) WO2008101217A2 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100331652A1 (en) * 2009-06-29 2010-12-30 Roche Diagnostics Operations, Inc. Modular diabetes management systems
US20100331651A1 (en) * 2009-06-29 2010-12-30 Roche Diagnostics Operations, Inc. Blood glucose management and interface systems and methods
US20110155584A1 (en) * 2009-12-30 2011-06-30 Lifescan, Inc. Systems, Devices, and Methods for Measuring Whole Blood Hematocrit Based on Initial Fill Velocity
US20110155585A1 (en) * 2009-12-30 2011-06-30 Lifescan, Inc. Systems, Devices, and Methods for Improving Accuracy of Biosensors Using Fill Time
WO2011112974A1 (en) * 2010-03-11 2011-09-15 University Of Virginia Patent Foundation Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes
US8617370B2 (en) 2010-09-30 2013-12-31 Cilag Gmbh International Systems and methods of discriminating between a control sample and a test fluid using capacitance
US8932445B2 (en) 2010-09-30 2015-01-13 Cilag Gmbh International Systems and methods for improved stability of electrochemical sensors
US9445445B2 (en) 2013-03-14 2016-09-13 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US9681807B2 (en) 2013-03-14 2017-06-20 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
WO2017124099A1 (en) * 2016-01-14 2017-07-20 Bigfoot Biomedical, Inc. Diabetes management system
US20180356386A1 (en) * 2015-05-01 2018-12-13 Ahkeo Labs, Llc Systems and methods for dipstick diagnostic tools and related methods
US10163311B2 (en) 2016-02-16 2018-12-25 Above the Fold, LLP Systems for tracking medications
CN109669042A (en) * 2019-03-01 2019-04-23 青岛大学附属医院 A kind of division of endocrinology's diabetes fast testing apparatus
US10860687B2 (en) 2012-12-31 2020-12-08 Dexcom, Inc. Remote monitoring of analyte measurements
US10856736B2 (en) 2012-12-31 2020-12-08 Dexcom, Inc. Remote monitoring of analyte measurements
US10881335B2 (en) 2016-03-31 2021-01-05 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US10932672B2 (en) 2015-12-28 2021-03-02 Dexcom, Inc. Systems and methods for remote and host monitoring communications
US11077312B2 (en) * 2019-01-03 2021-08-03 Avive Solutions, Inc. Defibrillator communications architecture
US20210268174A1 (en) * 2007-09-06 2021-09-02 Bigfoot Biomedical, Inc. Operating a portable medical device
US11330058B2 (en) 2014-01-13 2022-05-10 Carefusion 303, Inc. Remote flashing during infusion

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US7640048B2 (en) 2004-07-13 2009-12-29 Dexcom, Inc. Analyte sensor
WO2006127694A2 (en) 2004-07-13 2006-11-30 Dexcom, Inc. Analyte sensor
US20060020192A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20080199894A1 (en) * 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
EP2252196A4 (en) 2008-02-21 2013-05-15 Dexcom Inc Systems and methods for processing, transmitting and displaying sensor data
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
CN102395880A (en) * 2009-04-17 2012-03-28 环球生物医疗感测仪私人有限公司 On-board control detection
US9041730B2 (en) 2010-02-12 2015-05-26 Dexcom, Inc. Receivers for analyzing and displaying sensor data
US8394343B2 (en) * 2010-04-27 2013-03-12 Roche Diagnostics Operations, Inc. Integrated test strip container with retaining insert
US8855550B2 (en) * 2011-01-14 2014-10-07 Covidien Lp Wireless relay module having emergency call functionality
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
CN106061528B (en) 2013-10-24 2020-10-16 波士顿大学信托人 Infusion system for preventing misdirection of multiple medicaments
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
CN103705247A (en) * 2013-12-09 2014-04-09 杨荣 Blood glucose meter with blood glucose change recording function
CA2935565A1 (en) 2013-12-31 2015-07-09 Senseonics, Incorporated Continuous analyte monitoring system
US10832495B2 (en) 2014-04-18 2020-11-10 Carefusion 303, Inc. Remote maintenance of medical devices
US9878097B2 (en) 2015-04-29 2018-01-30 Bigfoot Biomedical, Inc. Operating an infusion pump system
JP7125204B2 (en) 2015-07-08 2022-08-24 トラスティーズ オブ ボストン ユニバーシティ Infusion system and its components
US10987468B2 (en) 2016-01-05 2021-04-27 Bigfoot Biomedical, Inc. Operating multi-modal medicine delivery systems
US10449294B1 (en) 2016-01-05 2019-10-22 Bigfoot Biomedical, Inc. Operating an infusion pump system
WO2018129354A1 (en) 2017-01-06 2018-07-12 Trustees Of Boston University Infusion system and components thereof
USD853583S1 (en) 2017-03-29 2019-07-09 Becton, Dickinson And Company Hand-held device housing
EP3634528B1 (en) 2017-06-07 2023-06-07 Shifamed Holdings, LLC Intravascular fluid movement devices, systems, and methods of use
WO2019094963A1 (en) 2017-11-13 2019-05-16 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
US10722631B2 (en) 2018-02-01 2020-07-28 Shifamed Holdings, Llc Intravascular blood pumps and methods of use and manufacture
CN108597619B (en) * 2018-04-26 2019-05-17 北京大医同盟健康管理有限责任公司 Based on distributed intelligence body temperature monitoring management system
WO2020056001A1 (en) 2018-09-11 2020-03-19 Senseonics, Incorporated An analyte monitoring system
DE112020003400T5 (en) 2019-07-16 2022-03-31 Beta Bionics, Inc. OUTPATIENT INSTITUTION AND ITS COMPONENTS
WO2021016372A1 (en) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
US11724089B2 (en) 2019-09-25 2023-08-15 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
US11660393B2 (en) * 2020-04-24 2023-05-30 Medtronic, Inc. Emergency management implantable drug delivery systems

Citations (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4245634A (en) * 1975-01-22 1981-01-20 Hospital For Sick Children Artificial beta cell
US4373527A (en) * 1979-04-27 1983-02-15 The Johns Hopkins University Implantable, programmable medication infusion system
US4425920A (en) * 1980-10-24 1984-01-17 Purdue Research Foundation Apparatus and method for measurement and control of blood pressure
US4494950A (en) * 1982-01-19 1985-01-22 The Johns Hopkins University Plural module medication delivery system
US4890620A (en) * 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US4986271A (en) * 1989-07-19 1991-01-22 The University Of New Mexico Vivo refillable glucose sensor
US4995402A (en) * 1988-10-12 1991-02-26 Thorne, Smith, Astill Technologies, Inc. Medical droplet whole blood and like monitoring
US5082550A (en) * 1989-12-11 1992-01-21 The United States Of America As Represented By The Department Of Energy Enzyme electrochemical sensor electrode and method of making it
US5279294A (en) * 1985-04-08 1994-01-18 Cascade Medical, Inc. Medical diagnostic system
US5285792A (en) * 1992-01-10 1994-02-15 Physio-Control Corporation System for producing prioritized alarm messages in a medical instrument
US5379238A (en) * 1989-03-03 1995-01-03 Stark; Edward W. Signal processing method and apparatus
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5489414A (en) * 1993-04-23 1996-02-06 Boehringer Mannheim, Gmbh System for analyzing compounds contained in liquid samples
US5593852A (en) * 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5711001A (en) * 1992-05-08 1998-01-20 Motorola, Inc. Method and circuit for acquisition by a radio receiver
US5711861A (en) * 1995-11-22 1998-01-27 Ward; W. Kenneth Device for monitoring changes in analyte concentration
US6024699A (en) * 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
US6032064A (en) * 1996-10-11 2000-02-29 Aspect Medical Systems, Inc. Electrode array system for measuring electrophysiological signals
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US20020019022A1 (en) * 1998-09-30 2002-02-14 Cygnus, Inc. Method and device for predicting physiological values
US20030004403A1 (en) * 2001-06-29 2003-01-02 Darrel Drinan Gateway platform for biological monitoring and delivery of therapeutic compounds
US20030023317A1 (en) * 2001-07-27 2003-01-30 Dexcom, Inc. Membrane for use with implantable devices
US20030032874A1 (en) * 2001-07-27 2003-02-13 Dexcom, Inc. Sensor head for use with implantable devices
US20030036145A1 (en) * 1997-09-18 2003-02-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030039298A1 (en) * 2001-08-22 2003-02-27 Lear Corporation System and method of vehicle climate control
US20040010207A1 (en) * 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
US20040011671A1 (en) * 1997-03-04 2004-01-22 Dexcom, Inc. Device and method for determining analyte levels
US6687546B2 (en) * 2000-01-21 2004-02-03 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a robust communication protocol
US6689056B1 (en) * 1999-04-07 2004-02-10 Medtronic Endonetics, Inc. Implantable monitoring probe
US6695860B1 (en) * 2000-11-13 2004-02-24 Isense Corp. Transcutaneous sensor insertion device
US20040073266A1 (en) * 2002-10-15 2004-04-15 Haefner Paul A. Automatic detection of defibrillation lead
US6743635B2 (en) * 2002-04-25 2004-06-01 Home Diagnostics, Inc. System and methods for blood glucose sensing
US20050004439A1 (en) * 2000-02-23 2005-01-06 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US20050004494A1 (en) * 2001-01-22 2005-01-06 Perez Edward P. Lancet device having capillary action
US20050027177A1 (en) * 2000-02-23 2005-02-03 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US20050031689A1 (en) * 2003-05-21 2005-02-10 Dexcom, Inc. Biointerface membranes incorporating bioactive agents
US20050038332A1 (en) * 2001-12-27 2005-02-17 Frank Saidara System for monitoring physiological characteristics
US20050043598A1 (en) * 2003-08-22 2005-02-24 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20060004270A1 (en) * 2004-06-23 2006-01-05 Michel Bedard Method and apparatus for the monitoring of clinical states
US20060001538A1 (en) * 2004-06-30 2006-01-05 Ulrich Kraft Methods of monitoring the concentration of an analyte
US20060015020A1 (en) * 2004-07-06 2006-01-19 Dexcom, Inc. Systems and methods for manufacture of an analyte-measuring device including a membrane system
US20060015024A1 (en) * 2004-07-13 2006-01-19 Mark Brister Transcutaneous medical device with variable stiffness
US20060020191A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060016700A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060031094A1 (en) * 2004-08-06 2006-02-09 Medtronic Minimed, Inc. Medical data management system and process
US20060029177A1 (en) * 2001-01-16 2006-02-09 International Business Machines Corporation Unified digital architecture
US6998247B2 (en) * 2002-03-08 2006-02-14 Sensys Medical, Inc. Method and apparatus using alternative site glucose determinations to calibrate and maintain noninvasive and implantable analyzers
US6997907B2 (en) * 1997-02-05 2006-02-14 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US7003340B2 (en) * 1998-03-04 2006-02-21 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US7003336B2 (en) * 2000-02-10 2006-02-21 Medtronic Minimed, Inc. Analyte sensor method of making the same
US20070016381A1 (en) * 2003-08-22 2007-01-18 Apurv Kamath Systems and methods for processing analyte sensor data
US20070027381A1 (en) * 2005-07-29 2007-02-01 Therasense, Inc. Inserter and methods of use
US20080009692A1 (en) * 2005-09-30 2008-01-10 Abbott Diabetes Care, Inc. Method and Apparatus for Providing Analyte Sensor and Data Processing Device
US20080021666A1 (en) * 2003-08-01 2008-01-24 Dexcom, Inc. System and methods for processing analyte sensor data
US20080017522A1 (en) * 1997-02-06 2008-01-24 Therasense, Inc. Integrated Lancing and Measurement Device
US20080029391A1 (en) * 2001-05-15 2008-02-07 Abbott Diabetes Care, Inc. Biosensor Membranes Composed of Polymers Containing Heterocyclic Nitrogens
US20080033254A1 (en) * 2003-07-25 2008-02-07 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US20080039702A1 (en) * 2006-08-09 2008-02-14 Abbott Diabetes Care, Inc. Method and System for Providing Calibration of an Analyte Sensor in an Analyte Monitoring System
US20080045824A1 (en) * 2003-10-28 2008-02-21 Dexcom, Inc. Silicone composition for biocompatible membrane
US20090005665A1 (en) * 2007-05-14 2009-01-01 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090006034A1 (en) * 2007-05-14 2009-01-01 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US7476827B1 (en) * 2001-08-29 2009-01-13 Roche Diagnostics Operations, Inc. Method of making a biosensor
US20090018425A1 (en) * 2005-12-28 2009-01-15 Tianmei Ouyang Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US20090018424A1 (en) * 2006-10-04 2009-01-15 Dexcom, Inc. Analyte sensor
US20090030294A1 (en) * 2004-05-03 2009-01-29 Dexcom, Inc. Implantable analyte sensor
US20090036763A1 (en) * 2004-07-13 2009-02-05 Dexcom, Inc. Analyte sensor
US20090036760A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090033482A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090036747A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090036758A1 (en) * 2003-12-09 2009-02-05 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100016698A1 (en) * 2003-11-19 2010-01-21 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US7651596B2 (en) * 2005-04-08 2010-01-26 Dexcom, Inc. Cellulosic-based interference domain for an analyte sensor

Family Cites Families (826)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935099A (en) 1992-09-09 1999-08-10 Sims Deltec, Inc. Drug pump systems and methods
GB1191363A (en) 1968-02-19 1970-05-13 Pavelle Ltd Improvements in or relating to Electronic Thermostats.
US3949388A (en) 1972-11-13 1976-04-06 Monitron Industries, Inc. Physiological sensor and transmitter
US3926760A (en) 1973-09-28 1975-12-16 Du Pont Process for electrophoretic deposition of polymer
US4036749A (en) 1975-04-30 1977-07-19 Anderson Donald R Purification of saline water
US4031449A (en) 1975-11-20 1977-06-21 Arthur D. Little, Inc. Electromagnetically coupled battery charger
US4055175A (en) 1976-05-07 1977-10-25 Miles Laboratories, Inc. Blood glucose control apparatus
US4129128A (en) 1977-02-23 1978-12-12 Mcfarlane Richard H Securing device for catheter placement assembly
US4344438A (en) 1978-08-02 1982-08-17 The United States Of America As Represented By The Department Of Health, Education And Welfare Optical sensor of plasma constituents
AU530979B2 (en) 1978-12-07 1983-08-04 Aus. Training Aids Pty. Ltd., Detecting position of bullet fired at target
AU546785B2 (en) 1980-07-23 1985-09-19 Commonwealth Of Australia, The Open-loop controlled infusion of diabetics
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4392849A (en) 1981-07-27 1983-07-12 The Cleveland Clinic Foundation Infusion pump controller
US4445090A (en) 1981-08-26 1984-04-24 Towmotor Corporation Voltage level monitoring and indicating apparatus
DE3138194A1 (en) 1981-09-25 1983-04-14 Basf Ag, 6700 Ludwigshafen WATER-INSOLUBLE POROESES PROTEIN MATERIAL, THEIR PRODUCTION AND USE
FI831399L (en) 1982-04-29 1983-10-30 Agripat Sa KONTAKTLINS AV HAERDAD POLYVINYL ALCOHOL
US4509531A (en) 1982-07-28 1985-04-09 Teledyne Industries, Inc. Personal physiological monitor
US4464170A (en) 1982-09-29 1984-08-07 Miles Laboratories, Inc. Blood glucose control apparatus and method
GB2128453A (en) 1982-10-08 1984-04-26 Philips Electronic Associated System identification in communications systems
US4527240A (en) 1982-12-29 1985-07-02 Kvitash Vadim I Balascopy method for detecting and rapidly evaluating multiple imbalances within multi-parametric systems
CA1226036A (en) 1983-05-05 1987-08-25 Irving J. Higgins Analytical equipment and sensor electrodes therefor
US5509410A (en) 1983-06-06 1996-04-23 Medisense, Inc. Strip electrode including screen printing of a single layer
US4538616A (en) 1983-07-25 1985-09-03 Robert Rogoff Blood sugar level sensing and monitoring transducer
US4583035A (en) 1984-03-05 1986-04-15 Sloan Albert H Apparatus for monitoring and charging electric storage battery
DE3429596A1 (en) 1984-08-10 1986-02-20 Siemens AG, 1000 Berlin und 8000 München DEVICE FOR THE PHYSIOLOGICAL FREQUENCY CONTROL OF A PACEMAKER PROVIDED WITH A PICTURE ELECTRODE
CA1254091A (en) 1984-09-28 1989-05-16 Vladimir Feingold Implantable medication infusion system
US4847785A (en) 1985-01-22 1989-07-11 International Business Machines Corp. Interactive display for trend or bar graph
US4671288A (en) 1985-06-13 1987-06-09 The Regents Of The University Of California Electrochemical cell sensor for continuous short-term use in tissues and blood
US5245314A (en) 1985-09-18 1993-09-14 Kah Jr Carl L C Location monitoring system
US4684245A (en) 1985-10-28 1987-08-04 Oximetrix, Inc. Electro-optical coupler for catheter oximeter
US4723625A (en) 1985-12-16 1988-02-09 Susan Komlos Sobriety tester
US4757022A (en) 1986-04-15 1988-07-12 Markwell Medical Institute, Inc. Biological fluid measuring device
US4703756A (en) 1986-05-06 1987-11-03 The Regents Of The University Of California Complete glucose monitoring system with an implantable, telemetered sensor module
US4731726A (en) 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
US5055171A (en) 1986-10-06 1991-10-08 T And G Corporation Ionic semiconductor materials and applications thereof
US4777953A (en) 1987-02-25 1988-10-18 Ash Medical Systems, Inc. Capillary filtration and collection method for long-term monitoring of blood constituents
US5002054A (en) 1987-02-25 1991-03-26 Ash Medical Systems, Inc. Interstitial filtration and collection device and method for long-term monitoring of physiological constituents of the body
US4854322A (en) 1987-02-25 1989-08-08 Ash Medical Systems, Inc. Capillary filtration and collection device for long-term monitoring of blood constituents
US4759828A (en) 1987-04-09 1988-07-26 Nova Biomedical Corporation Glucose electrode and method of determining glucose
US4749985A (en) 1987-04-13 1988-06-07 United States Of America As Represented By The United States Department Of Energy Functional relationship-based alarm processing
EP0290683A3 (en) 1987-05-01 1988-12-14 Diva Medical Systems B.V. Diabetes management system and apparatus
US4818994A (en) 1987-10-22 1989-04-04 Rosemount Inc. Transmitter with internal serial bus
GB8725936D0 (en) 1987-11-05 1987-12-09 Genetics Int Inc Sensing system
US4925268A (en) 1988-07-25 1990-05-15 Abbott Laboratories Fiber-optic physiological probes
EP0353328A1 (en) 1988-08-03 1990-02-07 Dräger Nederland B.V. A polarographic-amperometric three-electrode sensor
US5340722A (en) 1988-08-24 1994-08-23 Avl Medical Instruments Ag Method for the determination of the concentration of an enzyme substrate and a sensor for carrying out the method
US5360404A (en) 1988-12-14 1994-11-01 Inviro Medical Devices Ltd. Needle guard and needle assembly for syringe
US5068536A (en) 1989-01-19 1991-11-26 Futrex, Inc. Method for providing custom calibration for near infrared instruments for measurement of blood glucose
US5305008A (en) 1991-08-12 1994-04-19 Integrated Silicon Design Pty. Ltd. Transponder system
JPH02298855A (en) 1989-03-20 1990-12-11 Assoc Univ Inc Electrochemical biosensor using immobilized enzyme and redox polymer
US4953552A (en) 1989-04-21 1990-09-04 Demarzo Arthur P Blood glucose monitoring system
EP0396788A1 (en) 1989-05-08 1990-11-14 Dräger Nederland B.V. Process and sensor for measuring the glucose content of glucosecontaining fluids
FR2648353B1 (en) 1989-06-16 1992-03-27 Europhor Sa MICRODIALYSIS PROBE
US5431160A (en) 1989-07-19 1995-07-11 University Of New Mexico Miniature implantable refillable glucose sensor and material therefor
US5264105A (en) 1989-08-02 1993-11-23 Gregg Brian A Enzyme electrodes
US5262035A (en) 1989-08-02 1993-11-16 E. Heller And Company Enzyme electrodes
US5264104A (en) 1989-08-02 1993-11-23 Gregg Brian A Enzyme electrodes
US5320725A (en) 1989-08-02 1994-06-14 E. Heller & Company Electrode and method for the detection of hydrogen peroxide
US5050612A (en) 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
US5342789A (en) 1989-12-14 1994-08-30 Sensor Technologies, Inc. Method and device for detecting and quantifying glucose in body fluids
US5051688A (en) 1989-12-20 1991-09-24 Rohm Co., Ltd. Crossed coil meter driving device having a plurality of input parameters
US5061941A (en) 1990-02-01 1991-10-29 Checkpoint Systems, Inc. Composite antenna for electronic article surveillance systems
US5165407A (en) 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor
US5112455A (en) 1990-07-20 1992-05-12 I Stat Corporation Method for analytically utilizing microfabricated sensors during wet-up
US5124661A (en) 1990-07-23 1992-06-23 I-Stat Corporation Reusable test unit for simulating electrochemical sensor signals for quality assurance of portable blood analyzer instruments
ATE106015T1 (en) 1990-09-28 1994-06-15 Pfizer METER DELIVERY DEVICE CONTAINING A HYDROPHOBIC AGENT.
JP2704672B2 (en) 1990-12-12 1998-01-26 シャーウッド・アイエムエス・インコーポレイテッド Infrared thermometer using calibration mapping
US5262305A (en) 1991-03-04 1993-11-16 E. Heller & Company Interferant eliminating biosensors
JPH04278450A (en) 1991-03-04 1992-10-05 Adam Heller Biosensor and method for analyzing subject
US5469855A (en) 1991-03-08 1995-11-28 Exergen Corporation Continuous temperature monitor
US5135004A (en) 1991-03-12 1992-08-04 Incontrol, Inc. Implantable myocardial ischemia monitor and related method
US5122925A (en) 1991-04-22 1992-06-16 Control Products, Inc. Package for electronic components
US5289497A (en) 1991-05-23 1994-02-22 Interdigital Technology Corporation Broadcast synchronized communication system
CA2074702C (en) 1991-07-29 1996-11-19 Donald J. Urbas Programmable transponder
GB9120144D0 (en) 1991-09-20 1991-11-06 Imperial College A dialysis electrode device
EP0566710A1 (en) 1991-09-26 1993-10-27 Hans BÄR Medico-technical process and means for measuring blood irrigation of organs
US5322063A (en) 1991-10-04 1994-06-21 Eli Lilly And Company Hydrophilic polyurethane membranes for electrochemical glucose sensors
US5372427A (en) 1991-12-19 1994-12-13 Texas Instruments Incorporated Temperature sensor
US5246867A (en) 1992-01-17 1993-09-21 University Of Maryland At Baltimore Determination and quantification of saccharides by luminescence lifetimes and energy transfer
IL104365A0 (en) 1992-01-31 1993-05-13 Gensia Pharma Method and apparatus for closed loop drug delivery
NL9200207A (en) 1992-02-05 1993-09-01 Nedap Nv IMPLANTABLE BIOMEDICAL SENSOR DEVICE, IN PARTICULAR FOR MEASUREMENT OF THE GLUCOSE CONCENTRATION.
US5328927A (en) 1992-03-03 1994-07-12 Merck Sharpe & Dohme, Ltd. Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
ZA931077B (en) 1992-03-05 1994-01-04 Qualcomm Inc Apparatus and method for reducing message collision between mobile stations simultaneously accessing a base station in a cdma cellular communications system
DE69319771T2 (en) 1992-03-31 1999-04-22 Dainippon Printing Co Ltd Immobilized enzyme electrode, composition for its production and electrically conductive enzymes
EP0636009B1 (en) 1992-04-03 2000-11-29 Micromedical Industries Limited system for physiological monitoring
FR2690622B1 (en) 1992-04-29 1995-01-20 Chronotec Programmable ambulatory infusion pump system.
GB9211402D0 (en) 1992-05-29 1992-07-15 Univ Manchester Sensor devices
DK95792A (en) 1992-07-24 1994-01-25 Radiometer As Sensor for non-invasive, in vivo determination of an analyte and blood flow
US5465079A (en) 1992-08-14 1995-11-07 Vorad Safety Systems, Inc. Method and apparatus for determining driver fitness in real time
WO1994010553A1 (en) 1992-10-23 1994-05-11 Optex Biomedical, Inc. Fibre-optic probe for the measurement of fluid parameters
US5956501A (en) 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
US20030212579A1 (en) 2002-05-08 2003-11-13 Brown Stephen J. Remote health management system
US5899855A (en) 1992-11-17 1999-05-04 Health Hero Network, Inc. Modular microprocessor-based health monitoring system
ZA938555B (en) 1992-11-23 1994-08-02 Lilly Co Eli Technique to improve the performance of electrochemical sensors
US5410326A (en) 1992-12-04 1995-04-25 Goldstein; Steven W. Programmable remote control device for interacting with a plurality of remotely controlled devices
US5342408A (en) 1993-01-07 1994-08-30 Incontrol, Inc. Telemetry system for an implantable cardiac device
US5499243A (en) 1993-01-22 1996-03-12 Hall; Dennis R. Method and apparatus for coordinating transfer of information between a base station and a plurality of radios
US5299571A (en) 1993-01-22 1994-04-05 Eli Lilly And Company Apparatus and method for implantation of sensors
US5371787A (en) 1993-03-01 1994-12-06 Dialogic Corporation Machine answer detection
US5600301A (en) 1993-03-11 1997-02-04 Schrader Automotive Inc. Remote tire pressure monitoring system employing coded tire identification and radio frequency transmission, and enabling recalibration upon tire rotation or replacement
US5400794A (en) 1993-03-19 1995-03-28 Gorman; Peter G. Biomedical response monitor and technique using error correction
US5558638A (en) 1993-04-30 1996-09-24 Healthdyne, Inc. Patient monitor and support system
WO1995006431A2 (en) 1993-08-24 1995-03-09 Robinson Mark R A robust accurate non-invasive analyte monitor
DE4329898A1 (en) 1993-09-04 1995-04-06 Marcus Dr Besson Wireless medical diagnostic and monitoring device
US5438983A (en) 1993-09-13 1995-08-08 Hewlett-Packard Company Patient alarm detection using trend vector analysis
US5582184A (en) 1993-10-13 1996-12-10 Integ Incorporated Interstitial fluid collection and constituent measurement
US5497772A (en) 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5791344A (en) 1993-11-19 1998-08-11 Alfred E. Mann Foundation For Scientific Research Patient monitoring system
FR2713372B1 (en) 1993-12-01 1996-03-01 Neopost Ind Thermal protection device for secure electronic device, in particular postage meter.
US5320715A (en) 1994-01-14 1994-06-14 Lloyd Berg Separation of 1-pentanol from cyclopentanol by extractive distillation
US5543326A (en) 1994-03-04 1996-08-06 Heller; Adam Biosensor including chemically modified enzymes
US5536249A (en) 1994-03-09 1996-07-16 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
AU2200895A (en) 1994-04-04 1995-10-23 Motorola, Inc. Method and apparatus for activating and accessing remote meter interface devices
US5609575A (en) 1994-04-11 1997-03-11 Graseby Medical Limited Infusion pump and method with dose-rate calculation
US5569186A (en) 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
DE4415896A1 (en) 1994-05-05 1995-11-09 Boehringer Mannheim Gmbh Analysis system for monitoring the concentration of an analyte in the blood of a patient
US5809417A (en) 1994-07-05 1998-09-15 Lucent Technologies Inc. Cordless telephone arranged for operating with multiple portable units in a frequency hopping system
US5462051A (en) 1994-08-31 1995-10-31 Colin Corporation Medical communication system
US6213972B1 (en) * 1994-09-13 2001-04-10 Alaris Medical Systems, Inc. Fluid flow resistance monitoring system
US5549115A (en) 1994-09-28 1996-08-27 Heartstream, Inc. Method and apparatus for gathering event data using a removable data storage medium and clock
US5724030A (en) 1994-10-13 1998-03-03 Bio Medic Data Systems, Inc. System monitoring reprogrammable implantable transponder
US5919141A (en) 1994-11-15 1999-07-06 Life Sensing Instrument Company, Inc. Vital sign remote monitoring device
ATE160079T1 (en) 1995-02-04 1997-11-15 Baumann & Haldi Sa SINGLE ARRANGEMENT FOR THE MEASURING, PROCESSING AND TRANSMISSION OF ESSENTIALLY PHYSIOLOGICAL PARAMETERS
US5586553A (en) 1995-02-16 1996-12-24 Minimed Inc. Transcutaneous sensor insertion set
US5568806A (en) 1995-02-16 1996-10-29 Minimed Inc. Transcutaneous sensor insertion set
KR100449615B1 (en) 1995-03-10 2004-12-08 메소 스케일 테크놀러지즈, 엘엘시 Multi-array, multi-specific electrochemiluminescence test
US5752512A (en) 1995-05-10 1998-05-19 Massachusetts Institute Of Technology Apparatus and method for non-invasive blood analyte measurement
US5628310A (en) 1995-05-19 1997-05-13 Joseph R. Lakowicz Method and apparatus to perform trans-cutaneous analyte monitoring
US5995860A (en) 1995-07-06 1999-11-30 Thomas Jefferson University Implantable sensor and system for measurement and control of blood constituent levels
US5581206A (en) 1995-07-28 1996-12-03 Micron Quantum Devices, Inc. Power level detection circuit
US5665222A (en) 1995-10-11 1997-09-09 E. Heller & Company Soybean peroxidase electrochemical sensor
US5748103A (en) 1995-11-13 1998-05-05 Vitalcom, Inc. Two-way TDMA telemetry system with power conservation features
FI960636A (en) 1996-02-12 1997-08-13 Nokia Mobile Phones Ltd A procedure for monitoring the health of a patient
US5833603A (en) 1996-03-13 1998-11-10 Lipomatrix, Inc. Implantable biosensing transponder
US5673322A (en) 1996-03-22 1997-09-30 Bell Communications Research, Inc. System and method for providing protocol translation and filtering to access the world wide web from wireless or low-bandwidth networks
DE19618597B4 (en) 1996-05-09 2005-07-21 Institut für Diabetestechnologie Gemeinnützige Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Method for determining the concentration of tissue glucose
US6130602A (en) 1996-05-13 2000-10-10 Micron Technology, Inc. Radio frequency data communications device
ES2195151T3 (en) 1996-06-18 2003-12-01 Alza Corp IMPROVEMENT OR SAMPLING DEVICE FOR TRANSDERMAL AGENTS.
US5830064A (en) 1996-06-21 1998-11-03 Pear, Inc. Apparatus and method for distinguishing events which collectively exceed chance expectations and thereby controlling an output
JP3581218B2 (en) 1996-07-03 2004-10-27 株式会社東芝 Mobile communication terminal device and its mobile phone and data terminal device
EP0923335B1 (en) 1996-07-08 2006-08-23 Animas Corporation Implantable sensor and system for in vivo measurement and control of fluid constituent levels
US5733313A (en) 1996-08-01 1998-03-31 Exonix Corporation RF coupled, implantable medical device with rechargeable back-up power source
US6544193B2 (en) 1996-09-04 2003-04-08 Marcio Marc Abreu Noninvasive measurement of chemical substances
US5729225A (en) 1996-09-23 1998-03-17 Motorola, Inc. Method and apparatus for asynchronous digital mixing
US5769873A (en) 1996-10-15 1998-06-23 Pacesetter, Inc. Meter for measuring battery charge delivered in an implantable device
US6071249A (en) 1996-12-06 2000-06-06 Abbott Laboratories Method and apparatus for obtaining blood for diagnostic tests
US5964993A (en) 1996-12-19 1999-10-12 Implanted Biosystems Inc. Glucose sensor
US6130623A (en) 1996-12-31 2000-10-10 Lucent Technologies Inc. Encryption for modulated backscatter systems
GB9700090D0 (en) 1997-01-04 1997-02-19 Horne James A Sleepiness detection for vehicle driver
US6122351A (en) 1997-01-21 2000-09-19 Med Graph, Inc. Method and system aiding medical diagnosis and treatment
US6293925B1 (en) 1997-12-31 2001-09-25 Minimed Inc. Insertion device for an insertion set and method of using the same
US6093172A (en) 1997-02-05 2000-07-25 Minimed Inc. Injector for a subcutaneous insertion set
US5749907A (en) 1997-02-18 1998-05-12 Pacesetter, Inc. System and method for identifying and displaying medical data which violate programmable alarm conditions
EP1011426A1 (en) 1997-02-26 2000-06-28 Diasense, Inc. Individual calibration of blood glucose for supporting noninvasive self-monitoring blood glucose
US7114502B2 (en) 1997-02-26 2006-10-03 Alfred E. Mann Foundation For Scientific Research Battery-powered patient implantable device
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7657297B2 (en) 2004-05-03 2010-02-02 Dexcom, Inc. Implantable analyte sensor
US6001067A (en) 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US6741877B1 (en) 1997-03-04 2004-05-25 Dexcom, Inc. Device and method for determining analyte levels
US6558321B1 (en) 1997-03-04 2003-05-06 Dexcom, Inc. Systems and methods for remote monitoring and modulation of medical devices
US7192450B2 (en) 2003-05-21 2007-03-20 Dexcom, Inc. Porous membranes for use with implantable devices
US20050033132A1 (en) 1997-03-04 2005-02-10 Shults Mark C. Analyte measuring device
US5959529A (en) 1997-03-07 1999-09-28 Kail, Iv; Karl A. Reprogrammable remote sensor monitoring system
US6699187B2 (en) 1997-03-27 2004-03-02 Medtronic, Inc. System and method for providing remote expert communications and video capabilities for use during a medical procedure
US6270455B1 (en) 1997-03-28 2001-08-07 Health Hero Network, Inc. Networked system for interactive communications and remote monitoring of drug delivery
US5942979A (en) 1997-04-07 1999-08-24 Luppino; Richard On guard vehicle safety warning system
US5935224A (en) 1997-04-24 1999-08-10 Microsoft Corporation Method and apparatus for adaptively coupling an external peripheral device to either a universal serial bus port on a computer or hub or a game port on a computer
US6558351B1 (en) 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US5954643A (en) 1997-06-09 1999-09-21 Minimid Inc. Insertion set for a transcutaneous sensor
US7267665B2 (en) 1999-06-03 2007-09-11 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
JP2002505008A (en) 1997-06-16 2002-02-12 エラン コーポレーション ピーエルシー Methods for calibrating and testing sensors for in vivo measurement of analytes and devices for use in such methods
US6056435A (en) 1997-06-24 2000-05-02 Exergen Corporation Ambient and perfusion normalized temperature detector
US6651975B2 (en) 1997-06-27 2003-11-25 Canon Kabushiki Kaisha Sheet pack and printer
US6085253A (en) 1997-08-01 2000-07-04 United Video Properties, Inc. System and method for transmitting and receiving data
DE19836401A1 (en) 1997-09-19 2000-02-17 Salcomp Oy Salo Device for charging accumulators
US6117290A (en) 1997-09-26 2000-09-12 Pepex Biomedical, Llc System and method for measuring a bioanalyte such as lactate
US20020013538A1 (en) 1997-09-30 2002-01-31 David Teller Method and apparatus for health signs monitoring
US6867720B1 (en) 1997-10-06 2005-03-15 The Regents Of The University Of Michigan Beamformed ultrasonic imager with delta-sigma feedback control
DE59810949D1 (en) 1997-10-15 2004-04-15 Nokia Corp Mobile phone for internet applications
US6088608A (en) 1997-10-20 2000-07-11 Alfred E. Mann Foundation Electrochemical sensor and integrity tests therefor
US6119028A (en) 1997-10-20 2000-09-12 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces
FI107080B (en) 1997-10-27 2001-05-31 Nokia Mobile Phones Ltd measuring device
US6144922A (en) 1997-10-31 2000-11-07 Mercury Diagnostics, Incorporated Analyte concentration information collection and communication system
ES2281143T3 (en) 1997-11-12 2007-09-16 Lightouch Medical, Inc. METHOD FOR THE NON-INVASIVE MEASUREMENT OF AN ANALYTE.
KR100258969B1 (en) 1997-11-20 2000-06-15 윤종용 Firmware upgrading method in wireless communication device and firmware upgrade supporting method in cell base station
CA2547299C (en) 1997-12-04 2009-03-03 Roche Diagnostics Corporation Instrument and method
US6579690B1 (en) 1997-12-05 2003-06-17 Therasense, Inc. Blood analyte monitoring through subcutaneous measurement
US6055316A (en) 1997-12-26 2000-04-25 Sun Microsystems, Inc. System and method for deriving an appropriate initialization vector for secure communications
US7222054B2 (en) 1998-03-03 2007-05-22 Card Guard Scientific Survival Ltd. Personal ambulatory wireless health monitor
US6103033A (en) 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6197181B1 (en) 1998-03-20 2001-03-06 Semitool, Inc. Apparatus and method for electrolytically depositing a metal on a microelectronic workpiece
US6218809B1 (en) 1998-03-20 2001-04-17 Dallas Semiconductor Corporation Method for monitoring operating parameters of a rechargeable power supply
US6579231B1 (en) 1998-03-27 2003-06-17 Mci Communications Corporation Personal medical monitoring unit and system
JP3104672B2 (en) 1998-03-31 2000-10-30 日本電気株式会社 Current detection type sensor element and method of manufacturing the same
US6721582B2 (en) 1999-04-06 2004-04-13 Argose, Inc. Non-invasive tissue glucose level monitoring
JPH11296598A (en) 1998-04-07 1999-10-29 Seizaburo Arita System and method for predicting blood-sugar level and record medium where same method is recorded
WO1999053287A2 (en) 1998-04-09 1999-10-21 California Institute Of Technology Electronic techniques for analyte detection
US6091987A (en) 1998-04-29 2000-07-18 Medtronic, Inc. Power consumption reduction in medical devices by employing different supply voltages
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
PT1077636E (en) 1998-05-13 2004-06-30 Cygnus Therapeutic Systems SIGNAL PROCESSING FOR PHYSIOLOGICAL ANALYZES MEDICATION
ATE245937T1 (en) 1998-05-13 2003-08-15 Cygnus Therapeutic Systems MONITORING PHYSIOLOGICAL ANALYTES
US6121611A (en) 1998-05-20 2000-09-19 Molecular Imaging Corporation Force sensing probe for scanning probe microscopy
US6302855B1 (en) 1998-05-20 2001-10-16 Novo Nordisk A/S Medical apparatus for use by a patient for medical self treatment of diabetes
US6862622B2 (en) 1998-07-10 2005-03-01 Van Drebbel Mariner Llc Transmission control protocol/internet protocol (TCP/IP) packet-centric wireless point to multi-point (PTMP) transmission system architecture
US6084523A (en) 1998-07-13 2000-07-04 The United States Of America As Represented By The Secretary Of The Army Non-intrusive battery status indicator and inventory system
US6493069B1 (en) 1998-07-24 2002-12-10 Terumo Kabushiki Kaisha Method and instrument for measuring blood sugar level
US7218890B1 (en) 1998-08-07 2007-05-15 Input/Output, Inc. Seismic telemetry system
US6248067B1 (en) 1999-02-05 2001-06-19 Minimed Inc. Analyte sensor and holter-type monitor system and method of using the same
US6558320B1 (en) 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US6359270B1 (en) 1998-09-04 2002-03-19 Ncr Corporation Communications module mounting for domestic appliance
KR20000019716A (en) 1998-09-15 2000-04-15 박호군 Composition comprising bioflavonoid compounds for descending blood sugar
US6740518B1 (en) 1998-09-17 2004-05-25 Clinical Micro Sensors, Inc. Signal detection techniques for the detection of analytes
US6442672B1 (en) 1998-09-30 2002-08-27 Conexant Systems, Inc. Method for dynamic allocation and efficient sharing of functional unit datapaths
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US20060202859A1 (en) 1998-10-08 2006-09-14 Mastrototaro John J Telemetered characteristic monitor system and method of using the same
ATE514372T1 (en) 1998-10-08 2011-07-15 Medtronic Minimed Inc LICENSE PLATE MONITORING SYSTEM WITH REMOTE MEASUREMENT
US6591125B1 (en) 2000-06-27 2003-07-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6496729B2 (en) 1998-10-28 2002-12-17 Medtronic, Inc. Power consumption reduction in medical devices employing multiple supply voltages and clock frequency control
EP1126779A4 (en) 1998-11-03 2003-05-07 Shell Allan Michael Hand held physiological signal acquisition device
DE69924749T2 (en) 1998-11-20 2006-04-27 The University Of Connecticut, Farmington Generically integrated implantable potentiostat remote sensing device for electrochemical probes
US6540672B1 (en) 1998-12-09 2003-04-01 Novo Nordisk A/S Medical system and a method of controlling the system for use by a patient for medical self treatment
JP2002531884A (en) 1998-11-30 2002-09-24 ノボ ノルディスク アクティーゼルスカブ Method and system for assisting a user in self-treatment involving multiple actions
US6151517A (en) 1999-01-22 2000-11-21 Futrex Inc. Method and apparatus for noninvasive quantitative measurement of blood analytes
AU3363000A (en) 1999-02-12 2000-08-29 Cygnus, Inc. Devices and methods for frequent measurement of an analyte present in a biological system
EP1161277B1 (en) 1999-02-18 2006-10-11 Biovalve Technologies, Inc. Electroactive pore
US6360888B1 (en) 1999-02-25 2002-03-26 Minimed Inc. Glucose sensor package system
US6424847B1 (en) 1999-02-25 2002-07-23 Medtronic Minimed, Inc. Glucose monitor calibration methods
US7089780B2 (en) 1999-03-03 2006-08-15 Smiths Detection Inc. Apparatus, systems and methods for detecting and transmitting sensory data over a computer network
US8103325B2 (en) 1999-03-08 2012-01-24 Tyco Healthcare Group Lp Method and circuit for storing and providing historical physiological data
US7577469B1 (en) 1999-03-11 2009-08-18 Jack L. Aronowitz Noninvasive transdermal systems for detecting an analyte in a biological fluid and methods
GB9907815D0 (en) 1999-04-06 1999-06-02 Univ Cambridge Tech Implantable sensor
US6385473B1 (en) 1999-04-15 2002-05-07 Nexan Limited Physiological sensor device
US6494829B1 (en) 1999-04-15 2002-12-17 Nexan Limited Physiological sensor array
US6200265B1 (en) 1999-04-16 2001-03-13 Medtronic, Inc. Peripheral memory patch and access method for use with an implantable medical device
US6669663B1 (en) 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
US6546268B1 (en) 1999-06-02 2003-04-08 Ball Semiconductor, Inc. Glucose sensor
US6312378B1 (en) 1999-06-03 2001-11-06 Cardiac Intelligence Corporation System and method for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care
US7806886B2 (en) 1999-06-03 2010-10-05 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
US6298255B1 (en) 1999-06-09 2001-10-02 Aspect Medical Systems, Inc. Smart electrophysiological sensor system with automatic authentication and validation and an interface for a smart electrophysiological sensor system
US6423035B1 (en) 1999-06-18 2002-07-23 Animas Corporation Infusion pump with a sealed drive mechanism and improved method of occlusion detection
AU5747100A (en) 1999-06-18 2001-01-09 Therasense, Inc. Mass transport limited in vivo analyte sensor
US7522878B2 (en) 1999-06-21 2009-04-21 Access Business Group International Llc Adaptive inductive power supply with communication
US6804558B2 (en) 1999-07-07 2004-10-12 Medtronic, Inc. System and method of communicating between an implantable medical device and a remote computer system or health care provider
US7181505B2 (en) 1999-07-07 2007-02-20 Medtronic, Inc. System and method for remote programming of an implantable medical device
DE60022279T2 (en) 1999-08-06 2006-02-23 Matsushita Electric Industrial Co., Ltd., Kadoma Data transmission and receiving device
US6471689B1 (en) 1999-08-16 2002-10-29 Thomas Jefferson University Implantable drug delivery catheter system with capillary interface
US7113821B1 (en) 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US20030175992A1 (en) 1999-09-10 2003-09-18 Anthony Toranto Glucose assay
AT408182B (en) 1999-09-17 2001-09-25 Schaupp Lukas Dipl Ing Dr Tech DEVICE FOR VIVO MEASURING SIZES IN LIVING ORGANISMS
US6533733B1 (en) 1999-09-24 2003-03-18 Ut-Battelle, Llc Implantable device for in-vivo intracranial and cerebrospinal fluid pressure monitoring
EP1217942A1 (en) 1999-09-24 2002-07-03 Healthetech, Inc. Physiological monitor and associated computation, display and communication unit
US6294997B1 (en) 1999-10-04 2001-09-25 Intermec Ip Corp. RFID tag having timing and environment modules
US6478736B1 (en) 1999-10-08 2002-11-12 Healthetech, Inc. Integrated calorie management system
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
DK1230249T3 (en) 1999-11-15 2004-08-30 Therasense Inc Transition metal complexes with bidentate ligand having an imidazole ring
US6291200B1 (en) 1999-11-17 2001-09-18 Agentase, Llc Enzyme-containing polymeric sensors
US6925393B1 (en) 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
US6658396B1 (en) 1999-11-29 2003-12-02 Tang Sharon S Neural network drug dosage estimation
US6359594B1 (en) 1999-12-01 2002-03-19 Logitech Europe S.A. Loop antenna parasitics reduction technique
US6418346B1 (en) 1999-12-14 2002-07-09 Medtronic, Inc. Apparatus and method for remote therapy and diagnosis in medical devices via interface systems
US6602191B2 (en) 1999-12-17 2003-08-05 Q-Tec Systems Llp Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity
US6497655B1 (en) 1999-12-17 2002-12-24 Medtronic, Inc. Virtual remote monitor, alert, diagnostics and programming for implantable medical device systems
US7060031B2 (en) 1999-12-17 2006-06-13 Medtronic, Inc. Method and apparatus for remotely programming implantable medical devices
US20020091796A1 (en) 2000-01-03 2002-07-11 John Higginson Method and apparatus for transmitting data over a network using a docking device
US7286894B1 (en) 2000-01-07 2007-10-23 Pasco Scientific Hand-held computer device and method for interactive data acquisition, analysis, annotation, and calibration
WO2001052935A1 (en) 2000-01-21 2001-07-26 Medical Research Group, Inc. Ambulatory medical apparatus and method having telemetry modifiable control software
US7369635B2 (en) 2000-01-21 2008-05-06 Medtronic Minimed, Inc. Rapid discrimination preambles and methods for using the same
DK1248660T3 (en) 2000-01-21 2012-07-23 Medtronic Minimed Inc Microprocessor controlled outpatient medical device with handheld communication device
US6748445B1 (en) 2000-02-01 2004-06-08 Microsoft Corporation System and method for exchanging data
US20030060765A1 (en) 2000-02-16 2003-03-27 Arthur Campbell Infusion device menu structure and method of using the same
US7027931B1 (en) 2000-02-24 2006-04-11 Bionostics, Inc. System for statistical analysis of quality control data
US6893396B2 (en) 2000-03-01 2005-05-17 I-Medik, Inc. Wireless internet bio-telemetry monitoring system and interface
ATE281785T1 (en) 2000-03-21 2004-11-15 Radi Medical Systems PASSIVE BIOTELEMETRY
EP1267708A4 (en) 2000-03-29 2006-04-12 Univ Virginia Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
US6610012B2 (en) 2000-04-10 2003-08-26 Healthetech, Inc. System and method for remote pregnancy monitoring
US6441747B1 (en) 2000-04-18 2002-08-27 Motorola, Inc. Wireless system protocol for telemetry monitoring
US6561975B1 (en) 2000-04-19 2003-05-13 Medtronic, Inc. Method and apparatus for communicating with medical device systems
US6616613B1 (en) 2000-04-27 2003-09-09 Vitalsines International, Inc. Physiological signal monitoring system
US6440068B1 (en) 2000-04-28 2002-08-27 International Business Machines Corporation Measuring user health as measured by multiple diverse health measurement devices utilizing a personal storage device
US7447252B2 (en) 2000-05-01 2008-11-04 Andrzej Partyka Overhead reduction in frequency hopping system for intermittent transmission
AU2001263022A1 (en) 2000-05-12 2001-11-26 Therasense, Inc. Electrodes with multilayer membranes and methods of using and making the electrodes
US7181261B2 (en) 2000-05-15 2007-02-20 Silver James H Implantable, retrievable, thrombus minimizing sensors
US6442413B1 (en) 2000-05-15 2002-08-27 James H. Silver Implantable sensor
US6459917B1 (en) 2000-05-22 2002-10-01 Ashok Gowda Apparatus for access to interstitial fluid, blood, or blood plasma components
US7395158B2 (en) 2000-05-30 2008-07-01 Sensys Medical, Inc. Method of screening for disorders of glucose metabolism
CN1444749A (en) 2000-06-02 2003-09-24 阿克雷株式会社 Measurement assisting system and method
JP4454109B2 (en) 2000-06-14 2010-04-21 日本テキサス・インスツルメンツ株式会社 Method and apparatus for improving signal-to-noise ratio in digital-to-analog conversion processing of a pulse density modulation signal (PDM)
US6735479B2 (en) 2000-06-14 2004-05-11 Medtronic, Inc. Lifestyle management system
AU2001270092A1 (en) 2000-06-23 2002-01-08 Bodymedia, Inc. System for monitoring health, wellness and fitness
US6400974B1 (en) 2000-06-29 2002-06-04 Sensors For Medicine And Science, Inc. Implanted sensor processing system and method for processing implanted sensor output
US6580364B1 (en) 2000-07-06 2003-06-17 Trw Inc. Apparatus and method for tracking an abnormal tire condition
US7146636B2 (en) 2000-07-24 2006-12-05 Bluesocket, Inc. Method and system for enabling centralized control of wireless local area networks
WO2002017210A2 (en) 2000-08-18 2002-02-28 Cygnus, Inc. Formulation and manipulation of databases of analyte and associated values
CA2408338C (en) 2000-08-18 2009-09-08 Cygnus, Inc. Methods and devices for prediction of hypoglycemic events
EP1311189A4 (en) 2000-08-21 2005-03-09 Euro Celtique Sa Near infrared blood glucose monitoring system
WO2002018936A2 (en) 2000-08-28 2002-03-07 Cygnus, Inc. Methods of monitoring glucose levels in a subject and uses thereof
US6575905B2 (en) 2000-09-22 2003-06-10 Knobbe, Lim & Buckingham Method and apparatus for real-time estimation of physiological parameters
WO2002031909A1 (en) 2000-10-11 2002-04-18 Alfred E. Mann Foundation For Scientific Research Improved antenna for miniature implanted medical device
US7198603B2 (en) 2003-04-14 2007-04-03 Remon Medical Technologies, Inc. Apparatus and methods using acoustic telemetry for intrabody communications
US6915347B2 (en) 2000-10-17 2005-07-05 Sun Microsystems, Inc. Associating multiple display units in a grouped server environment
US6574510B2 (en) 2000-11-30 2003-06-03 Cardiac Pacemakers, Inc. Telemetry apparatus and method for an implantable medical device
US6480744B2 (en) 2000-12-04 2002-11-12 Medtronic, Inc. Implantable medical device telemetry control systems and methods of use
CA2430775A1 (en) 2000-12-11 2002-06-20 Resmed Ltd. Method and apparatus for stroke patient treatment
US6665558B2 (en) 2000-12-15 2003-12-16 Cardiac Pacemakers, Inc. System and method for correlation of patient health information and implant device data
US20020074162A1 (en) 2000-12-15 2002-06-20 Bor-Ray Su Substrate layout method and structure for reducing cross talk of adjacent signals
TW492117B (en) 2000-12-15 2002-06-21 Acer Labs Inc Substrate layout method and structure thereof for decreasing crosstalk between adjacent signals
US7052483B2 (en) 2000-12-19 2006-05-30 Animas Corporation Transcutaneous inserter for low-profile infusion sets
US8050625B2 (en) 2000-12-22 2011-11-01 Terahop Networks, Inc. Wireless reader tags (WRTs) with sensor components in asset monitoring and tracking systems
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US6603770B2 (en) 2001-01-16 2003-08-05 Physical Optics Corporation Apparatus and method for accessing a network
US20040197846A1 (en) 2001-01-18 2004-10-07 Linda Hockersmith Determination of glucose sensitivity and a method to manipulate blood glucose concentration
TW536689B (en) 2001-01-18 2003-06-11 Sharp Kk Display, portable device, and substrate
US6968743B2 (en) 2001-01-22 2005-11-29 Integrated Sensing Systems, Inc. Implantable sensing device for physiologic parameter measurement
US6721587B2 (en) 2001-02-15 2004-04-13 Regents Of The University Of California Membrane and electrode structure for implantable sensor
US6525330B2 (en) 2001-02-28 2003-02-25 Home Diagnostics, Inc. Method of strip insertion detection
US6611206B2 (en) 2001-03-15 2003-08-26 Koninklijke Philips Electronics N.V. Automatic system for monitoring independent person requiring occasional assistance
US6968294B2 (en) 2001-03-15 2005-11-22 Koninklijke Philips Electronics N.V. Automatic system for monitoring person requiring care and his/her caretaker
US20070026440A1 (en) 2001-04-06 2007-02-01 Broderick Patricia A Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using electrodes with microvoltammetry
US6983176B2 (en) 2001-04-11 2006-01-03 Rio Grande Medical Technologies, Inc. Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy
US7916013B2 (en) 2005-03-21 2011-03-29 Greatbatch Ltd. RFID detection and identification system for implantable medical devices
GR1003802B (en) 2001-04-17 2002-02-08 Micrel �.�.�. ������� ��������� ��������������� ��������� Tele-medicine system
US6698269B2 (en) 2001-04-27 2004-03-02 Oceana Sensor Technologies, Inc. Transducer in-situ testing apparatus and method
US20020180608A1 (en) 2001-05-04 2002-12-05 Sphericon Ltd. Driver alertness monitoring system
US7395214B2 (en) 2001-05-11 2008-07-01 Craig P Shillingburg Apparatus, device and method for prescribing, administering and monitoring a treatment regimen for a patient
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
WO2003000127A2 (en) 2001-06-22 2003-01-03 Cygnus, Inc. Method for improving the performance of an analyte monitoring system
US20030208113A1 (en) 2001-07-18 2003-11-06 Mault James R Closed loop glycemic index system
US6570386B2 (en) 2001-07-30 2003-05-27 Hewlett-Packard Development Company, L.P. System and method for providing power to electrical devices
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US7506046B2 (en) 2001-07-31 2009-03-17 Hewlett-Packard Development Company, L.P. Network usage analysis system and method for updating statistical models
US20030035371A1 (en) 2001-07-31 2003-02-20 Coke Reed Means and apparatus for a scaleable congestion free switching system with intelligent control
US6788965B2 (en) 2001-08-03 2004-09-07 Sensys Medical, Inc. Intelligent system for detecting errors and determining failure modes in noninvasive measurement of blood and tissue analytes
US20040260478A1 (en) 2001-08-03 2004-12-23 Schwamm Lee H. System, process and diagnostic arrangement establishing and monitoring medication doses for patients
US20040162678A1 (en) 2001-08-13 2004-08-19 Donald Hetzel Method of screening for disorders of glucose metabolism
JP4170218B2 (en) 2001-08-29 2008-10-22 メディアテック インコーポレーテッド Method and apparatus for improving the throughput of a cache-based embedded processor by switching tasks in response to a cache miss
JP3962250B2 (en) 2001-08-29 2007-08-22 株式会社レアメタル In vivo information detection system and tag device and relay device used therefor
US6740072B2 (en) 2001-09-07 2004-05-25 Medtronic Minimed, Inc. System and method for providing closed loop infusion formulation delivery
US6827702B2 (en) 2001-09-07 2004-12-07 Medtronic Minimed, Inc. Safety limits for closed-loop infusion pump control
CN1555244A (en) 2001-09-13 2004-12-15 Method for transmitting vital health statistics to a remote location form an aircraft
JP2003084101A (en) 2001-09-17 2003-03-19 Dainippon Printing Co Ltd Resin composition for optical device, optical device and projection screen
US7052591B2 (en) 2001-09-21 2006-05-30 Therasense, Inc. Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking
US7258665B2 (en) 2001-09-21 2007-08-21 Ge Medical Systems Global Technology Company, Llc High availability deployment of an off-site management system for digital cardiac electrocardiograms operating in an application service provider model
US6830562B2 (en) 2001-09-27 2004-12-14 Unomedical A/S Injector device for placing a subcutaneous infusion set
US20050137480A1 (en) 2001-10-01 2005-06-23 Eckhard Alt Remote control of implantable device through medical implant communication service band
US7095316B2 (en) 2001-11-15 2006-08-22 Siemens Vdo Automotive Corporation Tire pressure monitoring system transmission protocol
EP1448489B1 (en) 2001-11-16 2010-08-25 Stefan Ufer Flexible sensor and method of fabrication
US6708057B2 (en) 2001-11-20 2004-03-16 Eresearchtechnology, Inc. Method and system for processing electrocardiograms
WO2003049424A1 (en) 2001-12-03 2003-06-12 Nikon Corporation Electronic apparatus, electronic camera, electronic device, image display apparatus, and image transmission system
US7729776B2 (en) 2001-12-19 2010-06-01 Cardiac Pacemakers, Inc. Implantable medical device with two or more telemetry systems
US6993393B2 (en) 2001-12-19 2006-01-31 Cardiac Pacemakers, Inc. Telemetry duty cycle management system for an implantable medical device
US7082334B2 (en) 2001-12-19 2006-07-25 Medtronic, Inc. System and method for transmission of medical and like data from a patient to a dedicated internet website
US20030119457A1 (en) 2001-12-19 2003-06-26 Standke Randolph E. Filter technique for increasing antenna isolation in portable communication devices
US7204823B2 (en) 2001-12-19 2007-04-17 Medtronic Minimed, Inc. Medication delivery system and monitor
US7022072B2 (en) 2001-12-27 2006-04-04 Medtronic Minimed, Inc. System for monitoring physiological characteristics
US20050027182A1 (en) 2001-12-27 2005-02-03 Uzair Siddiqui System for monitoring physiological characteristics
US20080255438A1 (en) 2001-12-27 2008-10-16 Medtronic Minimed, Inc. System for monitoring physiological characteristics
US6980852B2 (en) 2002-01-25 2005-12-27 Subqiview Inc. Film barrier dressing for intravascular tissue monitoring system
US20030144711A1 (en) 2002-01-29 2003-07-31 Neuropace, Inc. Systems and methods for interacting with an implantable medical device
US6985773B2 (en) 2002-02-07 2006-01-10 Cardiac Pacemakers, Inc. Methods and apparatuses for implantable medical device telemetry power management
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7613491B2 (en) 2002-05-22 2009-11-03 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US8364229B2 (en) 2003-07-25 2013-01-29 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20030212379A1 (en) 2002-02-26 2003-11-13 Bylund Adam David Systems and methods for remotely controlling medication infusion and analyte monitoring
AU2003213638A1 (en) 2002-02-26 2003-09-09 Sterling Medivations, Inc. Insertion device for an insertion set and method of using the same
US7043305B2 (en) 2002-03-06 2006-05-09 Cardiac Pacemakers, Inc. Method and apparatus for establishing context among events and optimizing implanted medical device performance
US7468032B2 (en) 2002-12-18 2008-12-23 Cardiac Pacemakers, Inc. Advanced patient management for identifying, displaying and assisting with correlating health-related data
EP1343112A1 (en) 2002-03-08 2003-09-10 EndoArt S.A. Implantable device
JP3896879B2 (en) 2002-03-22 2007-03-22 日本電気株式会社 Traffic monitoring system
US6936006B2 (en) 2002-03-22 2005-08-30 Novo Nordisk, A/S Atraumatic insertion of a subcutaneous device
US20040030531A1 (en) 2002-03-28 2004-02-12 Honeywell International Inc. System and method for automated monitoring, recognizing, supporting, and responding to the behavior of an actor
GB2388898B (en) 2002-04-02 2005-10-05 Inverness Medical Ltd Integrated sample testing meter
WO2003088830A1 (en) 2002-04-16 2003-10-30 Carematix, Inc. Method and apparatus for remotely monitoring the condition of a patient
US7198606B2 (en) 2002-04-19 2007-04-03 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with analyte sensing
US7410468B2 (en) 2002-04-19 2008-08-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US6810309B2 (en) 2002-04-25 2004-10-26 Visteon Global Technologies, Inc. Vehicle personalization via biometric identification
EP1498067A1 (en) 2002-04-25 2005-01-19 Matsushita Electric Industrial Co., Ltd. Dosage determination supporting device, injector, and health management supporting system
WO2003094373A1 (en) 2002-05-02 2003-11-13 Sony Ericsson Mobile Communications Ab Integrated antenna assembly
GB2388715B (en) 2002-05-13 2005-08-03 Splashpower Ltd Improvements relating to the transfer of electromagnetic power
US7134994B2 (en) 2002-05-20 2006-11-14 Volcano Corporation Multipurpose host system for invasive cardiovascular diagnostic measurement acquisition and display
US7226978B2 (en) 2002-05-22 2007-06-05 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US6990317B2 (en) 2002-05-28 2006-01-24 Wireless Innovation Interference resistant wireless sensor and control system
US20040030581A1 (en) 2002-06-12 2004-02-12 Samuel Leven Heart monitoring device
US7124027B1 (en) 2002-07-11 2006-10-17 Yazaki North America, Inc. Vehicular collision avoidance system
JP2004054394A (en) 2002-07-17 2004-02-19 Toshiba Corp Radio information processing system, radio information recording medium, radio information processor and communication method for radio information processing system
US7470533B2 (en) 2002-12-20 2008-12-30 Acea Biosciences Impedance based devices and methods for use in assays
US7058719B2 (en) 2002-07-22 2006-06-06 Ricoh Company, Ltd. System, computer program product and method for managing and controlling a local network of electronic devices and reliably and securely adding an electronic device to the network
US6992580B2 (en) 2002-07-25 2006-01-31 Motorola, Inc. Portable communication device and corresponding method of operation
US7020508B2 (en) 2002-08-22 2006-03-28 Bodymedia, Inc. Apparatus for detecting human physiological and contextual information
US7404796B2 (en) 2004-03-01 2008-07-29 Becton Dickinson And Company System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
US7192405B2 (en) 2002-09-30 2007-03-20 Becton, Dickinson And Company Integrated lancet and bodily fluid sensor
KR101226540B1 (en) 2002-10-11 2013-01-25 벡톤 디킨슨 앤드 컴퍼니 System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or multi-needle intradermal (ID) delivery device
US7079977B2 (en) 2002-10-15 2006-07-18 Medtronic, Inc. Synchronization and calibration of clocks for a medical device and calibrated clock
US7420978B2 (en) 2002-10-31 2008-09-02 Unipoint Holdings, Inc. Method and apparatus for billing voice calls over an internet protocol network according to bandwidth criteria
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US7572237B2 (en) 2002-11-06 2009-08-11 Abbott Diabetes Care Inc. Automatic biological analyte testing meter with integrated lancing device and methods of use
JP2004234622A (en) 2002-11-19 2004-08-19 Seiko Instruments Inc Living body information measuring system
US20040100376A1 (en) 2002-11-26 2004-05-27 Kimberly-Clark Worldwide, Inc. Healthcare monitoring system
US7580395B2 (en) 2002-11-29 2009-08-25 Intermec Ip Corp. Information gathering apparatus and method having multiple wireless communication options
US6980828B2 (en) 2002-12-03 2005-12-27 Nokia Corporation Multi-media mobile communication device and related construction method
US7009511B2 (en) 2002-12-17 2006-03-07 Cardiac Pacemakers, Inc. Repeater device for communications with an implantable medical device
US7052472B1 (en) 2002-12-18 2006-05-30 Dsp Diabetes Sentry Products, Inc. Systems and methods for detecting symptoms of hypoglycemia
US20040122353A1 (en) 2002-12-19 2004-06-24 Medtronic Minimed, Inc. Relay device for transferring information between a sensor system and a fluid delivery system
US20050038680A1 (en) 2002-12-19 2005-02-17 Mcmahon Kevin Lee System and method for glucose monitoring
US7833151B2 (en) 2002-12-26 2010-11-16 Given Imaging Ltd. In vivo imaging device with two imagers
US20040128161A1 (en) 2002-12-27 2004-07-01 Mazar Scott T. System and method for ad hoc communications with an implantable medical device
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US7154398B2 (en) 2003-01-06 2006-12-26 Chen Thomas C H Wireless communication and global location enabled intelligent health monitoring system
US7228162B2 (en) 2003-01-13 2007-06-05 Isense Corporation Analyte sensor
JP2004260786A (en) 2003-02-05 2004-09-16 Fujitsu Ltd Antenna element, flat antenna, wiring board and communication system
US7927558B2 (en) 2003-02-18 2011-04-19 Microteq, Llc System and apparatus for detecting breach of exposure protection equipment
GB0304424D0 (en) 2003-02-26 2003-04-02 Glaxosmithkline Biolog Sa Novel compounds
WO2004084820A2 (en) 2003-03-19 2004-10-07 Harry Hebblewhite Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
US20040199056A1 (en) 2003-04-03 2004-10-07 International Business Machines Corporation Body monitoring using local area wireless interfaces
US7134999B2 (en) 2003-04-04 2006-11-14 Dexcom, Inc. Optimized sensor geometry for an implantable glucose sensor
US7587287B2 (en) 2003-04-04 2009-09-08 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US20040204868A1 (en) 2003-04-09 2004-10-14 Maynard John D. Reduction of errors in non-invasive tissue sampling
CN1806168B (en) 2003-04-15 2010-09-29 医药及科学传感器公司 System and method for attenuating the effect of ambient light on an optical sensor
US20040225199A1 (en) 2003-05-08 2004-11-11 Evanyk Shane Walter Advanced physiological monitoring systems and methods
ATE474611T1 (en) 2003-05-08 2010-08-15 Novo Nordisk As AN INJECTION DEVICE THAT CAN BE APPLIED TO THE SKIN WITH A SEPARABLE ACTUATING PART FOR INSERTING THE NEEDLE
US20040249677A1 (en) * 2003-05-19 2004-12-09 Debarshi Datta Comprehensive searchable medical record system supporting healthcare delivery and experiment
US7397785B2 (en) 2003-05-28 2008-07-08 Nokia Corporation Method for enhancing fairness and performance in a multihop ad hoc network and corresponding system
US7040139B2 (en) 2003-06-10 2006-05-09 Smiths Detection Inc. Sensor arrangement
US20040254433A1 (en) 2003-06-12 2004-12-16 Bandis Steven D. Sensor introducer system, apparatus and method
US7155290B2 (en) 2003-06-23 2006-12-26 Cardiac Pacemakers, Inc. Secure long-range telemetry for implantable medical device
US7510564B2 (en) 2003-06-27 2009-03-31 Abbott Diabetes Care Inc. Lancing device
US7242981B2 (en) 2003-06-30 2007-07-10 Codman Neuro Sciences Sárl System and method for controlling an implantable medical device subject to magnetic field or radio frequency exposure
US7722536B2 (en) 2003-07-15 2010-05-25 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
WO2005007223A2 (en) 2003-07-16 2005-01-27 Sasha John Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
WO2007120442A2 (en) 2003-07-25 2007-10-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7424318B2 (en) 2003-12-05 2008-09-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20050176136A1 (en) 2003-11-19 2005-08-11 Dexcom, Inc. Afinity domain for analyte sensor
EP1648298A4 (en) 2003-07-25 2010-01-13 Dexcom Inc Oxygen enhancing membrane systems for implantable devices
WO2005019795A2 (en) 2003-07-25 2005-03-03 Dexcom, Inc. Electrochemical sensors including electrode systems with increased oxygen generation
US7366556B2 (en) 2003-12-05 2008-04-29 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
EP1649260A4 (en) 2003-07-25 2010-07-07 Dexcom Inc Electrode systems for electrochemical sensors
US7467003B2 (en) 2003-12-05 2008-12-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US7460898B2 (en) 2003-12-05 2008-12-02 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US8285354B2 (en) 2003-08-01 2012-10-09 Dexcom, Inc. System and methods for processing analyte sensor data
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US20070208245A1 (en) 2003-08-01 2007-09-06 Brauker James H Transcutaneous analyte sensor
US8626257B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. Analyte sensor
US6954662B2 (en) 2003-08-19 2005-10-11 A.D. Integrity Applications, Ltd. Method of monitoring glucose level
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
JP2005094282A (en) 2003-09-17 2005-04-07 Renesas Technology Corp Semiconductor integrated circuit for communication
JP3612324B1 (en) 2003-09-29 2005-01-19 株式会社日立製作所 Blood glucose level display method and apparatus
DE602004026763D1 (en) 2003-09-30 2010-06-02 Roche Diagnostics Gmbh SENSOR WITH IMPROVED BIOKOMPATIBILITY
US7203549B2 (en) 2003-10-02 2007-04-10 Medtronic, Inc. Medical device programmer with internal antenna and display
US8140168B2 (en) 2003-10-02 2012-03-20 Medtronic, Inc. External power source for an implantable medical device having an adjustable carrier frequency and system and method related therefore
US7148803B2 (en) 2003-10-24 2006-12-12 Symbol Technologies, Inc. Radio frequency identification (RFID) based sensor networks
EP1761880B1 (en) 2003-10-29 2013-02-27 Innovision Research & Technology PLC Rfid apparatus
EP1683058A2 (en) 2003-10-29 2006-07-26 Novo Nordisk A/S Medical advisory system
US6928380B2 (en) 2003-10-30 2005-08-09 International Business Machines Corporation Thermal measurements of electronic devices during operation
US20050096516A1 (en) 2003-10-30 2005-05-05 Orhan Soykan Optical detector of organic analyte
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US7419573B2 (en) 2003-11-06 2008-09-02 3M Innovative Properties Company Circuit for electrochemical sensor strip
US7713229B2 (en) 2003-11-06 2010-05-11 Lifescan, Inc. Drug delivery pen with event notification means
WO2005048834A1 (en) 2003-11-13 2005-06-02 Medtronic Minimed, Inc. Long term analyte sensor array
EP1713379A4 (en) 2003-11-18 2009-09-02 Alive Technologies Pty Ltd The monitoring of vital signs and performance levels
US20050113648A1 (en) 2003-11-24 2005-05-26 Soohyun Yang Bidirectional monitoring system capable of a medical diagnosis and a commercial broadcast
US20050113886A1 (en) 2003-11-24 2005-05-26 Fischell David R. Implantable medical system with long range telemetry
FR2863175A1 (en) 2003-12-03 2005-06-10 Ela Medical Sa ACTIVE IMPLANTABLE MEDICAL DEVICE WITH HOLTER RECORDING FUNCTIONS
US8425417B2 (en) 2003-12-05 2013-04-23 Dexcom, Inc. Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device
US20080200788A1 (en) 2006-10-04 2008-08-21 Dexcorn, Inc. Analyte sensor
US8532730B2 (en) 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20100185071A1 (en) 2003-12-05 2010-07-22 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8425416B2 (en) 2006-10-04 2013-04-23 Dexcom, Inc. Analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8364230B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US20080197024A1 (en) 2003-12-05 2008-08-21 Dexcom, Inc. Analyte sensor
ATE480761T1 (en) 2003-12-05 2010-09-15 Dexcom Inc CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTICAL SENSOR
ATE474219T1 (en) 2003-12-08 2010-07-15 Dexcom Inc SYSTEMS AND METHODS FOR IMPROVING ELECTROCHEMICAL ANALYT SENSORS
US7384397B2 (en) 2003-12-30 2008-06-10 Medtronic Minimed, Inc. System and method for sensor recalibration
US7637868B2 (en) 2004-01-12 2009-12-29 Dexcom, Inc. Composite material for implantable device
CN1910600B (en) 2004-01-23 2011-12-14 株式会社半导体能源研究所 ID label, ID card, and ID tag
JP4526827B2 (en) 2004-02-03 2010-08-18 オムロンヘルスケア株式会社 Electronic blood pressure monitor
US8165651B2 (en) 2004-02-09 2012-04-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
WO2005079257A2 (en) 2004-02-12 2005-09-01 Dexcom, Inc. Biointerface with macro- and micro- architecture
CA2556331A1 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US20060154642A1 (en) 2004-02-20 2006-07-13 Scannell Robert F Jr Medication & health, environmental, and security monitoring, alert, intervention, information and network system with associated and supporting apparatuses
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
DE102004011135A1 (en) 2004-03-08 2005-09-29 Disetronic Licensing Ag Method and apparatus for calculating a bolus amount
US7228182B2 (en) 2004-03-15 2007-06-05 Cardiac Pacemakers, Inc. Cryptographic authentication for telemetry with an implantable medical device
US7831828B2 (en) 2004-03-15 2010-11-09 Cardiac Pacemakers, Inc. System and method for securely authenticating a data exchange session with an implantable medical device
JP5051767B2 (en) 2004-03-22 2012-10-17 ボディーメディア インコーポレイテッド Device for monitoring human condition parameters
JP2007535974A (en) 2004-03-26 2007-12-13 ノボ・ノルデイスク・エー/エス Display device for related data of diabetic patients
US20050221504A1 (en) 2004-04-01 2005-10-06 Petruno Patrick T Optoelectronic rapid diagnostic test system
US6971274B2 (en) 2004-04-02 2005-12-06 Sierra Instruments, Inc. Immersible thermal mass flow meter
US20060009727A1 (en) 2004-04-08 2006-01-12 Chf Solutions Inc. Method and apparatus for an extracorporeal control of blood glucose
US20070135697A1 (en) 2004-04-19 2007-06-14 Therasense, Inc. Method and apparatus for providing sensor guard for data monitoring and detection systems
US7324850B2 (en) 2004-04-29 2008-01-29 Cardiac Pacemakers, Inc. Method and apparatus for communication between a handheld programmer and an implantable medical device
US20050245799A1 (en) 2004-05-03 2005-11-03 Dexcom, Inc. Implantable analyte sensor
US7333013B2 (en) 2004-05-07 2008-02-19 Berger J Lee Medical implant device with RFID tag and method of identification of device
US7241266B2 (en) 2004-05-20 2007-07-10 Digital Angel Corporation Transducer for embedded bio-sensor using body energy as a power source
US7118667B2 (en) 2004-06-02 2006-10-10 Jin Po Lee Biosensors having improved sample application and uses thereof
US7289855B2 (en) 2004-06-09 2007-10-30 Medtronic, Inc. Implantable medical device package antenna
US7283867B2 (en) 2004-06-10 2007-10-16 Ndi Medical, Llc Implantable system and methods for acquisition and processing of electrical signals from muscles and/or nerves and/or central nervous system tissue
US20070100222A1 (en) 2004-06-14 2007-05-03 Metronic Minimed, Inc. Analyte sensing apparatus for hospital use
JP2006005774A (en) 2004-06-18 2006-01-05 Alps Electric Co Ltd Communication terminal device
US7565197B2 (en) 2004-06-18 2009-07-21 Medtronic, Inc. Conditional requirements for remote medical device programming
US7221977B1 (en) 2004-06-25 2007-05-22 Pacesetter, Inc. Method and apparatus for measuring battery depletion in implantable medical devices
DE102004031092A1 (en) 2004-06-28 2006-01-12 Giesecke & Devrient Gmbh transponder unit
ATE511159T1 (en) 2004-07-01 2011-06-15 Powerid Ltd BATTERY-ASSISTED BACKSCATTER RFID TRANSPONDER
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US20080242961A1 (en) 2004-07-13 2008-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US7640048B2 (en) 2004-07-13 2009-12-29 Dexcom, Inc. Analyte sensor
US7344500B2 (en) 2004-07-27 2008-03-18 Medtronic Minimed, Inc. Sensing system with auxiliary display
WO2006026741A1 (en) * 2004-08-31 2006-03-09 Lifescan Scotland Limited Wearable sensor device and system
WO2006029090A2 (en) 2004-09-02 2006-03-16 Proteus Biomedical, Inc. Methods and apparatus for tissue activation and monitoring
US7468033B2 (en) 2004-09-08 2008-12-23 Medtronic Minimed, Inc. Blood contacting sensor
EP1635508A1 (en) 2004-09-08 2006-03-15 Koninklijke Philips Electronics N.V. Secure pairing for wireless communications devices
CN101027674A (en) 2004-09-23 2007-08-29 诺和诺德公司 Device for self-care support
EP1845845B1 (en) 2004-11-02 2010-09-01 Medtronic, Inc. Techniques for user-activated data retention in an implantable medical device
US7408132B2 (en) 2004-11-08 2008-08-05 Rrc Power Solutions Gmbh Temperature sensor for power supply
US7237712B2 (en) 2004-12-01 2007-07-03 Alfred E. Mann Foundation For Scientific Research Implantable device and communication integrated circuit implementable therein
EP1669020A1 (en) * 2004-12-07 2006-06-14 Roche Diagnostics GmbH Storage case with integrated functions
ATE545361T1 (en) 2004-12-13 2012-03-15 Koninkl Philips Electronics Nv MOBILE MONITORING
US7461192B2 (en) 2004-12-15 2008-12-02 Rambus Inc. Interface for bridging out-of-band information and preventing false presence detection of terminating devices
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US7731657B2 (en) 2005-08-30 2010-06-08 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US20100331646A1 (en) 2009-06-30 2010-12-30 Abbott Diabetes Care Inc. Health Management Devices and Methods
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US20060166629A1 (en) 2005-01-24 2006-07-27 Therasense, Inc. Method and apparatus for providing EMC Class-B compliant RF transmitter for data monitoring an detection systems
US20060173260A1 (en) 2005-01-31 2006-08-03 Gmms Ltd System, device and method for diabetes treatment and monitoring
US7547281B2 (en) 2005-02-01 2009-06-16 Medtronic Minimed, Inc. Algorithm sensor augmented bolus estimator for semi-closed loop infusion system
US7545272B2 (en) * 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
KR100638727B1 (en) 2005-02-28 2006-10-30 삼성전기주식회사 Concurrent transceiver for zigbee and bluetooth
JP5086235B2 (en) 2005-03-09 2012-11-28 クティセンセ アクティーゼルスカブ Three-dimensional adhesive device with embedded microelectronic system
US20090076360A1 (en) 2007-09-13 2009-03-19 Dexcom, Inc. Transcutaneous analyte sensor
US20060202805A1 (en) 2005-03-14 2006-09-14 Alfred E. Mann Foundation For Scientific Research Wireless acquisition and monitoring system
US20070071681A1 (en) 2005-03-15 2007-03-29 Entelos, Inc. Apparatus and method for computer modeling type 1 diabetes
US7889069B2 (en) 2005-04-01 2011-02-15 Codman & Shurtleff, Inc. Wireless patient monitoring system
US8204565B2 (en) 2005-04-04 2012-06-19 University Of Iowa Research Foundation Reagentless optical analyte detection system
JP4718882B2 (en) 2005-04-08 2011-07-06 株式会社日立製作所 Sensor node
WO2006108809A1 (en) 2005-04-13 2006-10-19 Novo Nordisk A/S Medical skin mountable device and system
US7270633B1 (en) 2005-04-22 2007-09-18 Cardiac Pacemakers, Inc. Ambulatory repeater for use in automated patient care and method thereof
DE102005019306B4 (en) 2005-04-26 2011-09-01 Disetronic Licensing Ag Energy-optimized data transmission of a medical device
GB2425601B (en) 2005-04-26 2008-01-30 Bio Nano Sensium Technologies Sensor configuration
US8700157B2 (en) 2005-04-29 2014-04-15 Medtronic, Inc. Telemetry head programmer for implantable medical device and system and method
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US9233203B2 (en) 2005-05-06 2016-01-12 Medtronic Minimed, Inc. Medical needles for damping motion
US7604178B2 (en) 2005-05-11 2009-10-20 Intelleflex Corporation Smart tag activation
CA2612714C (en) 2005-05-13 2013-09-24 Trustees Of Boston University Fully automated control system for type 1 diabetes
US7541935B2 (en) 2005-05-19 2009-06-02 Proacticare Llc System and methods for monitoring caregiver performance
TWI265677B (en) * 2005-06-01 2006-11-01 Bionime Corp Coding module, bio measuring meter and system for operating bio measuring meter
US20070033074A1 (en) 2005-06-03 2007-02-08 Medtronic Minimed, Inc. Therapy management system
US20060272652A1 (en) 2005-06-03 2006-12-07 Medtronic Minimed, Inc. Virtual patient software system for educating and treating individuals with diabetes
US7387607B2 (en) 2005-06-06 2008-06-17 Intel Corporation Wireless medical sensor system
DK2260759T3 (en) 2005-06-17 2015-08-17 Hoffmann La Roche Feel and conditioning device and method for monitoring a connection, in particular glucose, in body tissue
US20070016449A1 (en) 2005-06-29 2007-01-18 Gary Cohen Flexible glucose analysis using varying time report deltas and configurable glucose target ranges
KR101136889B1 (en) 2005-07-12 2012-04-20 메사추세츠 인스티튜트 오브 테크놀로지 Wireless non-radiative energy transfer
US7413124B2 (en) 2005-07-19 2008-08-19 3M Innovative Properties Company RFID reader supporting one-touch search functionality
US20070093786A1 (en) 2005-08-16 2007-04-26 Medtronic Minimed, Inc. Watch controller for a medical device
US20070060869A1 (en) 2005-08-16 2007-03-15 Tolle Mike C V Controller device for an infusion pump
EP1758039A1 (en) 2005-08-27 2007-02-28 Roche Diagnostics GmbH Communication adaptor for portable medical or therapeutical devices
US20070053341A1 (en) 2005-09-06 2007-03-08 Lizzi Ronald S System and method for synchronizing companion electronic devices
US8298389B2 (en) 2005-09-12 2012-10-30 Abbott Diabetes Care Inc. In vitro analyte sensor, and methods
US7725148B2 (en) 2005-09-23 2010-05-25 Medtronic Minimed, Inc. Sensor with layered electrodes
US9072476B2 (en) 2005-09-23 2015-07-07 Medtronic Minimed, Inc. Flexible sensor apparatus
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US7756561B2 (en) 2005-09-30 2010-07-13 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US7701052B2 (en) 2005-10-21 2010-04-20 E. I. Du Pont De Nemours And Company Power core devices
US7782193B2 (en) 2005-10-25 2010-08-24 Cadi Scientific Pte Ltd. System for measuring and tracking at least one physiological parameter and a measuring device for doing the same
US7486977B2 (en) 2005-10-27 2009-02-03 Smiths Medical Pm, Inc. Single use pulse oximeter
US20090054747A1 (en) 2005-10-31 2009-02-26 Abbott Diabetes Care, Inc. Method and system for providing analyte sensor tester isolation
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
EP3064236B1 (en) 2005-11-08 2020-02-05 Bigfoot Biomedical, Inc. Method and system for manual and autonomous control of an infusion pump
US20070173706A1 (en) 2005-11-11 2007-07-26 Isense Corporation Method and apparatus for insertion of a sensor
WO2007062173A1 (en) 2005-11-22 2007-05-31 Vocollect Healthcare Systems, Inc. Advanced diabetes management system (adms)
US20070118030A1 (en) 2005-11-22 2007-05-24 Isense Corporation Method and apparatus for analyte data telemetry
US7963917B2 (en) 2005-12-05 2011-06-21 Echo Therapeutics, Inc. System and method for continuous non-invasive glucose monitoring
US8515518B2 (en) 2005-12-28 2013-08-20 Abbott Diabetes Care Inc. Analyte monitoring
CA2636034A1 (en) 2005-12-28 2007-10-25 Abbott Diabetes Care Inc. Medical device insertion
US8102789B2 (en) 2005-12-29 2012-01-24 Medtronic, Inc. System and method for synchronous wireless communication with a medical device
US20070173712A1 (en) 2005-12-30 2007-07-26 Medtronic Minimed, Inc. Method of and system for stabilization of sensors
US7574266B2 (en) 2006-01-19 2009-08-11 Medtronic, Inc. System and method for telemetry with an implantable medical device
US20070179349A1 (en) 2006-01-19 2007-08-02 Hoyme Kenneth P System and method for providing goal-oriented patient management based upon comparative population data analysis
US7557540B2 (en) 2006-01-23 2009-07-07 O2Micro International Ltd. Capacity measurement system for a battery with open circuit voltage detection
US7872574B2 (en) 2006-02-01 2011-01-18 Innovation Specialists, Llc Sensory enhancement systems and methods in personal electronic devices
EP3165247B1 (en) 2006-02-09 2020-10-28 DEKA Products Limited Partnership Pumping fluid delivery systems and methods using force application assembley
WO2007093981A2 (en) 2006-02-15 2007-08-23 Medingo Ltd. Systems and methods for sensing analyte and dispensing therapeutic fluid
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7826879B2 (en) 2006-02-28 2010-11-02 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7576657B2 (en) 2006-03-22 2009-08-18 Symbol Technologies, Inc. Single frequency low power RFID device
US7887682B2 (en) 2006-03-29 2011-02-15 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US8473022B2 (en) 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US7801582B2 (en) 2006-03-31 2010-09-21 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US7618369B2 (en) 2006-10-02 2009-11-17 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US9339217B2 (en) 2011-11-25 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US20070233013A1 (en) 2006-03-31 2007-10-04 Schoenberg Stephen J Covers for tissue engaging members
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
ES2336360T3 (en) 2006-04-20 2010-04-12 Lifescan Scotland Ltd METHOD FOR TRANSMITTING DATA IN A GLUCOSE SYSTEM IN BLOOD AND GLUCOSE SYSTEM IN BLOOD CORRESPONDING.
US7359837B2 (en) 2006-04-27 2008-04-15 Medtronic, Inc. Peak data retention of signal data in an implantable medical device
US20070255126A1 (en) 2006-04-28 2007-11-01 Moberg Sheldon B Data communication in networked fluid infusion systems
US20070258395A1 (en) 2006-04-28 2007-11-08 Medtronic Minimed, Inc. Wireless data communication protocols for a medical device network
US20070255125A1 (en) * 2006-04-28 2007-11-01 Moberg Sheldon B Monitor devices for networked fluid infusion systems
US8380300B2 (en) 2006-04-28 2013-02-19 Medtronic, Inc. Efficacy visualization
US20070253021A1 (en) 2006-04-28 2007-11-01 Medtronic Minimed, Inc. Identification of devices in a medical device network and wireless data communication techniques utilizing device identifiers
EP2014105B1 (en) 2006-05-02 2013-06-26 3M Innovative Properties Company A telecommunication enclosure monitoring system
GB0608829D0 (en) 2006-05-04 2006-06-14 Husheer Shamus L G In-situ measurement of physical parameters
US7496852B2 (en) 2006-05-16 2009-02-24 International Business Machines Corporation Graphically manipulating a database
DE102006023213B3 (en) 2006-05-17 2007-09-27 Siemens Ag Sensor operating method, involves detecting recording and evaluation device during order and non-order functions of monitoring device in check mode, and watching occurrence of results in mode by sensor, which automatically leaves mode
DE102006025485B4 (en) 2006-05-30 2008-03-20 Polylc Gmbh & Co. Kg Antenna arrangement and its use
US20090054749A1 (en) 2006-05-31 2009-02-26 Abbott Diabetes Care, Inc. Method and System for Providing Data Transmission in a Data Management System
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US8098159B2 (en) 2006-06-09 2012-01-17 Intelleflex Corporation RF device comparing DAC output to incoming signal for selectively performing an action
US7796038B2 (en) 2006-06-12 2010-09-14 Intelleflex Corporation RFID sensor tag with manual modes and functions
US7842174B2 (en) 2006-06-12 2010-11-30 Utah State University Electrochemical chip with miniaturized sensor array
WO2007149949A1 (en) 2006-06-20 2007-12-27 Rain Bird Corporation Sensor device for interrupting irrigation
US20070299617A1 (en) 2006-06-27 2007-12-27 Willis John P Biofouling self-compensating biosensor
US20090105560A1 (en) 2006-06-28 2009-04-23 David Solomon Lifestyle and eating advisor based on physiological and biological rhythm monitoring
US20090105571A1 (en) 2006-06-30 2009-04-23 Abbott Diabetes Care, Inc. Method and System for Providing Data Communication in Data Management Systems
US7680469B2 (en) 2006-07-06 2010-03-16 Hewlett-Packard Development Company, L.P. Electronic device power management system and method
EP2037798B1 (en) 2006-07-10 2012-10-31 Accenture Global Services Limited Mobile personal services platform for providing feedback
US7908334B2 (en) 2006-07-21 2011-03-15 Cardiac Pacemakers, Inc. System and method for addressing implantable devices
US7866026B1 (en) 2006-08-01 2011-01-11 Abbott Diabetes Care Inc. Method for making calibration-adjusted sensors
GB0616331D0 (en) 2006-08-16 2006-09-27 Innovision Res & Tech Plc Near Field RF Communicators And Near Field Communications Enabled Devices
US20090256572A1 (en) 2008-04-14 2009-10-15 Mcdowell Andrew F Tuning Low-Inductance Coils at Low Frequencies
US8758238B2 (en) 2006-08-31 2014-06-24 Health Hero Network, Inc. Health related location awareness
US7769456B2 (en) 2006-09-01 2010-08-03 Cardiac Pacemakers, Inc. Frequency-agile system for telemetry with implantable device
US20080057484A1 (en) 2006-09-05 2008-03-06 Shinichi Miyata Event-driven method for tutoring a user in the determination of an analyte in a bodily fluid sample
US20080058678A1 (en) 2006-09-05 2008-03-06 Shinichi Miyata Kit for the determination of an analyte in a bodily fluid sample that includes a meter with a display-based tutorial module
US20080071328A1 (en) 2006-09-06 2008-03-20 Medtronic, Inc. Initiating medical system communications
US9056165B2 (en) 2006-09-06 2015-06-16 Medtronic Minimed, Inc. Intelligent therapy recommendation algorithm and method of using the same
US7696941B2 (en) 2006-09-11 2010-04-13 Elster Electricity, Llc Printed circuit notch antenna
DE102006043484B4 (en) 2006-09-15 2019-11-28 Infineon Technologies Ag Fuse structure and method for producing the same
US7779332B2 (en) 2006-09-25 2010-08-17 Alfred E. Mann Foundation For Scientific Research Rotationally invariant non-coherent burst coding
CA2701006C (en) 2006-09-27 2016-07-12 University Of Connecticut Implantable biosensor and methods of use thereof
US20090312622A1 (en) 2006-09-28 2009-12-17 Werner Regittnig Device And Method For Determining A Value Of A Physiological Parameter Of A Body Fluid
US8275438B2 (en) 2006-10-04 2012-09-25 Dexcom, Inc. Analyte sensor
US7831287B2 (en) 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8449464B2 (en) 2006-10-04 2013-05-28 Dexcom, Inc. Analyte sensor
US8447376B2 (en) 2006-10-04 2013-05-21 Dexcom, Inc. Analyte sensor
US8298142B2 (en) 2006-10-04 2012-10-30 Dexcom, Inc. Analyte sensor
US8478377B2 (en) 2006-10-04 2013-07-02 Dexcom, Inc. Analyte sensor
US8562528B2 (en) 2006-10-04 2013-10-22 Dexcom, Inc. Analyte sensor
US8233456B1 (en) 2006-10-16 2012-07-31 Marvell International Ltd. Power save mechanisms for dynamic ad-hoc networks
US20080092638A1 (en) 2006-10-19 2008-04-24 Bayer Healthcare Llc Wireless analyte monitoring system
US8126728B2 (en) 2006-10-24 2012-02-28 Medapps, Inc. Systems and methods for processing and transmittal of medical data through an intermediary device
AU2007308804A1 (en) 2006-10-26 2008-05-02 Abbott Diabetes Care, Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
EP1918837A1 (en) 2006-10-31 2008-05-07 F. Hoffmann-La Roche AG Method for processing a chronological sequence of measurements of a time dependent parameter
US20080119705A1 (en) 2006-11-17 2008-05-22 Medtronic Minimed, Inc. Systems and Methods for Diabetes Management Using Consumer Electronic Devices
US20130324823A1 (en) 2006-11-20 2013-12-05 Modz Oy Measurement device, system and method
WO2008061552A1 (en) 2006-11-23 2008-05-29 Lifescan Scotland Limited Blood glucose meter capable of wireless communication
US20080139910A1 (en) 2006-12-06 2008-06-12 Metronic Minimed, Inc. Analyte sensor and method of using the same
KR100833511B1 (en) 2006-12-08 2008-05-29 한국전자통신연구원 Passive tag with volatile memory
WO2008071218A1 (en) 2006-12-14 2008-06-19 Egomedical Swiss Ag Monitoring device
US8120493B2 (en) 2006-12-20 2012-02-21 Intel Corporation Direct communication in antenna devices
US20080154513A1 (en) 2006-12-21 2008-06-26 University Of Virginia Patent Foundation Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes
US7946985B2 (en) 2006-12-29 2011-05-24 Medtronic Minimed, Inc. Method and system for providing sensor redundancy
US20080161666A1 (en) 2006-12-29 2008-07-03 Abbott Diabetes Care, Inc. Analyte devices and methods
US7999674B2 (en) 2007-01-15 2011-08-16 Deka Products Limited Partnership Device and method for food management
US8098160B2 (en) 2007-01-22 2012-01-17 Cisco Technology, Inc. Method and system for remotely provisioning and/or configuring a device
US8808515B2 (en) 2007-01-31 2014-08-19 Abbott Diabetes Care Inc. Heterocyclic nitrogen containing polymers coated analyte monitoring device and methods of use
US10154804B2 (en) 2007-01-31 2018-12-18 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
US9597019B2 (en) 2007-02-09 2017-03-21 Lifescan, Inc. Method of ensuring date and time on a test meter is accurate
CN101589578B (en) 2007-02-13 2014-06-04 Sk电信有限公司 Method for allocating an address of device in wireless personal area network (wpan) and wpan device
US20080199894A1 (en) * 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
KR101421240B1 (en) 2007-03-02 2014-07-18 삼성전자주식회사 A router and queue process method thereof
US20090093687A1 (en) 2007-03-08 2009-04-09 Telfort Valery G Systems and methods for determining a physiological condition using an acoustic monitor
US20100113897A1 (en) 2007-03-19 2010-05-06 Bayer Health Care Llc Continuous analyte monitoring assembly and methods of using the same
EP1972267A1 (en) 2007-03-20 2008-09-24 Roche Diagnostics GmbH System for in vivo measurement of an analyte concentration
US7659823B1 (en) 2007-03-20 2010-02-09 At&T Intellectual Property Ii, L.P. Tracking variable conditions using radio frequency identification
US20080234943A1 (en) 2007-03-20 2008-09-25 Pinaki Ray Computer program for diabetes management
DK1972270T3 (en) 2007-03-23 2011-01-24 Hoffmann La Roche Method and glucose monitoring system for monitoring individual metabolic response
US9029157B2 (en) 2007-04-12 2015-05-12 Nipro Diagnostics, Inc. Error detection and rejection for a diagnostic testing system
CA2683959C (en) 2007-04-14 2017-08-29 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US7768387B2 (en) 2007-04-14 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
WO2009096992A1 (en) 2007-04-14 2009-08-06 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
WO2008130896A1 (en) 2007-04-14 2008-10-30 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
CA2683930A1 (en) 2007-04-14 2008-10-23 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9008743B2 (en) 2007-04-14 2015-04-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9554721B1 (en) 2007-04-23 2017-01-31 Neurowave Systems Inc. Seizure detector, brain dysfunction monitor and method
CN101715555A (en) 2007-04-27 2010-05-26 艾伯特糖尿病护理公司 Test strip identification using conductive patterns
US8236166B2 (en) 2007-04-27 2012-08-07 Abbott Diabetes Care Inc. No calibration analyte sensors and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20080278332A1 (en) 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080281179A1 (en) 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20080281171A1 (en) 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US7996158B2 (en) 2007-05-14 2011-08-09 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en) 2007-05-14 2012-01-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8600681B2 (en) 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8239166B2 (en) 2007-05-14 2012-08-07 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080312845A1 (en) 2007-05-14 2008-12-18 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US8260558B2 (en) 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080294024A1 (en) 2007-05-24 2008-11-27 Cosentino Daniel L Glucose meter system and monitor
KR101391151B1 (en) 2007-06-01 2014-05-02 삼성전자주식회사 Method and apparatus for authenticating between clients using session key shared with server
US8072310B1 (en) 2007-06-05 2011-12-06 Pulsed Indigo Inc. System for detecting and measuring parameters of passive transponders
WO2008154312A1 (en) 2007-06-08 2008-12-18 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US20080312518A1 (en) 2007-06-14 2008-12-18 Arkal Medical, Inc On-demand analyte monitor and method of use
EP3533387A3 (en) 2007-06-21 2019-11-13 Abbott Diabetes Care, Inc. Health management devices and methods
CA2690870C (en) 2007-06-21 2017-07-11 Abbott Diabetes Care Inc. Health monitor
EP2170158B1 (en) 2007-06-27 2017-07-05 F. Hoffmann-La Roche AG Patient information input interface for a therapy system
EP2170159B8 (en) 2007-06-29 2016-09-21 Roche Diabetes Care GmbH Combination communication device and medical device for communicating wirelessly with a remote medical device
US7804197B2 (en) 2007-06-29 2010-09-28 Seiko Epson Corporation Power transmission control device, power transmission device, electronic instrument, and non-contact power transmission system
US7731658B2 (en) 2007-08-16 2010-06-08 Cardiac Pacemakers, Inc. Glycemic control monitoring using implantable medical device
US9968742B2 (en) 2007-08-29 2018-05-15 Medtronic Minimed, Inc. Combined sensor and infusion set using separated sites
US20090063402A1 (en) 2007-08-31 2009-03-05 Abbott Diabetes Care, Inc. Method and System for Providing Medication Level Determination
US9848058B2 (en) 2007-08-31 2017-12-19 Cardiac Pacemakers, Inc. Medical data transport over wireless life critical network employing dynamic communication link mapping
US8515547B2 (en) 2007-08-31 2013-08-20 Cardiac Pacemakers, Inc. Wireless patient communicator for use in a life critical network
JP5523323B2 (en) 2007-09-24 2014-06-18 バイエル・ヘルスケア・エルエルシー Analyte test sensor
DE102007047351A1 (en) 2007-10-02 2009-04-09 B. Braun Melsungen Ag System and method for monitoring and controlling blood glucose levels
US20090085768A1 (en) 2007-10-02 2009-04-02 Medtronic Minimed, Inc. Glucose sensor transceiver
US9167505B2 (en) 2007-10-08 2015-10-20 Qualcomm Incorporated Access management for wireless communication
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US8000918B2 (en) 2007-10-23 2011-08-16 Edwards Lifesciences Corporation Monitoring and compensating for temperature-related error in an electrochemical sensor
US8216138B1 (en) 2007-10-23 2012-07-10 Abbott Diabetes Care Inc. Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US20090112626A1 (en) 2007-10-30 2009-04-30 Cary Talbot Remote wireless monitoring, processing, and communication of patient data
US7783442B2 (en) 2007-10-31 2010-08-24 Medtronic Minimed, Inc. System and methods for calibrating physiological characteristic sensors
US8098201B2 (en) 2007-11-29 2012-01-17 Electronics & Telecommunications Research Institute Radio frequency identification tag and radio frequency identification tag antenna
US8103241B2 (en) 2007-12-07 2012-01-24 Roche Diagnostics Operations, Inc. Method and system for wireless device communication
JP5663310B2 (en) 2007-12-10 2015-02-04 バイエル・ヘルスケア・エルエルシーBayer HealthCareLLC Rapid charging and power management of battery-powered fluid analyte measuring devices
US9839395B2 (en) 2007-12-17 2017-12-12 Dexcom, Inc. Systems and methods for processing sensor data
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US20090164190A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Physiological condition simulation device and method
JP2011510402A (en) 2008-01-15 2011-03-31 コーニング ケーブル システムズ エルエルシー RFID system and method for automatically detecting and / or indicating the physical configuration of a complex system
DE102008008072A1 (en) 2008-01-29 2009-07-30 Balluff Gmbh sensor
US20090299155A1 (en) 2008-01-30 2009-12-03 Dexcom, Inc. Continuous cardiac marker sensor system
JP5091881B2 (en) 2008-02-20 2012-12-05 カルソニックカンセイ株式会社 Collision detection device
CA2715624A1 (en) 2008-02-20 2009-08-27 Dexcom, Inc. Continuous medicament sensor system for in vivo use
EP2252196A4 (en) 2008-02-21 2013-05-15 Dexcom Inc Systems and methods for processing, transmitting and displaying sensor data
RU2501520C2 (en) 2008-03-10 2013-12-20 Конинклейке Филипс Электроникс Н.В. System of controlling ecg with wireless connection
WO2009116906A1 (en) 2008-03-19 2009-09-24 Telefonaktiebolaget Lm Ericsson (Publ) Nfc communications for implanted medical data acquisition devices
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US20090242399A1 (en) 2008-03-25 2009-10-01 Dexcom, Inc. Analyte sensor
US20090247855A1 (en) 2008-03-28 2009-10-01 Dexcom, Inc. Polymer membranes for continuous analyte sensors
NO2260423T3 (en) 2008-04-04 2018-07-28
EP2982383B1 (en) 2008-04-10 2019-05-15 Abbott Diabetes Care, Inc. Method for sterilizing an analyte sensor
WO2009125421A1 (en) 2008-04-11 2009-10-15 Indian Institute Of Science A sub-threshold capfet sensor for sensing analyte, a method and system thereof
US20090267765A1 (en) 2008-04-29 2009-10-29 Jack Greene Rfid to prevent reprocessing
US8102021B2 (en) 2008-05-12 2012-01-24 Sychip Inc. RF devices
CA2724446C (en) 2008-05-14 2017-04-04 Espenusa Holding, Llc Physical activity monitor and data collection unit
WO2009143289A2 (en) 2008-05-20 2009-11-26 Deka Products Limited Partnership Rfid system
US9356473B2 (en) 2008-05-28 2016-05-31 Georgia Tech Research Corporation Systems and methods for providing wireless power to a portable unit
US20090294277A1 (en) 2008-05-30 2009-12-03 Abbott Diabetes Care, Inc. Method and system for producing thin film biosensors
US7826382B2 (en) 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8394637B2 (en) 2008-06-02 2013-03-12 Roche Diagnostics Operations, Inc. Handheld analyzer for testing a sample
US8132037B2 (en) 2008-06-06 2012-03-06 Roche Diagnostics International Ag Apparatus and method for processing wirelessly communicated data and clock information within an electronic device
US8117481B2 (en) 2008-06-06 2012-02-14 Roche Diagnostics International Ag Apparatus and method for processing wirelessly communicated information within an electronic device
CN101621714B (en) 2008-06-30 2013-06-12 华为技术有限公司 Node and data processing system and data processing method
WO2010005806A2 (en) 2008-07-09 2010-01-14 Cardiac Pacemakers, Inc. Event-based battery monitor for implantable devices
US8876755B2 (en) 2008-07-14 2014-11-04 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US20100025238A1 (en) 2008-07-31 2010-02-04 Medtronic Minimed, Inc. Analyte sensor apparatuses having improved electrode configurations and methods for making and using them
US8111042B2 (en) 2008-08-05 2012-02-07 Broadcom Corporation Integrated wireless resonant power charging and communication channel
US8432070B2 (en) 2008-08-25 2013-04-30 Qualcomm Incorporated Passive receivers for wireless power transmission
US8094009B2 (en) 2008-08-27 2012-01-10 The Invention Science Fund I, Llc Health-related signaling via wearable items
US8102154B2 (en) 2008-09-04 2012-01-24 Medtronic Minimed, Inc. Energy source isolation and protection circuit for an electronic device
CA3132517A1 (en) 2008-09-15 2010-03-18 Deka Products Limited Partnership Systems and methods for fluid delivery
US20100095229A1 (en) 2008-09-18 2010-04-15 Abbott Diabetes Care, Inc. Graphical user interface for glucose monitoring system
EP2326944B1 (en) 2008-09-19 2020-08-19 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US8983568B2 (en) 2008-09-30 2015-03-17 Abbott Diabetes Care Inc. Analyte sensors comprising leveling agents
KR20110081250A (en) 2008-10-02 2011-07-13 레이덴 에너지 인코오포레이티드 Electronic current interrupt device for battery
US8649997B2 (en) 2008-10-03 2014-02-11 Bayer Healthcare Llc Systems and methods for predicting ambient temperature in a fluid analyte meter
CN102197304B (en) 2008-11-04 2013-08-28 松下电器产业株式会社 Measurement device, insulin infusion device, measurement method, method for controlling insulin infusion device, and program
US8098161B2 (en) 2008-12-01 2012-01-17 Raytheon Company Radio frequency identification inlay with improved readability
US8150516B2 (en) 2008-12-11 2012-04-03 Pacesetter, Inc. Systems and methods for operating an implantable device for medical procedures
US20100169035A1 (en) 2008-12-29 2010-07-01 Medtronic Minimed, Inc. Methods and systems for observing sensor parameters
US9320470B2 (en) 2008-12-31 2016-04-26 Medtronic Minimed, Inc. Method and/or system for sensor artifact filtering
US8974439B2 (en) 2009-01-02 2015-03-10 Asante Solutions, Inc. Infusion pump system and methods
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
CN102308278A (en) 2009-02-04 2012-01-04 雅培糖尿病护理公司 Multi-function analyte test device and methods therefor
US8394246B2 (en) 2009-02-23 2013-03-12 Roche Diagnostics Operations, Inc. System and method for the electrochemical measurement of an analyte employing a remote sensor
US20100213057A1 (en) 2009-02-26 2010-08-26 Benjamin Feldman Self-Powered Analyte Sensor
US9446194B2 (en) 2009-03-27 2016-09-20 Dexcom, Inc. Methods and systems for promoting glucose management
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
EP2424426B1 (en) 2009-04-29 2020-01-08 Abbott Diabetes Care, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
EP2432393A2 (en) 2009-05-22 2012-03-28 Abbott Diabetes Care, Inc. Method and system for reducing false hypoglycemia alarm occurrence
EP2438527B1 (en) 2009-06-04 2018-05-02 Abbott Diabetes Care, Inc. Method and system for updating a medical device
US8124452B2 (en) 2009-06-14 2012-02-28 Terepac Corporation Processes and structures for IC fabrication
KR101334538B1 (en) 2009-06-17 2013-11-28 비덱스 에이/에스 Method of initializing a binaural hearing aid system and a hearing aid
EP2448469B1 (en) 2009-06-30 2021-07-21 Lifescan, Inc. Analyte testing methods and device for calculating basal insulin therapy
US9792408B2 (en) 2009-07-02 2017-10-17 Covidien Lp Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures
WO2011022418A2 (en) 2009-08-17 2011-02-24 The Regents Of The University Of California Distributed external and internal wireless sensor systems for characterization of surface and subsurface biomedical structure and condition
AU2010286917B2 (en) 2009-08-31 2016-03-10 Abbott Diabetes Care Inc. Medical devices and methods
EP2473098A4 (en) 2009-08-31 2014-04-09 Abbott Diabetes Care Inc Analyte signal processing device and methods
EP2473099A4 (en) 2009-08-31 2015-01-14 Abbott Diabetes Care Inc Analyte monitoring system and methods for managing power and noise
ES2912584T3 (en) 2009-08-31 2022-05-26 Abbott Diabetes Care Inc A glucose monitoring system and method
WO2011026130A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Inserter device including rotor subassembly
US8093991B2 (en) 2009-09-16 2012-01-10 Greatbatch Ltd. RFID detection and identification system for implantable medical devices
WO2011041449A1 (en) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Sensor inserter having introducer
WO2011044386A1 (en) 2009-10-07 2011-04-14 Abbott Diabetes Care Inc. Sensor inserter assembly having rotatable trigger
US20110270112A1 (en) 2009-11-02 2011-11-03 Applied Cardiac Systems, Inc. Multi-Function Health Monitor
US8478389B1 (en) 2010-04-23 2013-07-02 VivaQuant, LLC System for processing physiological data
US9331772B2 (en) 2009-11-13 2016-05-03 Koninklijke Philips N.V. Quick re-connect diversity radio system for communicating patient data out of a shielded MR room
KR101414103B1 (en) 2009-12-08 2014-07-02 엘지디스플레이 주식회사 Transparent liquid crystal display device
US9949672B2 (en) 2009-12-17 2018-04-24 Ascensia Diabetes Care Holdings Ag Apparatus, systems and methods for determining and displaying pre-event and post-event analyte concentration levels
US20110184268A1 (en) 2010-01-22 2011-07-28 Abbott Diabetes Care Inc. Method, Device and System for Providing Analyte Sensor Calibration
CA2766947A1 (en) 2010-04-16 2011-10-20 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9198623B2 (en) 2010-04-22 2015-12-01 Abbott Diabetes Care Inc. Devices, systems, and methods related to analyte monitoring and management
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
WO2012010298A1 (en) 2010-07-23 2012-01-26 Roche Diagnostics Gmbh System and method considering the effect of physical activity on the glucoregulatory system
EP2624745A4 (en) 2010-10-07 2018-05-23 Abbott Diabetes Care, Inc. Analyte monitoring devices and methods
US8849459B2 (en) 2010-10-15 2014-09-30 Roche Diagnostics Operations, Inc. Power management system for a handheld medical device
ES2755497T3 (en) 2010-10-31 2020-04-22 Univ Boston Blood glucose monitoring system
US8608921B2 (en) 2011-01-20 2013-12-17 Medtronic Minimed, Inc. Layered enzyme compositions for use with analyte sensors
US20140088392A1 (en) 2011-02-11 2014-03-27 Abbott Diabetes Care Inc. Feedback from Cloud or HCP to Payer or Patient via Meter or Cell Phone
EP3583901A3 (en) 2011-02-28 2020-01-15 Abbott Diabetes Care, Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
DK2685895T3 (en) 2011-03-17 2019-01-21 Univ Newcastle System for self-monitoring and regulation of blood glucose
WO2013022775A1 (en) 2011-08-05 2013-02-14 Dexcom, Inc. Systems and methods for detecting glucose level data patterns
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US20130235166A1 (en) 2012-03-07 2013-09-12 Cambridge Silicon Radio Limited Synchronisation method
US10327714B2 (en) 2012-03-29 2019-06-25 Senseonics, Incorporated Analyte concentration alert function for analyte sensor system
US20150326072A1 (en) 2014-05-07 2015-11-12 Energous Corporation Boost-Charger-Boost System for Enhanced Power Delivery
US9211092B2 (en) 2013-01-03 2015-12-15 Dexcom, Inc. End of life detection for analyte sensors
US20170053552A1 (en) 2015-08-21 2017-02-23 Medtronic Minimed, Inc. Management and prioritization of the delivery of glycemic insight messages

Patent Citations (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4245634A (en) * 1975-01-22 1981-01-20 Hospital For Sick Children Artificial beta cell
US4373527A (en) * 1979-04-27 1983-02-15 The Johns Hopkins University Implantable, programmable medication infusion system
US4373527B1 (en) * 1979-04-27 1995-06-27 Univ Johns Hopkins Implantable programmable medication infusion system
US4425920A (en) * 1980-10-24 1984-01-17 Purdue Research Foundation Apparatus and method for measurement and control of blood pressure
US4494950A (en) * 1982-01-19 1985-01-22 The Johns Hopkins University Plural module medication delivery system
US5279294A (en) * 1985-04-08 1994-01-18 Cascade Medical, Inc. Medical diagnostic system
US4890620A (en) * 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US4995402A (en) * 1988-10-12 1991-02-26 Thorne, Smith, Astill Technologies, Inc. Medical droplet whole blood and like monitoring
US5379238A (en) * 1989-03-03 1995-01-03 Stark; Edward W. Signal processing method and apparatus
US4986271A (en) * 1989-07-19 1991-01-22 The University Of New Mexico Vivo refillable glucose sensor
US5082550A (en) * 1989-12-11 1992-01-21 The United States Of America As Represented By The Department Of Energy Enzyme electrochemical sensor electrode and method of making it
US6514718B2 (en) * 1991-03-04 2003-02-04 Therasense, Inc. Subcutaneous glucose electrode
US5285792A (en) * 1992-01-10 1994-02-15 Physio-Control Corporation System for producing prioritized alarm messages in a medical instrument
US5711001A (en) * 1992-05-08 1998-01-20 Motorola, Inc. Method and circuit for acquisition by a radio receiver
US5489414A (en) * 1993-04-23 1996-02-06 Boehringer Mannheim, Gmbh System for analyzing compounds contained in liquid samples
US5593852A (en) * 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5711861A (en) * 1995-11-22 1998-01-27 Ward; W. Kenneth Device for monitoring changes in analyte concentration
US6032064A (en) * 1996-10-11 2000-02-29 Aspect Medical Systems, Inc. Electrode array system for measuring electrophysiological signals
US6997907B2 (en) * 1997-02-05 2006-02-14 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US7335294B2 (en) * 1997-02-06 2008-02-26 Abbott Diabetes Care, Inc. Integrated lancing and measurement device and analyte measuring methods
US20080017522A1 (en) * 1997-02-06 2008-01-24 Therasense, Inc. Integrated Lancing and Measurement Device
US20040011671A1 (en) * 1997-03-04 2004-01-22 Dexcom, Inc. Device and method for determining analyte levels
US20030036145A1 (en) * 1997-09-18 2003-02-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7003340B2 (en) * 1998-03-04 2006-02-21 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US6024699A (en) * 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6990366B2 (en) * 1998-04-30 2006-01-24 Therasense, Inc. Analyte monitoring device and methods of use
US7003341B2 (en) * 1998-04-30 2006-02-21 Abbott Diabetes Care, Inc. Analyte monitoring devices and methods of use
US20020019022A1 (en) * 1998-09-30 2002-02-14 Cygnus, Inc. Method and device for predicting physiological values
US6689056B1 (en) * 1999-04-07 2004-02-10 Medtronic Endonetics, Inc. Implantable monitoring probe
US20050010269A1 (en) * 2000-01-21 2005-01-13 Medical Research Group, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US7171274B2 (en) * 2000-01-21 2007-01-30 Medtronic Minimed, Inc. Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data
US6687546B2 (en) * 2000-01-21 2004-02-03 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a robust communication protocol
US6694191B2 (en) * 2000-01-21 2004-02-17 Medtronic Minimed, Inc. Ambulatory medical apparatus and method having telemetry modifiable control software
US7003336B2 (en) * 2000-02-10 2006-02-21 Medtronic Minimed, Inc. Analyte sensor method of making the same
US20050004439A1 (en) * 2000-02-23 2005-01-06 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US20050027177A1 (en) * 2000-02-23 2005-02-03 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US6695860B1 (en) * 2000-11-13 2004-02-24 Isense Corp. Transcutaneous sensor insertion device
US20060029177A1 (en) * 2001-01-16 2006-02-09 International Business Machines Corporation Unified digital architecture
US20050004494A1 (en) * 2001-01-22 2005-01-06 Perez Edward P. Lancet device having capillary action
US20080029391A1 (en) * 2001-05-15 2008-02-07 Abbott Diabetes Care, Inc. Biosensor Membranes Composed of Polymers Containing Heterocyclic Nitrogens
US20030004403A1 (en) * 2001-06-29 2003-01-02 Darrel Drinan Gateway platform for biological monitoring and delivery of therapeutic compounds
US20030032874A1 (en) * 2001-07-27 2003-02-13 Dexcom, Inc. Sensor head for use with implantable devices
US20030023317A1 (en) * 2001-07-27 2003-01-30 Dexcom, Inc. Membrane for use with implantable devices
US20030039298A1 (en) * 2001-08-22 2003-02-27 Lear Corporation System and method of vehicle climate control
US7476827B1 (en) * 2001-08-29 2009-01-13 Roche Diagnostics Operations, Inc. Method of making a biosensor
US20050038332A1 (en) * 2001-12-27 2005-02-17 Frank Saidara System for monitoring physiological characteristics
US6998247B2 (en) * 2002-03-08 2006-02-14 Sensys Medical, Inc. Method and apparatus using alternative site glucose determinations to calibrate and maintain noninvasive and implantable analyzers
US6743635B2 (en) * 2002-04-25 2004-06-01 Home Diagnostics, Inc. System and methods for blood glucose sensing
US20040010207A1 (en) * 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
US20040073266A1 (en) * 2002-10-15 2004-04-15 Haefner Paul A. Automatic detection of defibrillation lead
US20050031689A1 (en) * 2003-05-21 2005-02-10 Dexcom, Inc. Biointerface membranes incorporating bioactive agents
US20080033254A1 (en) * 2003-07-25 2008-02-07 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US20080021666A1 (en) * 2003-08-01 2008-01-24 Dexcom, Inc. System and methods for processing analyte sensor data
US20090012379A1 (en) * 2003-08-01 2009-01-08 Dexcom, Inc. System and methods for processing analyte sensor data
US20050043598A1 (en) * 2003-08-22 2005-02-24 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20070016381A1 (en) * 2003-08-22 2007-01-18 Apurv Kamath Systems and methods for processing analyte sensor data
US20080045824A1 (en) * 2003-10-28 2008-02-21 Dexcom, Inc. Silicone composition for biocompatible membrane
US20100016698A1 (en) * 2003-11-19 2010-01-21 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US20100010324A1 (en) * 2003-12-09 2010-01-14 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090036758A1 (en) * 2003-12-09 2009-02-05 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090043182A1 (en) * 2003-12-09 2009-02-12 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090043181A1 (en) * 2003-12-09 2009-02-12 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100010332A1 (en) * 2003-12-09 2010-01-14 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100010331A1 (en) * 2003-12-09 2010-01-14 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100016687A1 (en) * 2003-12-09 2010-01-21 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100022855A1 (en) * 2003-12-09 2010-01-28 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090030294A1 (en) * 2004-05-03 2009-01-29 Dexcom, Inc. Implantable analyte sensor
US20060004270A1 (en) * 2004-06-23 2006-01-05 Michel Bedard Method and apparatus for the monitoring of clinical states
US20060001538A1 (en) * 2004-06-30 2006-01-05 Ulrich Kraft Methods of monitoring the concentration of an analyte
US20060015020A1 (en) * 2004-07-06 2006-01-19 Dexcom, Inc. Systems and methods for manufacture of an analyte-measuring device including a membrane system
US20060016700A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060020187A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060015024A1 (en) * 2004-07-13 2006-01-19 Mark Brister Transcutaneous medical device with variable stiffness
US20060036142A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
US20060036139A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
US20060020191A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060036140A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
US20060036141A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
US20060020192A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060020189A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060036143A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
US20060036144A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
US20060019327A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060020186A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060020190A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20090036763A1 (en) * 2004-07-13 2009-02-05 Dexcom, Inc. Analyte sensor
US20060020188A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060031094A1 (en) * 2004-08-06 2006-02-09 Medtronic Minimed, Inc. Medical data management system and process
US7651596B2 (en) * 2005-04-08 2010-01-26 Dexcom, Inc. Cellulosic-based interference domain for an analyte sensor
US20070027381A1 (en) * 2005-07-29 2007-02-01 Therasense, Inc. Inserter and methods of use
US20080009692A1 (en) * 2005-09-30 2008-01-10 Abbott Diabetes Care, Inc. Method and Apparatus for Providing Analyte Sensor and Data Processing Device
US20090018425A1 (en) * 2005-12-28 2009-01-15 Tianmei Ouyang Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US20080039702A1 (en) * 2006-08-09 2008-02-14 Abbott Diabetes Care, Inc. Method and System for Providing Calibration of an Analyte Sensor in an Analyte Monitoring System
US20090018424A1 (en) * 2006-10-04 2009-01-15 Dexcom, Inc. Analyte sensor
US20090006034A1 (en) * 2007-05-14 2009-01-01 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090005665A1 (en) * 2007-05-14 2009-01-01 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090033482A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090036747A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090036760A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system

Cited By (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210268174A1 (en) * 2007-09-06 2021-09-02 Bigfoot Biomedical, Inc. Operating a portable medical device
WO2011000527A3 (en) * 2009-06-29 2011-11-24 Roche Diagnostics Gmbh Modular diabetes management systems
US20100331651A1 (en) * 2009-06-29 2010-12-30 Roche Diagnostics Operations, Inc. Blood glucose management and interface systems and methods
US9218453B2 (en) 2009-06-29 2015-12-22 Roche Diabetes Care, Inc. Blood glucose management and interface systems and methods
US20100331652A1 (en) * 2009-06-29 2010-12-30 Roche Diagnostics Operations, Inc. Modular diabetes management systems
US8101065B2 (en) 2009-12-30 2012-01-24 Lifescan, Inc. Systems, devices, and methods for improving accuracy of biosensors using fill time
US8623198B2 (en) 2009-12-30 2014-01-07 Lifescan, Inc. Systems, devices, and methods for improving accuracy of biosensors using fill time
US8877034B2 (en) 2009-12-30 2014-11-04 Lifescan, Inc. Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity
US9927388B2 (en) 2009-12-30 2018-03-27 Lifescan, Inc. Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity
US20110155585A1 (en) * 2009-12-30 2011-06-30 Lifescan, Inc. Systems, Devices, and Methods for Improving Accuracy of Biosensors Using Fill Time
US20110155584A1 (en) * 2009-12-30 2011-06-30 Lifescan, Inc. Systems, Devices, and Methods for Measuring Whole Blood Hematocrit Based on Initial Fill Velocity
US9404888B2 (en) 2009-12-30 2016-08-02 Lifescan, Inc. Systems, devices and methods for improving accuracy of biosensors using fill time
WO2011112974A1 (en) * 2010-03-11 2011-09-15 University Of Virginia Patent Foundation Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes
US11069434B2 (en) 2010-03-11 2021-07-20 University Of Virginia Patent Foundation Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes
US8932445B2 (en) 2010-09-30 2015-01-13 Cilag Gmbh International Systems and methods for improved stability of electrochemical sensors
US9575027B2 (en) 2010-09-30 2017-02-21 Cilag Gmbh International Systems and methods of discriminating between a control sample and a test fluid using capacitance
US9575026B2 (en) 2010-09-30 2017-02-21 Cilag Gmbh International Systems and methods of discriminating between a control sample and a test fluid using capacitance
US9347910B2 (en) 2010-09-30 2016-05-24 Cilag Gmbh International Systems and methods for improved stability of electrochemical sensors
US8617370B2 (en) 2010-09-30 2013-12-31 Cilag Gmbh International Systems and methods of discriminating between a control sample and a test fluid using capacitance
US10151724B2 (en) 2010-09-30 2018-12-11 Lifescan Ip Holdings, Llc Systems and methods of discriminating between a control sample and a test fluid using capacitance
US11109757B2 (en) 2012-12-31 2021-09-07 Dexcom, Inc. Remote monitoring of analyte measurements
US10993617B2 (en) 2012-12-31 2021-05-04 Dexcom, Inc. Remote monitoring of analyte measurements
US11850020B2 (en) 2012-12-31 2023-12-26 Dexcom, Inc. Remote monitoring of analyte measurements
US11744463B2 (en) 2012-12-31 2023-09-05 Dexcom, Inc. Remote monitoring of analyte measurements
US11382508B2 (en) 2012-12-31 2022-07-12 Dexcom, Inc. Remote monitoring of analyte measurements
US11213204B2 (en) 2012-12-31 2022-01-04 Dexcom, Inc. Remote monitoring of analyte measurements
US11160452B2 (en) 2012-12-31 2021-11-02 Dexcom, Inc. Remote monitoring of analyte measurements
US10869599B2 (en) 2012-12-31 2020-12-22 Dexcom, Inc. Remote monitoring of analyte measurements
US10856736B2 (en) 2012-12-31 2020-12-08 Dexcom, Inc. Remote monitoring of analyte measurements
US10860687B2 (en) 2012-12-31 2020-12-08 Dexcom, Inc. Remote monitoring of analyte measurements
US9681807B2 (en) 2013-03-14 2017-06-20 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US11677443B1 (en) 2013-03-14 2023-06-13 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US9788354B2 (en) 2013-03-14 2017-10-10 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US9931037B2 (en) 2013-03-14 2018-04-03 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US9931036B2 (en) 2013-03-14 2018-04-03 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US9445445B2 (en) 2013-03-14 2016-09-13 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US10985804B2 (en) 2013-03-14 2021-04-20 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US11330058B2 (en) 2014-01-13 2022-05-10 Carefusion 303, Inc. Remote flashing during infusion
US20180356386A1 (en) * 2015-05-01 2018-12-13 Ahkeo Labs, Llc Systems and methods for dipstick diagnostic tools and related methods
US11275070B2 (en) * 2015-05-01 2022-03-15 Ahkeo Labs, Llc Systems and methods for dipstick diagnostic tools and related methods
US11399721B2 (en) 2015-12-28 2022-08-02 Dexcom, Inc. Systems and methods for remote and host monitoring communications
US10932672B2 (en) 2015-12-28 2021-03-02 Dexcom, Inc. Systems and methods for remote and host monitoring communications
US10293101B2 (en) 2016-01-14 2019-05-21 Bigfoot Biomedical, Inc. Diabetes management system
US10758670B2 (en) 2016-01-14 2020-09-01 Bigfoot Biomedical, Inc. Diabetes management system
WO2017124099A1 (en) * 2016-01-14 2017-07-20 Bigfoot Biomedical, Inc. Diabetes management system
US11147915B2 (en) 2016-01-14 2021-10-19 Bigfoot Biomedical, Inc. Diabetes management system
US10699539B2 (en) 2016-02-16 2020-06-30 Above the Fold, LLC Systems for tracking medications
US11776675B2 (en) 2016-02-16 2023-10-03 Above the Fold, LLC Systems for tracking medications
US10163311B2 (en) 2016-02-16 2018-12-25 Above the Fold, LLP Systems for tracking medications
US10980451B2 (en) 2016-03-31 2021-04-20 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US10980450B2 (en) 2016-03-31 2021-04-20 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US10980453B2 (en) 2016-03-31 2021-04-20 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US10881335B2 (en) 2016-03-31 2021-01-05 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US11452881B2 (en) 2019-01-03 2022-09-27 Avive Solutions, Inc. Defibrillator communications architecture
US11534618B2 (en) 2019-01-03 2022-12-27 Avive Solutions, Inc. Defibrillator communications architecture
US11077312B2 (en) * 2019-01-03 2021-08-03 Avive Solutions, Inc. Defibrillator communications architecture
US11839770B2 (en) 2019-01-03 2023-12-12 Avive Solutions, Inc. Defibrillator communications architecture
CN109669042A (en) * 2019-03-01 2019-04-23 青岛大学附属医院 A kind of division of endocrinology's diabetes fast testing apparatus

Also Published As

Publication number Publication date
WO2008101217A2 (en) 2008-08-21
US10617823B2 (en) 2020-04-14
BRPI0807500A2 (en) 2014-05-06
US20180311435A1 (en) 2018-11-01
WO2008101217A3 (en) 2008-11-27
US20150352283A1 (en) 2015-12-10
US10022499B2 (en) 2018-07-17
EP2124720A2 (en) 2009-12-02
RU2009134335A (en) 2011-03-20
EP2124720A4 (en) 2011-06-22
CA2677739A1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
US10617823B2 (en) Device and method for automatic data acquisition and/or detection
US8676601B2 (en) Device and method for automatic data acquisition and/or detection
US20080004601A1 (en) Analyte Monitoring and Therapy Management System and Methods Therefor
US11806110B2 (en) Method and system for providing data management in integrated analyte monitoring and infusion system
US10448834B2 (en) Smart messages and alerts for an infusion delivery and management system
US20190175119A1 (en) Method and system for providing integrated analyte monitoring and infusion system therapy management

Legal Events

Date Code Title Description
AS Assignment

Owner name: ABBOTT DIABETES CARE, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GALASSO, JOHN R.;REEL/FRAME:020809/0900

Effective date: 20080327

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION